{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/sundarg4/Covid/blob/main/biomarkers_finetuning.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Fine tune LLMs with pregenerated prompt as jsonl files"
      ],
      "metadata": {
        "id": "n6vNUxq0_BU1"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Setup the GDrive and install dependencies in colab environment"
      ],
      "metadata": {
        "id": "fAPm2VRd-06x"
      }
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "aIxMLJZGg6Me",
        "outputId": "6305359f-98a7-4608-d462-4a9f49d1863a"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"
          ]
        }
      ],
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "MPpqdH5pwEJu",
        "outputId": "32787046-95a3-421a-9529-6897d6a6d269"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "  Installing build dependencies ... \u001b[?25l\u001b[?25hdone\n",
            "  Getting requirements to build wheel ... \u001b[?25l\u001b[?25hdone\n",
            "  Preparing metadata (pyproject.toml) ... \u001b[?25l\u001b[?25hdone\n",
            "  Building wheel for transformers (pyproject.toml) ... \u001b[?25l\u001b[?25hdone\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m521.2/521.2 kB\u001b[0m \u001b[31m8.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m115.3/115.3 kB\u001b[0m \u001b[31m8.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m134.8/134.8 kB\u001b[0m \u001b[31m10.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m174.7/174.7 kB\u001b[0m \u001b[31m4.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m261.4/261.4 kB\u001b[0m \u001b[31m9.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m92.6/92.6 MB\u001b[0m \u001b[31m19.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m133.9/133.9 kB\u001b[0m \u001b[31m3.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m100.8/100.8 kB\u001b[0m \u001b[31m8.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.1/2.1 MB\u001b[0m \u001b[31m15.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m190.6/190.6 kB\u001b[0m \u001b[31m21.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m251.7/251.7 kB\u001b[0m \u001b[31m306.9 kB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m62.7/62.7 kB\u001b[0m \u001b[31m8.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h"
          ]
        }
      ],
      "source": [
        "!pip install -q torch\n",
        "!pip install -q git+https://github.com/huggingface/transformers #huggingface transformers for downloading models weights\n",
        "!pip install -q datasets #huggingface datasets to download and manipulate datasets\n",
        "!pip install -q peft #Parameter efficient finetuning - for qLora Finetuning\n",
        "!pip install -q bitsandbytes #For Model weights quantisation\n",
        "!pip install -q trl #Transformer Reinforcement Learning - For Finetuning using Supervised Fine-tuning\n",
        "!pip install -q wandb -U #Used to monitor the model score during training"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "qYrJM6U9ygFq",
        "outputId": "e2509a0b-8eac-4a83-eecf-565063f8e0ab"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/trl/trainer/ppo_config.py:141: UserWarning: The `optimize_cuda_cache` arguement will be deprecated soon, please use `optimize_device_cache` instead.\n",
            "  warnings.warn(\n"
          ]
        }
      ],
      "source": [
        "import json\n",
        "import re\n",
        "from pprint import pprint\n",
        "\n",
        "import pandas as pd\n",
        "import torch\n",
        "from datasets import Dataset, load_dataset\n",
        "from huggingface_hub import notebook_login\n",
        "from peft import LoraConfig, PeftModel\n",
        "from transformers import (\n",
        "    AutoModelForCausalLM,\n",
        "    AutoTokenizer,\n",
        "    BitsAndBytesConfig,\n",
        "    TrainingArguments,\n",
        "    pipeline,\n",
        "    logging,\n",
        ")\n",
        "from trl import SFTTrainer # For supervised finetuning"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### EXECUTE THE BELOW CODE when A UTF-8 locale required error in notebook\n",
        ": A UTF-8 locale is required. Got ANSI_X3.4-1968"
      ],
      "metadata": {
        "id": "5av0-MzdjEr8"
      }
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "xHc1qCNIE1bA"
      },
      "outputs": [],
      "source": [
        "# execute only when NotImplementedError: A UTF-8 locale is required. Got ANSI_X3.4-1968\n",
        "##import locale\n",
        "#locale.getpreferredencoding = lambda: \"UTF-8\""
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Import Train Dataset"
      ],
      "metadata": {
        "id": "_mUPBB1XIipF"
      }
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000,
          "referenced_widgets": [
            "8fa943c95bc74a06af42e7734aa8f559",
            "de23f9411f444ac38459a2aa6b11ee80",
            "24e668b07f234ed384d36210d672755f",
            "d89f3f8b9f664c97bfaf1da535578a63",
            "f4090a57f4d24189b8869a7137a91c72",
            "4b1300419470471fb3c4b5d124f48952",
            "c6266c0d21d748328d6fe2034808a027",
            "95c6d852e4f84021bee40890976e2661",
            "84b798b9778d4f22af64c7d4f34afc62",
            "2df473cdaae8489f9fe3feb94d5e7d5b",
            "b5a5b8a4c94d4f768d12bd30f50dabf4",
            "1a5c729aaf4444aa89c0364a2184070b",
            "19cc823392a341ff85f360f61f9e7949",
            "5dadccaae49144248129d6e26fc3aabe",
            "84670b0536354265a3db98329c997db3",
            "6b3c4c4ef4b5423ebfd5f4dfe45b1329",
            "d9717187cb2a4bcc97bdd75c8679d347",
            "3b43f3ea893f47879dd33c2e18e27fa1",
            "16640ea12c1d49ab992dd899dd474ae7",
            "8701c3ace8a74c0dbf918f296c768442",
            "f68dd2b4f6b14b22b5dbaeab6b0294ba",
            "3ce6d5a376694cd29e129dff73446ef4",
            "e89bf173756c418792c39233edbd5e78",
            "1bae0da705a7454887f9534b3526e086",
            "1dedd1aa882e460cba71b9622d000d25",
            "c63018c0409146cc818df5d691b7859e",
            "d5c96f4e5ece4557b7d2c208cb2b3d08",
            "5e65177d60b648ccadc305a2da72beee",
            "00112f25d5fe4ca684eba34e237e4899",
            "56c4e0fa6b7a434bbb78ac5f46fcaba1",
            "b816f484672f4f52b2992a9ce32973a1",
            "1cb935f5100c4fe59ca1b89123398e6b",
            "a823ba6d27c9463e973d9556ccda9217"
          ]
        },
        "id": "jqIfhdnQin-C",
        "outputId": "11114506-4f7d-40b9-c366-ec9e4dabd137"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "mkdir: cannot create directory ‘/content/data’: File exists\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading data files:   0%|          | 0/1 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "8fa943c95bc74a06af42e7734aa8f559"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Extracting data files:   0%|          | 0/1 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "1a5c729aaf4444aa89c0364a2184070b"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Generating train split: 0 examples [00:00, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "e89bf173756c418792c39233edbd5e78"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\u001b[1;30;43mStreaming output truncated to the last 5000 lines.\u001b[0m\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. The ovarian tumors have to be either estrogen receptor or progesterone receptor positive.\n",
            " \n",
            " BIOMARKER = progesterone receptor positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase I/IIa, First-in-human (FIH), Open-label, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of CLDN6 CAR-T With or Without CLDN6 RNA-LPX in Patients With CLDN6-positive Relapsed or Refractory Advanced Solid Tumors;\n",
            "INCLUSION_CRITERIA: * Each patient enrolled in the trial must have CLDN6-positive tumor regardless of tumor histology defined as ≥ 50% of tumor cells expressing ≥ 2+ CLDN6 protein using a semi-quantitative immunohistochemistry (IHC) assay in a central laboratory for specific detection of CLDN6 protein expression in formalin-fixed, paraffin-embedded (FFPE) neoplastic tissues. * Women of childbearing potential (WOCBP) must have a negative serum (beta-human chorionic gonadotropin) test/value at screening. Patients who are post-menopausal or permanently sterilized can be considered as not having reproductive potential.\n",
            "EXCLUSION_CRITERIA: * Has an active autoimmune disease including but not limited to inflammatory bowel disease, systemic lupus erythematosus, ankylosing spondylitis, scleroderma, or multiple sclerosis. Has any active immunologic disorder requiring immunosuppression with steroids or other immunosuppressive agents with the exception of patients with isolated vitiligo, resolved childhood asthma or atopic dermatitis, controlled hypoadrenalism or hypopituitarism, and euthyroid patients with a history of Grave's disease. Patients with controlled hyperthyroidism must be negative for thyroglobulin, thyroid peroxidase antibodies, and thyroid-stimulating immunoglobulin prior to trial drug administration.\n",
            " \n",
            " BIOMARKER = thyroglobulin negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC;\n",
            "TITLE: A Phase III, Open-Label, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC.\n",
            "INCLUSION_CRITERIA: 4. The patient's tumor tissue or blood sample test result meets 1 of the following two criteria: a. Previous tumor tissue or blood samples are confirmed as RET fusion positive by local laboratory testing. b. If there is no previous RET fusion positive test report, a compliant tumor tissue or blood sample is required to be provided at the central laboratory, using a next-generation sequencing (NGS)-based assay to confirm RET fusion positive.\n",
            "EXCLUSION_CRITERIA: 1. Patients carried known major driver genetic alterations other than RET. e.g. EGFR, MET, ALK, ROS1, NTRK, BRAF V600, KRAS G12C, etc. (If a patient has a co-mutation, discuss with the investigators whether enrollment is possible).\n",
            " \n",
            " BIOMARKER = RET genetic alterations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors;\n",
            "TITLE: A Phase 1, Multicenter, Open-Label, Dose Escalation and Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Intravenously Administered FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors;\n",
            "INCLUSION_CRITERIA: 2. Subject must have a diagnosis of SS or a SMARCB1-loss tumor:    - Evidence of the SS18-SSX rearrangement and/or a confirmed pathologic diagnosis of SS must be available.    • SMARCB1-loss tumor:    * A solid tumor primarily characterized by SMARCB1 loss (eg, malignant rhabdoid tumors, epithelioid sarcoma, poorly differentiated chordoma) Documentation of biallelic SMARCB1 alterations and/or corresponding protein loss, and/or a confirmed pathologic diagnosis of a solid tumor primarily characterized by SMARCB1 loss, must be available.    * Other solid tumors with SMARCB1 loss. Documentation of biallelic SMARCB1 alterations and/or corresponding protein loss must be available.\n",
            "EXCLUSION_CRITERIA: 2. Subject has other malignancy which may interfere with the diagnosis and/or treatment of SS/SMARCB1-loss tumors and/or interpretation of outcome results. 4. Subject has active hepatitis B virus (HBV) or hepatitis C virus (HCV) infections; subjects with a sustained viral response to HCV treatment or immunity to prior HBV infection will be permitted. Subject has known positive human immunodeficiency virus (HIV) antibody results or acquired immunodeficiency syndrome (AIDS)-related illness; subjects with CD4+ T-cell counts ≥ 350 cells/µL will be permitted, as will subjects who have not had an AIDS-related illness within the past 12 months.\n",
            " \n",
            " BIOMARKER = SMARCB1 loss, SMARCB1 Loss, INI1 loss \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer;\n",
            "TITLE: A Phase Ib Study of Osimertinib (AZD9291) and Telaglenastat (CB-839) HCl in Patients With EGFR Mutant Non-Small Cell Lung Cancer;\n",
            "INCLUSION_CRITERIA: * Activating mutation present in the EGFR gene (L858R or exon 19 deletion, alone or in combination with other EGFR mutations) as per local assessment of a tissue biopsy/cytology specimen. The tissue biopsy must have been obtained since the time of disease progression on most recent targeted therapy. Liquid biopsies (i.e. blood based) biopsies cannot be used for eligibility determination;\n",
            " \n",
            " BIOMARKER = EGFR exon 19 deletion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial);\n",
            "TITLE: A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY);\n",
            "INCLUSION_CRITERIA: * Participants must have documentation of NSCLC with a MET exon 14 skipping mutation determined by tissue-based or blood-based (circulating tumor DNA [ctDNA]) next generation sequencing (NGS) assay done within a laboratory with Clinical Laboratory Improvement Act (CLIA), International Organization for Standardization (ISO)/ International Electrotechnical Commission (IEC), College of American Pathologists (CAP), or similar certification. Documentation must either be:   * Submitted documentation in the LUNGMAP Rave Electronic Data Capture System of a MET exon 14 skipping mutation from a previously completed tissue or blood-based NGS test NOTE: Participants previously tested for and determined to have a MET exon 14 skipping mutation, outside of LUNGMAP, must also submit tissue for central Foundation Medicine (FMI) testing on the LUNGMAP screening protocol, if available; * Participants must not have other known actionable oncogenic alterations, such as (but not limited to) EGFR sensitizing mutations, EGFR T790M mutation, ALK gene fusion, ROS1 gene rearrangement, RET gene rearrangement, NTRK rearrangement, HER2 mutation, KRAS activating mutations, and BRAF V600E mutation;\n",
            " \n",
            " BIOMARKER = EGFR sensitizing mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer;\n",
            "INCLUSION_CRITERIA: * Histologically confirmed, treatment naïve, metastatic squamous or non-squamous NSCLC with documented high PD-L1 expression, with no epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) genomic tumor aberrations.\n",
            " \n",
            " BIOMARKER = EGFR tumor aberrations, epidermal growth factor receptor tumor aberrations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Liver metastatic MSS-mCRC or NSCLC without EGFR or AKT mutations;\n",
            " \n",
            " BIOMARKER = EGFR mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients with metastatic breast cancer for which no standard therapy exists will be recruited for this study; more specifically, for patients with hormone receptor positive/human epidermal growth factor receptor 2 (Her2) negative disease, this includes previous therapy with tamoxifen or an aromatase inhibitor and one line of chemotherapy in the metastatic setting; for patients with Her2 positive disease, this includes 2 lines of Her2 directed therapy in the metastatic setting; and for patients with triple negative disease, this includes one line of chemotherapy in the metastatic setting; once we have identified the dose of [14C]oxaliplatin, we will only recruit triple negative breast cancer patients that progressed after one line of chemotherapy in the metastatic setting;\n",
            " \n",
            " BIOMARKER = triple negative triple negative, Her2 negative, human epidermal growth factor receptor 2 negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Documentation of activating FGFR3 mutation or gene fusion on an assay performed in a CLIA-certified laboratory.\n",
            " \n",
            " BIOMARKER = FGFR3 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Central and/or local testing of EGFR with no EGFR exon 19 deletion or EGFR L858 R mutation (applicable to non-squamous patients only); * Central and/or local testing of ALK with no ALK rearrangement (failed testing is considered negative) (applicable to non-squamous patients only);\n",
            " \n",
            " BIOMARKER = EGFR exon 19 deletion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer;\n",
            "TITLE: Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC);\n",
            "INCLUSION_CRITERIA: * Patient must have somatic activating sensitizing mutation in EGFR (e.g. but not limited to Exon 19 deletion, L858R, E709X, G719X, exon 19 insertions, L861Q, S768I). Patients with non-sensitizing mutations in EGFR (EGFR exon 20 insertions) are not eligible. Test results originating from a Clinical Laboratory Improvement Act (CLIA)-certified or similarly accredited laboratory are acceptable; no specific assay is mandated. Plasma, cytology, or tumor tissue can be utilized for mutation testing;\n",
            " \n",
            " BIOMARKER = EGFR G719X \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 4. Pathologically confirmed non-small cell lung cancer (NSCLC) with documented EGFR sensitive mutation (EGFR 19del and L858R) positive before Osimertinib 1L.\n",
            " \n",
            " BIOMARKER = EGFR 19del \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * HER2 negative (positive HER2 status is defined by a positive IHC test of 3+ or IHC of 2+ with positive FISH);\n",
            "EXCLUSION_CRITERIA: * Known DPD deficiency;\n",
            " \n",
            " BIOMARKER = DPD deficiency \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    * High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (HGBCL);    * Mantle cell lymphoma (MCL) (pathologically confirmed, with documentation of monoclonal B cells that have a chromosome translocation t(11;14)(q13;q32) and/or overexpress cyclin D1);    * Anti-CD20 monoclonal antibody (unless investigator determines that tumor is CD20-negative) and;    * Anti-CD20 monoclonal antibody (unless investigator determines that tumor is CD20-negative) and; 5. CD19 positive (detected by immunohistochemistry [IHC]).\n",
            " \n",
            " BIOMARKER = BCL2 rearrangements \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    (I) Histologically confirmed Triple Negative Breast Cancer by Institutional and American Society of Clinical Oncology (ASCO)/Cancer of American Pathologists (CAP) guidelines, either:\n",
            " \n",
            " BIOMARKER = Triple Negative Triple Negative, triple negative triple negative, TNBC TNBC, Triple negative Triple negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Known to have a germline mutation that predisposes them to an increased risk of breast cancer (e.g. BRCA1/2) and/or they are considered at high risk for contralateral breast cancer on the basis of a strong family history of cancer;\n",
            " \n",
            " BIOMARKER = BRCA1/2 germline mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Arm 2 (colorectal/appendiceal): Known dihydropyrimidine dehydrogenase deficiency (DPD) deficiency;\n",
            " \n",
            " BIOMARKER = dihydropyrimidine dehydrogenase deficiency \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase II Study of the BRAF Inhibitor Encorafenib in Combination With the MEK Inhibitor Binimetinib in Patients With BRAFV600E-mutant Metastatic Non-small Cell Lung Cancer;\n",
            "INCLUSION_CRITERIA: 6. Presence of a BRAFV600E mutation in lung cancer tissue as determined by a local laboratory assay. 7. The Investigator must confirm prior to enrolment that the patient has adequate tumor tissue available to determine BRAFV600E mutation status by central laboratory for confirmation.\n",
            "EXCLUSION_CRITERIA: 1. Patients with nonsquamous carcinoma who have documentation of any of the following: EGFR mutation, ALK fusion oncogene or ROS1 rearrangement.\n",
            " \n",
            " BIOMARKER = ROS1 rearrangement \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Known human epidermal growth factor receptor 2 (HER2) positive;\n",
            " \n",
            " BIOMARKER = human epidermal growth factor receptor 2 positive, HER2 positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase I Trial of Low-Dose Cyclophosphamide in Combination With Veliparib (ABT-888) in HER2/Neu-Negative Metastatic Breast Cancer;\n",
            "INCLUSION_CRITERIA: * Phase I: Patients must have histologically confirmed breast cancer (metastatic breast cancer [MBC]) that is human epidermal growth factor receptor 2 (HER2/neu) negative (as determined by local pathology or reference laboratory), and have disease that is metastatic (stage IV [TxNxM1]) or locally advanced and not amenable to potentially curative surgical resection (eg, clinical stage IIIB-C); * HER2/neu negative disease (performed on primary tumor and/or metastatic lesion using commercially available/approved assay in local institutional or reference laboratory), according to American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines; * National Comprehensive Cancer Network (NCCN) guidelines recommend for metastatic breast cancer ...biopsy documentation of first recurrence, if possible, and determination of hormone receptor status (estrogen receptor [ER] and progesterone receptor [PR]) and HER2 status....; therefore, histologic and/or cytologic confirmation of metastatic disease is encouraged whenever feasible, but not required; in some circumstances, histologic confirmation may not be feasible (eg, bone metastases not amenable to biopsy and elevated cancer antigen [CA]27-29 tumor marker); for patients who have had histologic confirmation of metastatic disease, it is required that the biopsy confirm that the metastatic tumor is ER and/or PR positive, and HER2/neu negative; for patients in whom biopsy confirmation of metastatic disease is not feasible, it is required that the primary tumor be ER and/or PR-positive and HER2/neu negative; * Phase I: Patients must have received at least one prior chemotherapy regimen for metastatic disease; patients with deleterious germ line mutations in breast cancer (BRCA)1 or BRCA2 are not required to have received prior chemotherapy for metastatic disease;\n",
            " \n",
            " BIOMARKER = BRCA2 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase II Study of the BRAF Inhibitor Encorafenib in Combination With the MEK Inhibitor Binimetinib in Patients With BRAFV600E-mutant Metastatic Non-small Cell Lung Cancer;\n",
            "INCLUSION_CRITERIA: 6. Presence of a BRAFV600E mutation in lung cancer tissue as determined by a local laboratory assay. 7. The Investigator must confirm prior to enrolment that the patient has adequate tumor tissue available to determine BRAFV600E mutation status by central laboratory for confirmation.\n",
            "EXCLUSION_CRITERIA: 1. Patients with nonsquamous carcinoma who have documentation of any of the following: EGFR mutation, ALK fusion oncogene or ROS1 rearrangement.\n",
            " \n",
            " BIOMARKER = ROS1 rearrangement \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors;\n",
            "TITLE: PREDIX Luminal A - Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors. Part of a Platform of Translational Phase II Trials Based on Molecular Subtypes;\n",
            "INCLUSION_CRITERIA: 3. Tumor and blood samples available. Luminal A type confirmed by immunohistochemistry with ER and PR positive ≥50% and the proliferation marker Ki 67 <20% and not HER2 amplified;\n",
            " \n",
            " BIOMARKER = ER positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Patients in Cohort 1 must have (i) a germline or somatic mutation in BRCA1 or BRCA2; and (ii) must have received PARPi monotherapy or PARPi combination-therapy as their immediate prior therapy;   * Patients in Cohort 2 must have: (i) a germline or somatic mutation in any of the following deoxyribonucleic acid (DNA) damage response (DDR) genes: BARD1; FANCA; BRIP1; PALB2; RAD51; RAD51C; RAD51D, with no evidence of mutations in BRCA1 or BRCA2; and (ii) must have received PARPi monotherapy or PARPi combination therapy as the immediate prior therapy;   * Patients in Cohort 3 must be (i) patients who have had PR/CR on prior PARPi monotherapy or PARPi combination treatment; (ii) patients with no evidence of BRCA1 or BRCA2 mutations or any of the relevant DDR aberrations listed in cohort 2; and (iii) patients with no intervening therapy following prior PARP inhibitor-based treatment. Patients with ovarian cancer should not have progressed on platinum-therapy within six months of therapy;   * Patients in Cohort 4 must have KRAS mutated advanced solid tumors. Prior treatments with KRAS inhibitors are permitted. Patients with KRAS G12C mutations must have already had KRAS G12C targeted therapy (e.g., sotorasib) previously;\n",
            " \n",
            " BIOMARKER = KRAS G12C \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 2.18-75 years old on the day of signing the ICF. 3.Locally advanced/metastatic non-small cell lung cancer diagnosed by histology or cytology. no epidermal growth factor receptor (EGFR) sensitive mutations, anaplastic lymphoma kinase (ALK) gene rearrangement, ROS Proto-oncogene 1 (ROS1) gene fusion.\n",
            " \n",
            " BIOMARKER = epidermal growth factor receptor sensitive mutations, EGFR sensitive mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Pathogenic somatic mutation detected in genes encoding tyrosine kinase receptors (CSFR1, ERBB3 or ALK), RAS or RAF (may be from original or subsequent biopsy or peripheral blood/bone marrow aspirate). Clinical mutation reports may include quantitative polymerase chain reaction (PCR) (e.g. BRAFV600E) and/or Sanger or next generation sequencing. Immunohistochemistry (e.g. VE1 antibody for BRAFV600E) alone is not sufficient;\n",
            "EXCLUSION_CRITERIA: * Patients with activating mutations in MAP2K1 are not eligible for this study due to drug target specificity. Mutation status will be submitted to study team within 7 days of enrollment;\n",
            " \n",
            " BIOMARKER = ERBB3 somatic mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Patient with mutation in a known predisposition gene (NF-2, SMARCE-1).\n",
            " \n",
            " BIOMARKER = SMARCE-1 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair;\n",
            "TITLE: Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair;\n",
            "INCLUSION_CRITERIA: * Presence of deficient (d) DNA mismatch repair (dMMR); MMR status must be assessed by immunohistochemistry (IHC) for MMR protein expression (MLH1, MSH2, MSH6, PMS2) where loss of one or more proteins indicates dMMR; dMMR may be determined either locally or by site-selected reference lab; Note: loss of MLH1 and PMS2 commonly occur together; formalin-fixed paraffin-embedded (FFPE) tumor tissue is required for subsequent retrospective central confirmation of dMMR status; * Patients who are known to have Lynch syndrome, have been found to carry a specific germline mutation in an MMR gene (MLH1, MSH2, MSH6, PMS2), and have been shown to be dMMR by IHC are eligible to participate;\n",
            "EXCLUSION_CRITERIA: * Patients with testing that did not show dMMR (loss of MMR protein) are not eligible to participate; patients whose tumors show MSI-H by PCR-based assay are not eligible to participate unless they also have MMR testing by IHC and are found to have dMMR (i.e. loss of one or more MMR proteins);\n",
            " \n",
            " BIOMARKER = MSH6 germline mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer;\n",
            "TITLE: A Phase 1B Study of AZD9291 in Combination With Navitoclax in EGFR-Mutant Non-Small Cell Lung Cancer Following Resistance to Initial EGFR Kinase Inhibitor;\n",
            "INCLUSION_CRITERIA: * Prior genotyping positive for an EGFR activating mutation (L858R, exon 19 deletion, G719X, L861Q); * Adequate archival tissue from a biopsy performed after progression of disease on previous EGFR TKI; or willing to undergo a new tumor biopsy prior to registration (for the dose escalation portion only this requirement can be waived if T790M status has already been determined using a local assay); * For the dose expansion portion only, patient must: 1) have a tumor which is EGFR-T790M positive and 2) be treatment naive to T790M-directed EGFR TKI (e.g. AZD9291, rociletinib, etc); T790M testing may be done locally or centrally on study, but if done locally, tissue must be available for central confirmation;\n",
            " \n",
            " BIOMARKER = EGFR L858R \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations;\n",
            "TITLE: A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations;\n",
            "INCLUSION_CRITERIA: 1. Documented genetic ALK, ROS1, or NTRK1-3 alteration (point mutation, fusion, amplification) as identified by local testing in a Clinical Laboratory Improvement Amendments (CLIA) laboratory in the US or equivalently accredited diagnostic lab outside the United States (US) is required.    * Cohort 1: Subjects with NTRK fusion gene positive (NTRK+) advanced solid tumors (including primary CNS tumors), that are tropomyosin receptor kinase (TRK) TKI naïve;    * Cohort 2: subjects with NTRK+ advanced solid tumors (including primary CNS tumors), that are TRK TKI pre-treated;    * Cohort 3: subjects with tumors or ALCL characterized by other ALK/ROS1/NTRK alterations or NTRK fusions without centrally confirmed measurable disease or not otherwise eligible for Cohort 1 or 2.\n",
            " \n",
            " BIOMARKER = NTRK1-3 fusion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer;\n",
            "TITLE: Multicenter Prospective Randomized Clinical Trial of Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer;\n",
            "INCLUSION_CRITERIA: * Histopathological diagnosis of rectal adenocarcinoma; tumor biopsy immunohistochemistry showed pMMR, that is, MSH1, MSH2, MSH6 and PMS2 four proteins are positive, or genetic testing suggests MSI-L or MSS.\n",
            " \n",
            " BIOMARKER = MSH6 positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 6. Germline BRCA mutation status:    * Cohorts A and B: Patients with unknown BRCA status or negative BRCA germline mutation status will be permitted to enroll in the study. Patients with known BRCA germline mutations will be permitted to enroll up to a maximum of 10 subjects per cohort.    * Cohort C and Cohort D Part II: All subjects must have either a germline or somatic BRCA mutation, or other HRD mutation, or tumor is HRD positive. Other HRD mutations will be reviewed for consideration for enrollment by study review committee or University of Pennsylvania principal investigator.    * Cohort D Part I: Patients will be enrolled irrespective of BRCA status.\n",
            " \n",
            " BIOMARKER = BRCA mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations;\n",
            "INCLUSION_CRITERIA:     * NSCLC with uncommon EGFR mutation (eg, G719X) following standard-of-care therapy with an EGFR inhibitor.     * NSCLC with acquired resistance EGFR mutation (eg, C797S), following a 3rd generation EGFR inhibitor in the 1st line setting (in the absence of concurrent T790M).     * NSCLC with intrinsic resistance EGFR mutation (eg, L858R, G719X) with up to 2 lines of standard-of-care therapy with an EGFR inhibitor.     * NSCLC with acquired resistance EGFR mutation (eg, C797S) with up to 2 lines of therapy, the first line of which must be a 3rd generation EGFR inhibitor (in the absence of concurrent T790M). • Identification of one (or more) EGFR mutations identified in the absence of other known resistance mutations: * Intrinsic resistance EGFR mutations [eg, L858R [dose expansion only], G719X). * EGFR acquired resistance mutation (eg, C797S) to a 3rd generation EGFR inhibitor. * Tumor evidence of EGFR alterations including variants, or mutations with or without amplifications (eg, A289T/V, G598V, S645C).\n",
            " \n",
            " BIOMARKER = EGFR A289T/V \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study;\n",
            "INCLUSION_CRITERIA: 6. Invasive breast cancer is estrogen receptor positive with an Allred score of 6, 7 or 8 by local institution standard protocol. If an Allred Score is not reported on the diagnostic pathology report, ER positivity in > 66% cells is eligible. If ER positivity is ≤ 66%, the staining intensity (weak, intermediate, strong) is needed to calculate the Allred Score to determine eligibility. 7. Invasive breast cancer is Human Epidermal Growth Factor Receptor 2 (HER2)- A patient is considered to have HER2 negative breast cancer if one of the following applies:\n",
            "EXCLUSION_CRITERIA: 5. Tumor estrogen receptor (ER) Allred score between 0-5 or HER2 positive by IHC (3+) or amplified by FISH > 2.0.\n",
            " \n",
            " BIOMARKER = HER2 positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase I/Ib Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias Harboring KMT2A, NPM1, or Nucleoporin Gene Alterations;\n",
            "INCLUSION_CRITERIA: * Acute leukemia harboring histone-lysine N-methyltransferase 2A (KMT2A) or nucleophosmin 1 gene (NPM1) or nucleoporin (NUP98 or NUP214) alterations;\n",
            " \n",
            " BIOMARKER = KMT2A Alterations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations;\n",
            "TITLE: A Multicenter, Randomized, Controlled, Double Blind, Double Simulated, Phase III Clinical Study of Befotertinib vs Icotinib for Postoperative Adjuvant Treatment of IB-IIIB (T3N2M0) Stage Non Small Cell Lung Cancer With Positive EGFR Sensitive Mutations;\n",
            "INCLUSION_CRITERIA: 6. Confirmation by the central laboratory that the tumor harbors one of the 2 common EGFR mutations known to be associated with EGFR-TKI sensitivity (Ex19del, L858R).\n",
            " \n",
            " BIOMARKER = EGFR L858R \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    Note: there is no minimum B7-H3 expression level mandatory for entry into the study.     * Has received prior treatment with platinum-based chemotherapy regimen and/or anti-PD-1/PD-L1 antibody-based regimen in the advanced/unresectable, or metastatic setting unless unable or unwilling. Participants with NSCLC known to harbor a genomic alteration(s) other than EGFR mutation(s) (e.g., ALK rearrangement, ROS1 rearrangement, KRAS G12C mutation, BRAF V600E mutation, NTRK1/2/3 Gene fusion, MET Exon 14 skipping, RET rearrangement etc.) for which treatment is available must have also received prior treatment with at least 1 genotype-directed therapy.     * If participants with BRAF gene mutant melanoma, must have had a prior treatment regimen that included vemurafenib, dabrafenib, or another BRAF gene and/or mitogen-activated protein kinase (MEK) protein inhibitor.\n",
            " \n",
            " BIOMARKER = KRAS mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Part 1 only: Advanced recurrent or refractory solid tumors with potential SEZ6 expression including small cell lung cancer (SCLC), high-grade central nervous system (CNS) tumors (glioblastoma [GBM], IDH-wildtype Grade 4; oligodendroglioma, IDH-mutant, and 1p/19q-codeleted Grade 3; astrocytoma, IDH-mutant Grade 3 or Grade 4), neuroendocrine prostate cancer (NEPC), high-grade poorly differentiated gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC)s, large cell neuroendocrine carcinoma (LCNEC)s, SCLC transformed from epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), atypical lung carcinoids, and other high-grade poorly differentiated NECs, who have progressed on or after standard of care (SoC) therapy and with no curative therapy available. For SCLC, participants must have histologically or cytologically confirmed SCLC that is relapsed or refractory following at least 1 prior platinum-containing chemotherapy. * Part 3a only: Participants with R/R SCLC following at least 1 prior platinum-containing chemotherapy or R/R poorly differentiated NECs, e.g., NEPC, GEP-NECs, LCNECs, SCLC transformed from EGFR mutant Non-small cell lung cancer (NSCLC), atypical lung carcinoids, other high-grade poorly differentiated NECs. * Part 3b only: Participants with R/R SCLC who have only progressed following a frontline regimen containing a platinum-based chemotherapy or R/R NECs, e.g., NEPC, GEP-NECs, LCNECs, SCLC transformed from EGFR mutant NSCLC, atypical lung carcinoids, other NECs. * Part 4a only: Participants with R/R high-grade CNS tumors (GBM, IDH-wildtype Grade 4; oligodendroglioma, IDH-mutant, and 1p/19q-codeleted Grade 3; astrocytoma, IDH-mutant Grade 3 or Grade 4) who have progressed on SoC therapy and with no curative therapy options available. * Part 4b only: Participants with R/R neuroendocrine tumors, including NEPC, GEP-NECs, LCNECs, SCLC transformed from EGFR mutant NSCLC, atypical lung carcinoids, and other high-grade poorly differentiated NECs, who have progressed on SoC therapy and with no curative therapy options available. * Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 for participants with extracranial solid tumors or Response Assessment for Neuro-Oncology (RANO)for participants with primary high-grade CNS tumors (GBM, IDH-wildtype Grade 4; oligodendroglioma, IDH-mutant, and 1p/19q-codeleted Grade 3; astrocytoma, IDH-mutant Grade 3 or Grade 4). * Fresh or archival tumor tissue available for submission, for retrospective SEZ6 expression analysis as outlined in the protocol.\n",
            " \n",
            " BIOMARKER = IDH mutant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases;\n",
            "TITLE: A Phase II Trial of Osimertinib (AZD9291) With or Without Bevacizumab in Patients With EGFR Mutation Positive NSCLC and Brain Metastases;\n",
            "INCLUSION_CRITERIA: * Non-small cell lung cancer (NSCLC) with an activating EGFR mutation (exon 19 deletion, L858R point mutation, or any other mutation known to be associated with EGFR TKI sensitivity); presence of an activating EGFR mutation may be documented in tumor tissue or by plasma testing if performed in a Clinical Laboratory Improvement Act (CLIA)-certified laboratory;\n",
            " \n",
            " BIOMARKER = EGFR exon 19 deletion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Randomized, Open-Label, Phase 3 Study to Evaluate Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer With No Epidermal Growth Factor Receptor or Anaplastic Lymphoma Kinase Genomic Tumor Aberrations;\n",
            "INCLUSION_CRITERIA:   * Have documented negative test results for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutations. * Have no actionable genomic alterations such as ROS proto-oncogene 1 (ROS1), neurotrophic tyrosine receptor kinase (NTRK), proto-oncogene B-raf (BRAF), RET mutations, or other driver oncogenes with approved frontline therapies.\n",
            " \n",
            " BIOMARKER = ALK mutations, anaplastic lymphoma kinase mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Women scheduled for unilateral or bilateral mastectomy for breast cancer therapy, pathology confirmed stage 0-III (including ductal carcinoma in situ), or prophylaxis (BRCA1/2 mutation carriers, women with strong family history or lobular carcinoma in situ or other conditions where prophylactic mastectomy has been elected);\n",
            "EXCLUSION_CRITERIA: * Endometrial intraepithelial neoplasia (also known as atypical hyperplasia) or a high risk of uterine cancer, defined here as known carriers of Lynch syndrome mutations (MLH1, MSH2, MSH6, PMS2);\n",
            " \n",
            " BIOMARKER = PMS2 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 2. Other causes of chronic liver disease (HBV, HCV, HDV, HEV, HIV), autoimmune diseases or chronic cholestatic liver disease, drug induced liver injury, hereditary haemochromatosis, Wilson disease, α-1-Antitrypsin deficiency;\n",
            " \n",
            " BIOMARKER = α-1-Antitrypsin deficiency \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Known driver mutations such as EGFR, ALK, ROS1, RET, METex14, and NTRK alterations.\n",
            " \n",
            " BIOMARKER = ROS1 alterations, ROS1 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 6. Progression during previous treatment with another BTK inhibitor, and/or presence of known mutations associated with resistance to therapy, e.g. Bruton´s Tyrosine Kinase (BTK) and Phospholipase C Gamma 2 (PLCg2);\n",
            " \n",
            " BIOMARKER = BTK mutations, Bruton´s Tyrosine Kinase mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Written pathology report indicating the diagnosis of DDLPS with positive mouse double minute 2 homolog (MDM2) immunohistochemistry or MDM2 amplification as demonstrated by fluorescence in situ hybridization or next generation sequencing (NGS) must be available.\n",
            "EXCLUSION_CRITERIA: * Known mutation in the TP53 gene (screening for TP53 status is not required).\n",
            " \n",
            " BIOMARKER = MDM2 amplification \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Non-small cell lung cancer (NSCLC), which is known to be PD-L1-positive, with no actionable genomic alteration for which approved therapy exists, after having received immune checkpoint inhibitor at any stage of their prior therapy;   * Head and neck squamous cell carcinoma or cervical cancer, which is known to be PD-L1-positive, after having received immune checkpoint inhibitor at any stage of their prior therapy;   * Colorectal cancer with low level microsatellite instability (MSI-low);\n",
            "EXCLUSION_CRITERIA: * Participants with unknown PD-L1 status for the following tumor types: NSCLC, head and neck squamous cell carcinoma, or cervical cancer; * Participants with known negative PD-L1 status;\n",
            " \n",
            " BIOMARKER = PD-L1 negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase 1 Study of the Polymerase Theta (POLQ) Inhibitor Novobiocin in BRCA-Mutant and Other DNA Damage Repair-Deficient Solid Tumors;\n",
            "INCLUSION_CRITERIA: * Patients must have histologically confirmed solid tumor with a known pathogenic mutation in BRCA1/2, PALB2, RAD51C, RAD51D, ATM, BARD1, BLM, BRIP1, CDK12, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCM, MRE11A, NBN (NBS1), RAD50 and RAD51B as confirmed by a Clinical Laboratory Improvement Amendments (CLIA)-certified method. Patients with alterations defined only by germline testing are eligible;\n",
            " \n",
            " BIOMARKER = FANCM mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Must not have germline BRCA1 or BRCA2 mutation.\n",
            " \n",
            " BIOMARKER = BRCA2 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:       * Poor risk molecular features including but not limited to presence of FLT3 internal tandem duplication mutation.       * Poor risk cytogenetics: Philadelphia Chromosome, t(4;11), KMT2A translocation, t(8;14), complex karyotype (⩾ 5 chromosomal abnormalities) and low hypodiploidy (30-39 chromosomes)/near triploidy (60-78 chromosomes);    i. Poor-risk cytogenetics (including but not limited to 7/7q minus or complex cytogenetics) ii. IPSS score of INT-2 or greater iii. Treatment-related or Secondary MDS iv. MDS diagnosed before age 21 years v. Progression on or lack of response to standard DNA-methyltransferase inhibitor therapy vi. Life-threatening cytopenias, including those generally requiring greater than weekly transfusions vii. Poor risk molecular features including but not limited to the presence of BCOR, ASXL1, p53 or RUNX1 mutations e. Mixed lineage and biphenotypic leukemia;\n",
            " \n",
            " BIOMARKER = BCOR mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations;\n",
            "TITLE: A Phase I/II Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations;\n",
            "INCLUSION_CRITERIA: * IDH1 or IDH2 mutation status confirmed by TSO500 performed in LP, NCI;\n",
            " \n",
            " BIOMARKER = IDH1/2 mutation status, IDH2 mutation status \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   3. After completion of Dose level 3, subjects will need to demonstrate a defect in one or more DDR genes such as: ATM (including ATM protein loss by IHC), ATRX, ARID1A, BARD1, BRCA1, BRCA2, BRIP1, CDK12, CHEK2, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCM, MRE11A, MSH2, NBN, PALB2, RAD51, RAD51B, RAD51C, RAD51D, or other related genes at the discretion of the investigator in consultation with sponsor Medical Monitor; Or mutations in p53 pathway/MYC pathway.\n",
            " \n",
            " BIOMARKER = RAD51D defect \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy;\n",
            "TITLE: Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-Hydroxyglutarate (2-HG) Using MR Spectroscopy;\n",
            "INCLUSION_CRITERIA: * Patients must have histologically confirmed glioma with IDH1 or IDH2 mutation confirmed by DNA sequencing. * Age greater than or equal to18 years. Tumor biology of IDH-mutant gliomas are different in pediatric tumors. Therefore, children will be excluded from the study.\n",
            " \n",
            " BIOMARKER = IDH1 mutation, IDH 1 or 2 mutation, IDH1 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation;\n",
            "TITLE: The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome;\n",
            "INCLUSION_CRITERIA: * Patients must have a documented IDH1 or IDH2 mutation within 30 days of inclusion based on mutational testing. Only specific mutations that lead to a neomorphic phenotype will be eligible for enrollment, and include those listed below:   * IDH1: R132V, R132G, R132S, R132L, R132C and R132H;   * IDH2: R140W, R140L, R140Q, R172W, R172G, R172S, R172M, R172K.\n",
            "EXCLUSION_CRITERIA: * Management of treatment for patients with co-occurring mutations, like FLT3, will be prioritized by the treating physician after discussion of treatment options with the patient.\n",
            " \n",
            " BIOMARKER = IDH1 mutation, IDH1/2 mutation, IDH1/2 mutant, IDH1/2 variation, IDH1 mutant, IDH1/2 variant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Diagnosed with ER+ breast cancer; * CONTROL SUBJECTS: Newly diagnosed ER+ breast cancer patients of the same age group as above on TAM for 0-6 months. This criterion is based on our preliminary results showing that patients taking TAM for 6-7 months exhibit near baseline level of NETs;\n",
            "EXCLUSION_CRITERIA: * History of severe congenital neutropenia due to genetic disorders, such as Kostmann Disorder (HAX1 gene mutation), ELA2 gene mutation, Wiskott-Aldrich syndrome (WAS), growth factor independent 1 protein (GFI1) gene mutation, colony stimulating factor 3 receptor (CSF3R) gene mutation, Schwachman-Diamond syndrome, Barth syndrome, warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome, and Chadiak-Higashi syndrome (this list notably does not include myelodysplastic syndrome, or acute/chronic myeloid leukemia);\n",
            " \n",
            " BIOMARKER = ELA2 gene mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer;\n",
            "TITLE: A Phase III, Single-Arm Multicenter Study of Atezolizumab (Anti-PD-L1 Antibody) in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer;\n",
            "EXCLUSION_CRITERIA: * Known sensitizing mutation in the EGFR gene or ALK fusion oncogene.\n",
            " \n",
            " BIOMARKER = EGFR sensitizing mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Known tumor programmed death-ligand 1 (PD-L1) status;\n",
            "EXCLUSION_CRITERIA: * Mutations in epidermal growth factor receptor (EGFR) gene or anaplastic lymphoma kinase (ALK) fusion oncogene; * Known targetable c-ROS oncogene 1 (ROS1) or BRAFV600E genomic aberration.\n",
            " \n",
            " BIOMARKER = anaplastic lymphoma kinase fusion, ALK fusion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Participant with identified mutation in Kirsten rat sarcoma viral oncogene (KRAS), neuroblastoma RAS viral oncogene homolog (NRAS), v-raf murine sarcoma viral oncogene homolog B (BRAF), or epidermal growth factor receptor (EGFR) ectodomain, or ERBB2/HER2 amplification by central circulating tumor deoxyribonucleic acid (ctDNA) testing at screening;\n",
            " \n",
            " BIOMARKER = v-raf murine sarcoma viral oncogene homolog B mutation, BRAF mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    Approximately 20 evaluable patients will be included with FLT-3 ITD AML and approximately 10 evaluable patients with FLT-3 wild type AML, both confirmed by local laboratories within 28 days prior to dosing;\n",
            " \n",
            " BIOMARKER = FLT-3 wild type \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * For non-small cell lung cancer participants only: pathogenic somatic mutations or gene fusions in the following genes: EGFR, ALK, ROS1, NTRK, BRAF V600E and KRAS;\n",
            " \n",
            " BIOMARKER = ALK somatic mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * With brain metastasis, BRAF-V600E mutation, HER-2 overexpression, MSI-H, NTRK fusion gene patients;\n",
            " \n",
            " BIOMARKER = BRAF V600E \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions);\n",
            "TITLE: An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements;\n",
            "INCLUSION_CRITERIA: * Histologically- or cytologically-confirmed diagnosis of locally advanced or metastatic solid tumor that harbors an NTRK1/2/3, ROS1, or ALK gene rearrangement;   - Note: prior treatment with crizotinib is permitted only in ALK- or ROS1-rearranged NSCLC patients presenting with CNS-only progression. Other ALK inhibitors are prohibited.\n",
            "EXCLUSION_CRITERIA:   - Note: prior treatment with crizotinib is permitted only in ALK- or ROS1-rearranged NSCLC patients presenting with CNS-only progression. Other ALK inhibitors are prohibited.\n",
            " \n",
            " BIOMARKER = ROS1 rearrangement, ROS1 Rearrangements, ROS1 rearranged \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status;\n",
            "TITLE: Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status;\n",
            "INCLUSION_CRITERIA: 3. RAS gene mutation or wild type, BRAF wild type, MSS type;\n",
            "EXCLUSION_CRITERIA: 14. BRAF gene mutation type, MSI-H;\n",
            " \n",
            " BIOMARKER = BRAF mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Metastatic squamous or nonsquamous non-small cell lung cancer (NSCLC) (without known targetable EGFR, ALK, ROS1, or BRAF mutations) who either;\n",
            " \n",
            " BIOMARKER = EGFR mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Known human epidermal growth factor receptor 2 (HER2) positive;\n",
            " \n",
            " BIOMARKER = human epidermal growth factor receptor 2 positive, HER2 positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 1. CD19 expressing B-cell Acute Lymphoblastic Leukemia;\n",
            "EXCLUSION_CRITERIA: 7. Subjects with Burkitt's lymphoma/leukemia (i.e. subjects with mature B-ALL, leukemia with B-cell [sIg positive and kappa or lambda restricted positivity] ALL, with FAB L3 morphology and /or a MYC translocation);\n",
            " \n",
            " BIOMARKER = MYC translocation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor (TKI)-naïve Epidermal Growth Factor Receptor (EGFR)-Mutant Locally Advanced or Metastatic NSCLC;\n",
            "INCLUSION_CRITERIA:   * NSCLC which harbours EGFR Exon 19 deletion.   * NSCLC which harbours EGFR L858R mutation. EGFR deletion/mutation must be documented by a Clinical Laboratory Improvement Amendments (CLIA) certified test (either from tissue or ctDNA from blood is allowed). If EGFR deletion/mutation testing has not been done, it should be ordered per standard of care.\n",
            " \n",
            " BIOMARKER = EGFR Exon 19 deletion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    * Neuroblastoma- Patients that have relapsed following standard of care therapy (such as high risk patients, patient presenting after age 15 months or MYCN amplified, and only following (for eligible patients) high-dose chemotherapy followed by hematopoietic stem cell transplantation and maintenance therapy with retinoic acid and antibody therapy) or having progressed during standard of care therapy and non-responsive/progressive to accepted curative chemotherapy.\n",
            " \n",
            " BIOMARKER = MYCN amplified \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients must have PD-L1 expression Tumor Proportion Score (TPS) >= 1% in tumor cells. If PD-L1 expression TPS is unevaluable or the testing could not be completed, the patients are not eligible. The assay must have been performed by a Clinical Laboratory Improvement Act (CLIA) (or equivalent) certified laboratory; * Patients with known EGFR mutations (except exon 20 insertion), BRAF mutations (V600) or ALK or ROS1 translocations or other driver mutations that can be treated with oral tyrosine kinase inhibitors are excluded;\n",
            " \n",
            " BIOMARKER = EGFR mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 2. Histologically confirmed stage 4 NSCLC or stage 3B/3C not able to receive chemoradiation with no sensitizing EGFR or ALK mutations.\n",
            " \n",
            " BIOMARKER = EGFR mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. Tumor tissue required for an evaluable PD-L1 expression result;\n",
            " \n",
            " BIOMARKER = PD-L1 expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase 3,Single Arm,Open-Label Study Evaluating Ovarian Suppression Following 3 Month Leuprolide Acetate For Injectable Suspension (TOL2506) in Combination With Endocrine Therapy in Premenopausal Subjects With Hormone-Receptor-Positive (HR+),Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer;\n",
            "INCLUSION_CRITERIA: 3. Diagnosis of Stage I, II, or III HR+, HER2-negative breast cancer (ER>1% and/or, PR>1%, HER2-negative per ASCO CAP guidelines);\n",
            " \n",
            " BIOMARKER = HER2 -Negative, HER2 -, ,Human Epidermal Growth Factor Receptor 2 -Negative, HER2 -negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer;\n",
            "TITLE: JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy;\n",
            "INCLUSION_CRITERIA: * Determined to have detectable mutations in codons 12 or 13 of the kirsten rat sarcoma (KRAS) oncogene by an investigational assay at the study central laboratory. A KRAS positive mutation result in codons 12 or 13 of the KRAS oncogene from tumor tissue per local laboratory will be permitted in no more than 10% of randomized participants.\n",
            " \n",
            " BIOMARKER = KRAS mutations in codons 12 or 13, kirsten rat sarcoma mutations in codons 12 or 13 \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Confirmed presence of a cancer-associated alteration considered pathogenic/likely pathogenic by FM and/or the Genetics Review Panel in one or more of the following genes: BRCA1, BRCA2, ATM, BAP1, MSH2, PALB2, and BRIP1 or in one or more of the DNA-repair genes tested in the FoundationOne FoundationOneCDx (F1CDx) panel including the following genes (Foundation One mutation analysis results performed prior to enrollment on this study may be accepted for eligibility review and in the event that a patient cannot undergo a biopsy and tumor is not available, Foundation Medicine liquid biopsy may be performed): ABL1, ATR, ATRX, BARD1, BRD4, CCND1, CHEK1, CHEK2, DOT1L, FANCC, FANCE, FANCG, FANCL, IKBKE, MEN1, MLH1, MSH2, MSH6, MUTYH, NPM1, PMS2, POLD1, POLE, RAD51, SMARCB1, STK11, TP53;\n",
            "EXCLUSION_CRITERIA: * Other malignancy within the last 5 years except: adequately treated non-melanoma skin cancer, curatively treated in situ cancer of the cervix, ductal carcinoma in situ (DCIS), stage 1, grade 1 endometrial carcinoma, or other solid tumors including lymphomas (without bone marrow involvement) curatively treated with no evidence of disease for >= 5 years. Patients with a history of localized triple negative breast cancer or localized resected prostate cancer may be eligible, provided they completed their adjuvant chemotherapy more than three years prior to registration, and that the patient remains free of recurrent or metastatic disease;\n",
            " \n",
            " BIOMARKER = FANCG alteration \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. BRCA1, BRCA2, PALB2, ATM, MLH1, MSH2, MSH6, PMS2, EPCAM pathogenic or likely pathogenic variant AND 1 first or second degree relative with PDAC; age 50+ or 10 years younger than earliest PDAC in family; 4. Familial Atypical Moles and Malignant Melanoma (FAMMM) with pathogenic or likely pathogenic CDKN2A variant; age 40+; 5. Peutz-Jegher syndrome with STK11 pathogenic or likely pathogenic variant; age 35+; 6. Hereditary pancreatitis with PRSS1 pathogenic or likely pathogenic variant and history of pancreatitis; age 40+; 1. ATM, BRCA1, BRCA2, or PALB2 pathogenic or likely pathogenic variant regardless of family history, age 50+; 2. Personal or family history of a pathogenic or likely pathogenic germline variant in ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2,PMS2, PRSS1, STK11;\n",
            " \n",
            " BIOMARKER = MSH6 variant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase 1 Multi-Country, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A1811 in HER2 Expressing or Mutated Advanced Malignant Solid Tumor Subjects;\n",
            "INCLUSION_CRITERIA: * Advanced/unresectable or metastatic solid tumor with HER2 expression or mutation that is refractory to or intolerable with standard treatment, or for which no standard treatment is available;\n",
            " \n",
            " BIOMARKER = HER2 Mutated, HER2 mutation, HER2 mutated \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial);\n",
            "TITLE: A Phase II Study of Talazoparib Plus Avelumab in Patients With Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer Bearing Pathogenic STK11 Genomic Alterations (LUNG-MAP Sub-Study);\n",
            "INCLUSION_CRITERIA: * Patients must be assigned to S1900C. Assignment to S1900C is determined by the LUNGMAP protocol genomic profiling using the FoundationOne assay. Biomarker eligibility for S1900C is based on the identification of a pathogenic somatic mutation in STK11 or STK11 bi-allelic loss on tumor;\n",
            " \n",
            " BIOMARKER = STK11 mutation, STK11 somatic mutation, STK11 Alterations, STK11 Mutation, STK11 mutations, STK11 alterations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Baseline tissue-based KRAS, NRAS, EGFR, BRAF and MEK1 wild-type tumor;\n",
            "EXCLUSION_CRITERIA: * Baseline tissue-based KRAS, NRAS, EGFR, BRAF and MEK1 mutated tumor;\n",
            " \n",
            " BIOMARKER = BRAF mutated \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements;\n",
            "TITLE: A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1);\n",
            "INCLUSION_CRITERIA: 1. Histologically or cytologically confirmed diagnosis of locally advanced, or metastatic solid tumor (including primary CNS tumors) (Stage IV, American Joint Committee on Cancer v.7) that harbors an ALK, ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement by protocol specified tests. 1. Histologically or cytologically confirmed diagnosis of locally advanced, or metastatic solid tumor (including primary CNS tumors) that harbors a ROS1, or NTRK1-3 gene fusion. 2. Subject must have a documented ROS1 or NTRK1-3 gene fusion determined by tissue-based local testing using either: 7. Subjects with advanced solid tumors harboring ROS1, NTRK1, NTRK2, or NTRK3 rearrangement will be assigned into 6 distinct expansion (EXP) cohorts provided all inclusion and exclusion criteria are met.    i. EXP-1: ROS1 TKI-naïve ROS1+ NSCLC ii. EXP-2: 1 Prior ROS1 TKI and 1 Platinum based chemo ROS1+ NSCLC iii. EXP-3: 2 Prior ROS1 TKIs ROS1+ NSCLC (No Chemo or IO) iv. EXP-4: 1 Prior ROS1 TKI ROS1+ NSCLC (No Chemo or IO) v. EXP-5: TRK TKI-naïve NTRK+ solid tumors vi. EXP-6: TRK TKI-pretreated NTRK+ solid tumors;\n",
            " \n",
            " BIOMARKER = ROS1 rearrangement, ROS1 Rearrangements \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation;\n",
            "TITLE: Randomized Phase II Trial of Encorafenib and Cetuximab With or Without Nivolumab (NSC #748726) for Patients With Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer;\n",
            "INCLUSION_CRITERIA: * Participants must have BRAF^V600E mutated colorectal cancer as tested in a Clinical Laboratory Improvement Act (CLIA)-certified laboratory; * Participants must have proficient mismatch repair (pMMR) or microsatellite stable (MSS) status as tested in a CLIA-certified laboratory and documented by the treating clinician. Proficient mismatch repair status can be determined by intact expression by immunohistochemistry of all 4 mismatch repair proteins (MLH1, MSH2, MSH6, and PMS2). Microsatellite instability can be determined by polymerase chain reaction (PCR);\n",
            " \n",
            " BIOMARKER = MLH1 expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Participants with known epidermal growth factor receptor (EGFR) mutations which are sensitive to available targeted inhibitor therapy (including, but not limited to, deletions in exon 19 and exon 21 [L858R] substitution mutations) are excluded; * Participants with known anaplastic lymphoma kinase (ALK) translocations which are sensitive to available targeted inhibitor therapy are excluded;\n",
            " \n",
            " BIOMARKER = epidermal growth factor receptor deletions in exon 19, EGFR deletions in exon 19 \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation;\n",
            "TITLE: The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome;\n",
            "INCLUSION_CRITERIA: * Patients must have a documented IDH1 or IDH2 mutation within 30 days of inclusion based on mutational testing. Only specific mutations that lead to a neomorphic phenotype will be eligible for enrollment, and include those listed below:   * IDH1: R132V, R132G, R132S, R132L, R132C and R132H;   * IDH2: R140W, R140L, R140Q, R172W, R172G, R172S, R172M, R172K.\n",
            "EXCLUSION_CRITERIA: * Management of treatment for patients with co-occurring mutations, like FLT3, will be prioritized by the treating physician after discussion of treatment options with the patient.\n",
            " \n",
            " BIOMARKER = IDH1 R132S \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Tissue must demonstrate mTOR+: PTEN loss OR PIK3C2B or AKT3 amplification on aCGH OR mutations for PIK3CA or PIK3R1, or mTOR or PTEN mutations using next-generation sequencing analysis OR pS6 positivity on immunohistochemistry (≥30% for pS6).\n",
            " \n",
            " BIOMARKER = mTOR mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients must have histologically or cytologically confirmed CD2+, CD3+, or CD4+ acute, lymphoma or poor-risk chronic subtypes of ATLL including previously untreated or previously treated individuals who have received no more than 1 previous cycle of combination chemotherapy. If the patient has a cycle of EPOCH prior to entering on the study, doses of EPOCH during the first cycle with lenalidomide should be altered as described for cycle 2 EPOCH modifications below; * Documentation of HTLV infection by enzyme-linked immunosorbent assay (ELISA) in individuals with confirmation of HTLV-1 infection (by immunoblot or polymerase chain reaction [PCR]) or a consistent clinical picture (including two of three of: 1) CD4+ leukemia or lymphoma, 2) hypercalcemia, and/or 3) Japanese, Caribbean, or South American birthplace) is required for enrollment. Confirmation of HTLV-1 infection is required to continue the subject on protocol after the first cycle of therapy. Patients will be enrolled based on reports from local or referral labs (e.g., Mayo Clinic or LabCorp). Confirmation will be performed by Ratner Lab at Washington University, retrospectively, but this is not a Clinical Laboratory Improvement Amendments (CLIA) assay and is not reimbursed by insurance;\n",
            " \n",
            " BIOMARKER = CD4 + \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC;\n",
            "TITLE: A Phase III, Open-Label, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC.\n",
            "INCLUSION_CRITERIA: 4. The patient's tumor tissue or blood sample test result meets 1 of the following two criteria: a. Previous tumor tissue or blood samples are confirmed as RET fusion positive by local laboratory testing. b. If there is no previous RET fusion positive test report, a compliant tumor tissue or blood sample is required to be provided at the central laboratory, using a next-generation sequencing (NGS)-based assay to confirm RET fusion positive.\n",
            "EXCLUSION_CRITERIA: 1. Patients carried known major driver genetic alterations other than RET. e.g. EGFR, MET, ALK, ROS1, NTRK, BRAF V600, KRAS G12C, etc. (If a patient has a co-mutation, discuss with the investigators whether enrollment is possible).\n",
            " \n",
            " BIOMARKER = KRAS G12C \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 4. Having documented actionable mutations or genomic alterations in any of the following genes: EGFR, ALK, ROS1, HER2, MET, BRAF, RET or NTRK;. Exception: KRAS mutations are not excluded.\n",
            " \n",
            " BIOMARKER = HER2 mutations, HER2 alterations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation;\n",
            "TITLE: The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome;\n",
            "INCLUSION_CRITERIA: * Patients must have a documented IDH1 or IDH2 mutation within 30 days of inclusion based on mutational testing. Only specific mutations that lead to a neomorphic phenotype will be eligible for enrollment, and include those listed below:   * IDH1: R132V, R132G, R132S, R132L, R132C and R132H;   * IDH2: R140W, R140L, R140Q, R172W, R172G, R172S, R172M, R172K.\n",
            "EXCLUSION_CRITERIA: * Management of treatment for patients with co-occurring mutations, like FLT3, will be prioritized by the treating physician after discussion of treatment options with the patient.\n",
            " \n",
            " BIOMARKER = IDH1 R132G \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    Presence of FLT3 mutations or internal tandem duplication or other mutations designated as adverse-risk by the ELN Leukemia Net AML Classification (see Appendix 2):    * t(6;9)(p23;q34.1); DEK-NUP214;    * t(v;11q23.3); KMT2A rearranged;    * t(9;22)(q34.1;q11.2); BCR-ABL1;    * inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2,MECOM(EVI1);    * Wild-type NPM1 and FLT3-ITDhigh;    * Mutated RUNX1;    * Mutated ASXL1;    * Mutated TP53 (iv) FAB M6 or M7 classification; (v) Adverse cytogenetics: -5, del 5q, -7, del7q, abnormalities involving 3q, 9q, 11q, 20q, 21q, 17, +8 or complex karyotype [> 3 abnormalities]; or other mutations designated as adverse-risk by the ELN criteria; (vi) Treatment-related AML (vii) Primary induction failure with partial response to therapy who achieve adequate cytoreduction (viii) Aplastic/hypoplastic marrow with or without detectable persistent disease after induction chemotherapy or after salvage chemotherapy.\n",
            " \n",
            " BIOMARKER = type NPM1 and FLT3 Wild-type, NPM1 and FLT3 Wild-type, NPM1 Wild-type \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 2. History of a histopathologically and molecularly confirmed glioblastoma, per Consortium to Inform Molecular and Practical Approaches to Central Nervous System Tumor Taxonomy (c-IMPACT-NOW) criteria (diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, World Health Organization [WHO] grade IV; this requires presence of amplification of EGFR, whole chromosome 7 gain AND whole chromosome 10 loss, or Telomerase reverse transcriptase (TERT) promoter mutation. 8. Tumor O-6-methylguanine-deoxyribonucleic acid (DNA) methyltransferase (MGMT) methylation status must be available from any prior GBM tumor specimen; results of routinely used methods for MGMT methylation testing (e.g., mutagenically separated polymerase chain reaction [MSPCR] or quantitative polymerase chain reaction [PCR]) are acceptable and results can be from a local lab or central lab used by a prior study.\n",
            "EXCLUSION_CRITERIA: 3. Known somatic tumor mutation in IDH1 or IDH2 gene. If not previously completed, sequencing of the IDH1 and IDH2 genes is not required to determine trial eligibility. 4. Known germline DNA repair defect (mismatch repair deficiency, POLE mutation, e.g.). If not previously completed, germline sequencing is not required to determine trial eligibility.\n",
            " \n",
            " BIOMARKER = IDH1 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer;\n",
            "TITLE: Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC);\n",
            "INCLUSION_CRITERIA: * Patient must have somatic activating sensitizing mutation in EGFR (e.g. but not limited to Exon 19 deletion, L858R, E709X, G719X, exon 19 insertions, L861Q, S768I). Patients with non-sensitizing mutations in EGFR (EGFR exon 20 insertions) are not eligible. Test results originating from a Clinical Laboratory Improvement Act (CLIA)-certified or similarly accredited laboratory are acceptable; no specific assay is mandated. Plasma, cytology, or tumor tissue can be utilized for mutation testing;\n",
            " \n",
            " BIOMARKER = EGFR exon 20 insertions) \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * For non-small cell lung cancer participants only: pathogenic somatic mutations or gene fusions in the following genes: EGFR, ALK, ROS1, NTRK, BRAF V600E and KRAS;\n",
            " \n",
            " BIOMARKER = BRAF somatic mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: Registration-Inclusion Criteria for FAMILIAL PANCREATIC CANCER (FPC) and those with a BRCA1, BRCA2, LYNCH SYNDROME, ATM, PALB2, CDKN2A, or related gene mutation (one of the following is required for questions 1-3); 3. The individual is a known mutation carrier of BRCA1, BRCA2, MLH1, MSH2, MSH6, or PMS2, ATM, PALB2, CDKN2A, or similar high-risk gene mutation and has at least 1 first- or second-degree relative with PC.\n",
            " \n",
            " BIOMARKER = BRCA1 gene mutation, BRCA1 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Participants with known epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), reactive oxygen species (ROS), BRAF, or other actionable mutations are not eligible;   * Participants with known EGFR, ALK, ROS, BRAF, tropomyosin receptor kinase (TRK), or other actionable mutations are not eligible;   * Participants with known human epidermal growth factor receptor 2 (HER2) overexpression must have received prior HER2-targeted therapy;   * Must have received BRAF +/- MEK inhibitor therapy if BRAF mutated (Part C);\n",
            " \n",
            " BIOMARKER = epidermal growth factor receptor mutations, EGFR mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Her2 negative on immunohistochemistry or nonamplified breast cancer;   * Patient with triple-negative breast cancer without prior treatment in the metastatic setting.   * Patient with hormone receptor-positive breast cancer that has exhausted or refused all endocrine monotherapy or endocrine therapeutic combinatorial options AND has not yet been treated with chemotherapy in the metastatic settings, but for whom chemotherapy is indicated.\n",
            " \n",
            " BIOMARKER = PR -positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 7. Estrogen receptor status (ER) positive on biopsy; 8. Her2 negative on biopsy;\n",
            "EXCLUSION_CRITERIA: 2. A known deleterious mutation in BRCA 1 and/or BRCA 2; 17. Estrogen receptor status (ER) not known;\n",
            " \n",
            " BIOMARKER = BRCA 2 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations;\n",
            "TITLE: An Open-label, Randomized, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Trastuzumab Deruxtecan as First-line Treatment of Unresectable, Locally Advanced, or Metastatic NSCLC Harboring HER2 Exon 19 or 20 Mutations (DESTINY-Lung04);\n",
            "INCLUSION_CRITERIA: * Histologically documented non-squamous NSCLC with HER2 mutation in exons 19 or 20 by tissue NGS or ctDNA;\n",
            "EXCLUSION_CRITERIA: * Tumors with targetable alterations to EGFR (or other targetable mutations including but not limited to ALK, if routinely tested as a targetable alteration with approved available therapy);\n",
            " \n",
            " BIOMARKER = EGFR alterations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Tumor PD-L1 expression as determined by immunohistochemistry assay of archival tumor tissue or tissue obtained at screening; * Tumor PD-L1 expression as determined by immunohistochemistry assay of archival tumor tissue or tissue obtained at screening;\n",
            "EXCLUSION_CRITERIA: * Participants with the following muations, rearrangements, translocations are not eligible: EGFR, ALK, ROS1, BRAFV600E, and NTRK;\n",
            " \n",
            " BIOMARKER = ROS1 rearrangements \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma;\n",
            "TITLE: The BAMM2 (BRAF, Autophagy, MEK Inhibition in Melanoma) Study: A Randomized Double Blind Phase II Study of Dabrafenib and Trametinib With or Without Hydroxychloroquine in Advanced BRAF V600E/K Melanoma;\n",
            "INCLUSION_CRITERIA: * Patient must have BRAF V600E or BRAF V600K tumor genotype based on a Clinical Laboratory Improvement Act (CLIA) approved assay;\n",
            " \n",
            " BIOMARKER = BRAF V600K, BRAF V600E/K \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Randomised, Open-label, Multi-centre, Two-arm Phase 3 Study Comparing Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil to Trifluridine/Tipiracil Single Agent With a Safety Lead-In Part in Participants With KRAS/NRAS and BRAF Wild Type Metastatic Colorectal Cancer Previously Treated With Standard Treatment and Anti-EGFR Therapy;\n",
            "INCLUSION_CRITERIA: * Histologically or cytologically confirmed adenocarcinoma of metastatic colorectal cancer (mCRC), not amenable to surgical intervention due to either medical contraindications or non-resectability of the tumour without RAS (KRAS and NRAS) and BRAF V600E mutations based on Circulating tumour DNA (ctDNA) screening blood test analysis;\n",
            " \n",
            " BIOMARKER = BRAF V600E \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1);\n",
            "TITLE: Phase 3, Open-Label, Randomized, Study Comparing Gedatolisib Combined With Fulvestrant & With or Without Palbociclib to Standard-of-Care Therapies in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination w/Non-Steroidal Aromatase Inhibitor Therapy;\n",
            "INCLUSION_CRITERIA: 3. Confirmed diagnosis of estrogen receptor positive and/or progesterone receptor positive, as per American Society of Clinical Oncology/College of American Pathologists (ASCO-CAP) guidelines (2020), based on most recent tumor biopsy utilizing an assay consistent with local standards; 4. Documented HER2 immunohistochemistry (IHC) negative as per ASCO-CAP 2018 guidance; 5. Adequate archival or fresh tumor tissue for the analysis of PIK3CA mutational status;\n",
            " \n",
            " BIOMARKER = progesterone receptor positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 7. Subjects whose tumors have been tested for PD-L1 expression.\n",
            "EXCLUSION_CRITERIA: 9. Patients with targetable genomic aberrations for which FDA-approved targeted therapy is available (e.g. ROS1, MET exon 14 skipping mutations, BRAFV600E, ALK, EGFR, ALK, RET, and NTRK fusions).\n",
            " \n",
            " BIOMARKER = NTRK aberrations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients with HER2 negative disease (HER2 negativity by immunohistochemistry [IHC] or fluorescent in situ hybridization [FISH] ratio according to the American Society of Clinical Oncology-College of American Pathologists guideline criteria) (Hammond et al., 2010; Wolff et al., 2013). Hormone-receptor positive (estrogen receptor [ER]-positive and/or progesterone receptor [PR]-positive) as well as triple-negative (ER-negative, PR-negative and no overexpression of HER2) breast cancer may be enrolled. Hormone receptor status will be determined at the local institution. ER and PR negativity will be defined as < 1% tumor staining by IHC; * Patient must be eligible to receive therapy with paclitaxel for the treatment of their breast cancer. Patients with hormone-receptor positive disease should have progressed on at least one prior line of hormone therapy and a CDK4/6 inhibitor in the metastatic setting to be eligible (except if patient had a contraindication or intolerable toxicity with the use of these agents). Previous radiation and chemotherapy for the treatment of metastatic breast cancer is allowed;\n",
            " \n",
            " BIOMARKER = PR -negative, PR negativity, triple-negative triple-negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase III, Randomized, Open-Label Study of Pralsetinib Versus Standard of Care for First-Line Treatment of RET Fusion-Positive, Metastatic Non-Small Cell Lung Cancer;\n",
            "INCLUSION_CRITERIA: * Participant must have a documented RET-fusion;\n",
            "EXCLUSION_CRITERIA: * Participant's tumor has any additional known primary driver alterations other than RET, such as targetable mutations of EGFR, ALK, ROS1, MET, and BRAF. Investigators should discuss enrollment with Sponsor designee regarding co-mutations.\n",
            " \n",
            " BIOMARKER = ROS1 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Non-squamous tumors must not be positive for EGFR exon 19 deletion or exon 21 L858R mutation (centrally as part of the ALCHEMIST-SCREEN protocol) and ALK rearrangement (centrally as part of ALCHEMIST-SCREEN and/or locally);   * NOTE: if the results of the central EGFR testing are negative, but the ALK testing was not able to be completed by the ALCHEMIST central lab, the ALK status will be considered negative (unless locally positive for ALK rearrangement) and the patient may be considered for enrollment onto EA5142, once PD-L1 results are received and all other eligibility requirements are met; * Tumors must have PD-L1 status tested centrally as part of the ALCHEMIST-SCREEN protocol;\n",
            " \n",
            " BIOMARKER = ALK rearrangement \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Previously treated individuals with inoperable metastatic colorectal cancer (mCRC) who are ineligible for checkpoint inhibitor therapy (microsatellite instability (MSI)-H or mismatch repair deficient (dMMR) and are excluded). * Histologically or cytologically confirmed adenocarcinoma originating in the colon or rectum (excluding appendiceal and anal canal cancers) who have progressed on or after 1 prior systemic therapy in the setting where curative resection is not indicated. This therapy must have included chemotherapy based on 5-FU or capecitabine with oxaliplatin and either bevacizumab, or for patients with RAS wild-type and left-sided tumors, bevacizumab, cetuximab, or panitumumab.\n",
            "EXCLUSION_CRITERIA: * Known v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E or MSI-H mutations or dMMR. * Known dihydropyrimidine dehydrogenase deficiency.\n",
            " \n",
            " BIOMARKER = dihydropyrimidine dehydrogenase deficiency \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Clinical evidence of disease AND high serum human chorionic gonadotropin (HCG) or alpha-fetoprotein (AFP) levels;\n",
            " \n",
            " BIOMARKER = alpha-fetoprotein high, AFP high \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.\n",
            "TITLE: A Phase II Study Evaluating Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated Non-small Cell Lung Cancer (NSCLC);\n",
            "INCLUSION_CRITERIA: 2. Patients with EGFR sensitizing mutations (Ex19del or L858R).\n",
            "EXCLUSION_CRITERIA: 3. Other positive driver mutations, including ALK, ROS1, MET14 exon skipping, BRAF, RET, etc.\n",
            " \n",
            " BIOMARKER = RET mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Individuals diagnosed with Lynch syndrome (mutation in MLH1, MSH2, MSH6, PMS2, EPCAM) or suspected Lynch syndrome or individuals diagnosed with early onset colorectal cancer (CRC) (< 50 years old [yo]);\n",
            " \n",
            " BIOMARKER = EPCAM mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer;\n",
            "TITLE: A Phase 2b Study of ZEN003694 in Combination With Talazoparib in Patients With Triple-Negative Breast Cancer;\n",
            "INCLUSION_CRITERIA: 2. Parts 1 and 2 only: Histologically confirmed metastatic or recurrent or locally advanced triple-negative breast cancer (estrogen receptor (ER) ≤10%; progesterone receptor (PR) ≤10%; and HER2 negative by immunohistochemistry (IHC) or fluorescent in situ hybridization (FISH);    Expansion only: Histologically confirmed metastatic or recurrent, or locally advanced triple-negative breast cancer as defined by the most recent American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines.\n",
            "EXCLUSION_CRITERIA: 1. Documented germline mutations of BRCA1 or BRCA2; 16. Expansion only: Disease initially diagnosed with expression of estrogen receptor (ER) or progesterone receptor (PR) as ≥5%;\n",
            " \n",
            " BIOMARKER = BRCA1 germline mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * PART B: Patients with recurrent or refractory Ewing sarcoma, desmoid tumors, osteosarcoma, liver tumors (HCC and hepatoblastoma), Wilms tumor, and tumors with Wnt pathway aberrations. For the Wnt pathway aberrations cohort we will include the most common CTNNB1 mutations (S37F, S45F, T41A, S45P, S33C, S37C, D32Y, S33F, T41I, G34R, G34V, D32N, S33P, G34E, D32G) as well as any loss of function mutations in the APC, Axin2FBXW7, TCF7L2, and RNF43 genes or any gain-of-function mutations in the GSK3B, LRP6, and LGR5 genes. For patients without prior sequencing, immunohistochemistry (IHC), is required. IHC showing strong nuclear beta-catenin staining will be accepted for the following tumor types: colorectal carcinoma, melanoma, endometrial cancer, ovarian cancer, neuroblastoma, non-Hodgkin lymphoma, pancreatic ductal adenocarcinoma, and solid pseudopapillary tumor of the pancreas;\n",
            " \n",
            " BIOMARKER = CTNNB1 D32Y \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial;\n",
            "TITLE: Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial;\n",
            "INCLUSION_CRITERIA: * Participants must have an activating AKT mutation (a known mutation in AKT1, AKT2, or AKT3, a single nucleotide variant, insertion, or deletion) as determined by the ComboMATCH screening assessment;\n",
            "EXCLUSION_CRITERIA: * Participants must not have an activating KRAS, NRAS, HRAS, or BRAF mutation (a single nucleotide variant, insertion, or deletion) as determined by the ComboMATCH screening assessment; * Participants with known diabetes mellitus must not require insulin therapy or have a baseline fasting glucose >150 mg/dL (8.3 mmol/L) or high glycosylated hemoglobin (Hb)A1c, (>= 8.0%), suggesting poorly controlled diabetes;\n",
            " \n",
            " BIOMARKER = KRAS mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Central and/or local testing of EGFR with no EGFR exon 19 deletion or EGFR L858 R mutation (applicable to non-squamous patients only); * Central and/or local testing of ALK with no ALK rearrangement (failed testing is considered negative) (applicable to non-squamous patients only);\n",
            " \n",
            " BIOMARKER = EGFR mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 3. Her-2/neu expression;\n",
            " \n",
            " BIOMARKER = Her-2/neu expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Participants with a known sensitizing mutation for which an Food and Drug Administration (FDA)-approved targeted therapy for NSCLC exists (e.g., EGFR, ALK, ROS1, BRAF, RET, NTRK, KRAS, HER2 and MET sensitizing mutations), must have previously received at least one of the approved therapy(s). Prior targeted therapy for participants with targetable alterations is allowed if all other eligibility criteria are also met;\n",
            " \n",
            " BIOMARKER = ROS1 sensitizing mutation, ROS1 sensitizing mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    * R/R AMLwith FLT3 mutations who have been previously treated with a FLT3 inhibitor;    * R/R AML with spliceosome mutations of SF3B1 or U2AF1;    * R/R hrMDS (IPSS-R score > 3.5) with spliceosome mutations of SF3B1 or U2AF1;\n",
            " \n",
            " BIOMARKER = U2AF1 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Participants with history of germline BRCA1-Associated Protein-1 (BAP1) mutations.\n",
            " \n",
            " BIOMARKER = BRCA1-Associated Protein-1 somatic mutations, BRCA1-Associated Protein-1 mutations, BAP1 somatic mutations, BRCA1-Associated Protein-1 Mutations, BAP1 Mutations, BAP1 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   3. After completion of Dose level 3, subjects will need to demonstrate a defect in one or more DDR genes such as: ATM (including ATM protein loss by IHC), ATRX, ARID1A, BARD1, BRCA1, BRCA2, BRIP1, CDK12, CHEK2, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCM, MRE11A, MSH2, NBN, PALB2, RAD51, RAD51B, RAD51C, RAD51D, or other related genes at the discretion of the investigator in consultation with sponsor Medical Monitor; Or mutations in p53 pathway/MYC pathway.\n",
            " \n",
            " BIOMARKER = ATRX defect \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Cohorts 1 and 1A (combination of niraparib and PD-1 inhibitor): participants must have tumors with high PD-L1 expression (TPS >= 50%) per local assessment; with no known Epidermal Growth Factor Receptor (EGFR)-sensitizing mutation and/or ROS -1 or anaplastic lymphoma kinase (ALK) translocation, and no prior systemic chemotherapy or PD-1/PD-L1 inhibitor treatment for metastatic NSCLC. * Cohorts 2 and 2A (combination of niraparib and PD-1 inhibitor): participants must have tumors with PD-L1 expression (TPS between 1% and 49%) per local assessment, with no known EGFR-sensitizing mutation and/or ROS-1 or ALK translocation, and no prior systemic chemotherapy or PD-1/PD-L1 inhibitor treatment for metastatic NSCLC.\n",
            "EXCLUSION_CRITERIA: * Known EGFR (exon 19 and 21) mutations, ALK translocations, and/or ROS-1 translocations.\n",
            " \n",
            " BIOMARKER = EGFR mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Have histologically or cytologically confirmed NSCLC, with presence of EGFR mutation(s) sensitive to EGFR inhibitors, or KRAS G12C mutation.\n",
            "EXCLUSION_CRITERIA: * For participants with KRAS G12Cm NSCLC: prior therapy with a SHP2, ERK, or KRAS G12C inhibitor (depending on which cohort is being considered for enrollment).\n",
            " \n",
            " BIOMARKER = KRAS mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation;\n",
            "TITLE: The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome;\n",
            "INCLUSION_CRITERIA: * Patients must have a documented IDH1 or IDH2 mutation within 30 days of inclusion based on mutational testing. Only specific mutations that lead to a neomorphic phenotype will be eligible for enrollment, and include those listed below:   * IDH1: R132V, R132G, R132S, R132L, R132C and R132H;   * IDH2: R140W, R140L, R140Q, R172W, R172G, R172S, R172M, R172K.\n",
            "EXCLUSION_CRITERIA: * Management of treatment for patients with co-occurring mutations, like FLT3, will be prioritized by the treating physician after discussion of treatment options with the patient.\n",
            " \n",
            " BIOMARKER = IDH2 R140L \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Histological verification of recurrent glioblastoma, non-methylated MGMT promotor;\n",
            " \n",
            " BIOMARKER = MGMT methylated \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * histologically or cytologically confirmed metastatic or unresectable solid malignancy including ovarian cancer (must have epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer), endometrial cancer, non-small cell lung cancer, breast cancer (hormone receptor positive, HER2-negative and triple-negative), mesothelioma;\n",
            " \n",
            " BIOMARKER = Triple Negative Triple Negative, triple negative triple negative, triple-negative triple-negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. Dose escalation part: patients with histologically or cytologically confirmed diagnosis of advanced (unresectable or metastatic) mesothelioma or other solid tumors. Patients with solid tumors other than mesothelioma must have local available data for loss-of-function NF2/LATS1/LATS2 genetic alterations (truncating mutation or gene deletion; LATS1/LATS2 mutations will only be included in the dose escalation part), or functional YAP/TAZ fusions. Patients with malignant EHE can be enrolled with only histological confirmation of the disease. Patients must have failed available standard therapies, be intolerant of or ineligible for standard therapy, or for whom no standard therapy exists.    Group 2: Advanced (unresectable or metastatic) solid tumor patients with available local data for NF2 truncating mutation or deletions. Patient must have failed available standard therapies, be intolerant or ineligible to receive such therapy, or for whom no standard therapy exists.\n",
            "EXCLUSION_CRITERIA:    3. Total calcium (corrected for low serum albumin);\n",
            " \n",
            " BIOMARKER = LATS2 truncating mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor;\n",
            "TITLE: A Phase I Trial of Osimertinib (AZD9291) and Necitumumab in EGFR-Mutant Non-Small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor;\n",
            "INCLUSION_CRITERIA: * NSCLC must harbor at least one of the following EGFR activating mutations: Exon 21 L858R, Exon 19 deletion, Exon 18 G719X, Exon 21 L861Q or for EGFR Exon 20 insertion expansion cohort D, NSCLC must harbor an EGFR Exon 20 insertion performed by a Clinical Laboratory Improvement Act (CLIA) certified test; * For Dose Expansion Cohort A: patient must 1) have progression of disease on erlotinib, gefitinib or afatinib as last previous systemic treatment, 2) have biopsy of tumor taken after progression on erlotinib, gefitinib or afatinib which must be EGFR-T790M negative confirmed by central testing prior to treatment (if EGFR-T790M status is unknown, patients may consent for trial and for biopsy and testing for EGFR T790M will be performed as part of initial biopsy for trial), and 3) be treatment naive to 3rd generation EGFR-TKI (rociletinib, EGFR inhibitor HM61713 [HM61713] and osimertinib [AZD9291]) and EGFR monoclonal antibodies; * For Dose Expansion Cohort B (closed to accrual as of 8/30/18): patient must 1) have progression of disease on a 3rd generation EGFR-TKI such as AZD9291, rociletinib, HM61713, 2) be treatment naive to an EGFR monoclonal antibody, and 3) have a biopsy of tumor taken after progression on last EGFR-TKI that indicates loss of EGFR-T790M (EGFR-T790M negative) confirmed by central testing prior to treatment (if EGFR-T790M status is unknown, patients may consent for trial and for biopsy, and testing for EGFR T790M will be performed as part of initial biopsy for trial); * For Dose Expansion Cohort C: patient must 1) have progression of disease on a 3rd generation EGFR-TKI such as osimertinib (AZD9291), rociletinib, HM61713, 2) be treatment naive to an EGFR monoclonal antibody, 3) have a biopsy of tumor taken after progression on last EGFR-TKI that indicates preservation of EGFR-T790M post-progression on 3rd generation EGFR-TKI with biopsy confirmation by central testing prior to treatment (if EGFR-T790M status is unknown, patients may consent for trial and for biopsy, and testing for EGFR T790M will be performed as part of initial biopsy for trial); * For Dose Expansion Cohort D: patient must 1) tumor that harbors an EGFR Exon 20 insertion by a CLIA certified test, and 2) have progressive disease on or after platinum based chemotherapy, and 3) be treatment naïve to 3rd generation and beyond EGFR-TKI (i.e., osimertinib [AZD9291], poziotinib, TAK-778) and EGFR monoclonal antibody; patient who received 1st or 2nd generation EGFR-TKI (such as erlotinib, gefitinib, afatinib) are eligible provided that they did not achieve a response to treatment or they did not have a duration of treatment on EGFR-TKI of 6 months or more;\n",
            " \n",
            " BIOMARKER = EGFR G719X \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Estrogen receptor (ER), and/or progesterone receptor (PR) positive and HER2 negative,\n",
            " \n",
            " BIOMARKER = PR positive, progesterone receptor positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients in dose escalation and expansion of all arms must have actionable mutations in either PIK3CA hotspot (E542, E545, or H1047 are accepted) or PTEN (except for specific wild type cohorts). Local testing in Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory will be accepted. Only mutations that have been recognized as actionable by the MD Anderson Precision Oncology Decision Support (PODS) team will be accepted;\n",
            " \n",
            " BIOMARKER = PTEN mutations, PTEN alterations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    1. Cohort A: KRAS, NRAS, EGFR ectodomain, BRAF V600E wild-type status;    2. BRAF expansion Cohort: BRAF V600E mutation must be present;\n",
            " \n",
            " BIOMARKER = KRAS status \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Patients in Cohort 1 must have (i) a germline or somatic mutation in BRCA1 or BRCA2; and (ii) must have received PARPi monotherapy or PARPi combination-therapy as their immediate prior therapy;   * Patients in Cohort 2 must have: (i) a germline or somatic mutation in any of the following deoxyribonucleic acid (DNA) damage response (DDR) genes: BARD1; FANCA; BRIP1; PALB2; RAD51; RAD51C; RAD51D, with no evidence of mutations in BRCA1 or BRCA2; and (ii) must have received PARPi monotherapy or PARPi combination therapy as the immediate prior therapy;   * Patients in Cohort 3 must be (i) patients who have had PR/CR on prior PARPi monotherapy or PARPi combination treatment; (ii) patients with no evidence of BRCA1 or BRCA2 mutations or any of the relevant DDR aberrations listed in cohort 2; and (iii) patients with no intervening therapy following prior PARP inhibitor-based treatment. Patients with ovarian cancer should not have progressed on platinum-therapy within six months of therapy;   * Patients in Cohort 4 must have KRAS mutated advanced solid tumors. Prior treatments with KRAS inhibitors are permitted. Patients with KRAS G12C mutations must have already had KRAS G12C targeted therapy (e.g., sotorasib) previously;\n",
            " \n",
            " BIOMARKER = PALB2 somatic mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 2. Have at least 2 of the following high risk features associated with her DCIS - high-grade (grade II-III), palpable mass, hormone receptor negative (less than 1%), Her2 positive, young age (less than 45 years old), and large size (greater than 5 cm).\n",
            "EXCLUSION_CRITERIA: 3. Has hormone positive DCIS (HR+) that is not Her2+.\n",
            " \n",
            " BIOMARKER = Her2 +, Her2 positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial;\n",
            "TITLE: Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial;\n",
            "INCLUSION_CRITERIA: * Participants must have an activating AKT mutation (a known mutation in AKT1, AKT2, or AKT3, a single nucleotide variant, insertion, or deletion) as determined by the ComboMATCH screening assessment;\n",
            "EXCLUSION_CRITERIA: * Participants must not have an activating KRAS, NRAS, HRAS, or BRAF mutation (a single nucleotide variant, insertion, or deletion) as determined by the ComboMATCH screening assessment; * Participants with known diabetes mellitus must not require insulin therapy or have a baseline fasting glucose >150 mg/dL (8.3 mmol/L) or high glycosylated hemoglobin (Hb)A1c, (>= 8.0%), suggesting poorly controlled diabetes;\n",
            " \n",
            " BIOMARKER = HRAS mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC);\n",
            "TITLE: A Randomized Phase 2 Trial of Axitinib/Nivolumab Combination Therapy vs. Single Agent Nivolumab for the Treatment of TFE/Translocation Renal Cell Carcinoma (tRCC) Across All Age Groups;\n",
            "INCLUSION_CRITERIA:   * Patients must have a tumor showing the appropriate morphologic appearance, and either confirmed TFE3 nuclear protein expression by immunohistochemistry with appropriate positive and negative controls performed at a Clinical Laboratory Improvement Act (CLIA)-certified laboratory, or evidence of TFE3 or TFEb translocation by either fluorescence in situ hybridization (FISH) or reverse transcriptase- polymerase chain reaction (RT-PCR) performed at a CLIA-certified laboratory. For TFE3 immunohistochemistry, any nuclear positivity in the presence of appropriate positive and negative controls should be considered as evidence of TFE3 immunohistochemical expression. NOTE: If the institution is unable to perform these studies, unstained slides may be submitted to Dr. Elizabeth Perlman, who will perform TFE3 analysis at no charge. The slide will be returned to the referring institution for local evaluation, to be included in their institutional report;\n",
            " \n",
            " BIOMARKER = TFEb translocation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 6. Analysis of surgical specimens showed KRAS mutations and positive immunohistochemical staining of PD-L1;\n",
            "EXCLUSION_CRITERIA: 6. Analysis of surgical specimens showed KRAS wild type or negative immunohistochemical staining of PD-L1;\n",
            " \n",
            " BIOMARKER = PD-L1 negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor (TKI)-naïve Epidermal Growth Factor Receptor (EGFR)-Mutant Locally Advanced or Metastatic NSCLC;\n",
            "INCLUSION_CRITERIA:   * NSCLC which harbours EGFR Exon 19 deletion.   * NSCLC which harbours EGFR L858R mutation. EGFR deletion/mutation must be documented by a Clinical Laboratory Improvement Amendments (CLIA) certified test (either from tissue or ctDNA from blood is allowed). If EGFR deletion/mutation testing has not been done, it should be ordered per standard of care.\n",
            " \n",
            " BIOMARKER = EGFR deletion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * PART B: Patients with recurrent or refractory Ewing sarcoma, desmoid tumors, osteosarcoma, liver tumors (HCC and hepatoblastoma), Wilms tumor, and tumors with Wnt pathway aberrations. For the Wnt pathway aberrations cohort we will include the most common CTNNB1 mutations (S37F, S45F, T41A, S45P, S33C, S37C, D32Y, S33F, T41I, G34R, G34V, D32N, S33P, G34E, D32G) as well as any loss of function mutations in the APC, Axin2FBXW7, TCF7L2, and RNF43 genes or any gain-of-function mutations in the GSK3B, LRP6, and LGR5 genes. For patients without prior sequencing, immunohistochemistry (IHC), is required. IHC showing strong nuclear beta-catenin staining will be accepted for the following tumor types: colorectal carcinoma, melanoma, endometrial cancer, ovarian cancer, neuroblastoma, non-Hodgkin lymphoma, pancreatic ductal adenocarcinoma, and solid pseudopapillary tumor of the pancreas;\n",
            " \n",
            " BIOMARKER = LGR5 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 4. Tumors with PD-L1 expressed in ≥ 50% tumor cells.\n",
            "EXCLUSION_CRITERIA: 1. Known mutations in the epidermal growth factor receptor (EGFR) gene, anaplastic lymphoma kinase (ALK) fusion oncogene, BRAF V600E, or ROS1.\n",
            " \n",
            " BIOMARKER = ALK mutations, anaplastic lymphoma kinase mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Estrogen receptor positive (ER+);\n",
            "EXCLUSION_CRITERIA: * Known BRCA 1 or BRCA 2 mutation;\n",
            " \n",
            " BIOMARKER = BRCA 1 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Availability of a representative tumor specimen that is suitable for determination of PD-L1 status;\n",
            "EXCLUSION_CRITERIA: * NSCLC with an activating EGFR mutation or ALK fusion oncogene; * Known c-ros oncogene 1 (ROS1) rearrangement;\n",
            " \n",
            " BIOMARKER = ROS1 rearrangement \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    1. Cohort A: KRAS, NRAS, EGFR ectodomain, BRAF V600E wild-type status;    2. BRAF expansion Cohort: BRAF V600E mutation must be present;\n",
            " \n",
            " BIOMARKER = BRAF wild-type \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 9. Patients with tumors tested positive for epidermal growth factor receptor (EGFR) gene mutations, anaplastic lymphoma kinase (ALK) gene translocations, or ROS1 fusions (Part 2);\n",
            " \n",
            " BIOMARKER = ROS1 fusions \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * No BRCA1/2 or PALB2 mutation;\n",
            " \n",
            " BIOMARKER = BRCA1/2 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.\n",
            "TITLE: Epidemiologic Multicenter Prospective Study in Advanced NSCLC Patients With PDL1 Expression : Evaluation of Clinical and Pathological Characteristics of PDL1 High Expression Patients Compared to Patients With a Weak or no Expression of PDL1.\n",
            "INCLUSION_CRITERIA: * No known Epidermal Growth Factor Receptor (EGFR) or Anaplastic Lymphoma Kinase (ALK) / Reactive Oxygen Species (ROS) translocation;\n",
            " \n",
            " BIOMARKER = EGFR translocation, Epidermal Growth Factor Receptor translocation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. Has known deleterious/pathogenic mutation or suspected deleterious/pathogenic variant in BRCA1 or BRCA2 (HBOC) or MLH1, MSH2, MSH6, PMS2, or EPCAM (LS);\n",
            " \n",
            " BIOMARKER = MLH1 variant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase I Study of Autologous Transgenic T-Cells Expressing High Affinity Mesothelin-Specific T-Cell Receptor (TCR) (FH-TCR Tᴍsʟɴ) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma;\n",
            "INCLUSION_CRITERIA: * LEUKAPHERESIS: Tissue confirmation of pancreatic ductal adenocarcinoma and expression of mesothelin (MSLN): Participants must have metastatic disease. Confirmation of diagnosis must be or have been performed by internal pathology review of archival, initial or subsequent biopsy or other pathologic material at Fred Hutchinson Cancer Research Center (Fred Hutch)/University of Washington (UW). Baseline tissue will be stained by immunohistochemistry (IHC) to confirm MSLN expression;\n",
            "EXCLUSION_CRITERIA: * LEUKAPHERESIS: Expression of HLA B*1302: Participants will be excluded due to the risk of alloreactivity to this allele;\n",
            " \n",
            " BIOMARKER = HLA B Expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    Presence of FLT3 mutations or internal tandem duplication or other mutations designated as adverse-risk by the ELN Leukemia Net AML Classification (see Appendix 2):    * t(6;9)(p23;q34.1); DEK-NUP214;    * t(v;11q23.3); KMT2A rearranged;    * t(9;22)(q34.1;q11.2); BCR-ABL1;    * inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2,MECOM(EVI1);    * Wild-type NPM1 and FLT3-ITDhigh;    * Mutated RUNX1;    * Mutated ASXL1;    * Mutated TP53 (iv) FAB M6 or M7 classification; (v) Adverse cytogenetics: -5, del 5q, -7, del7q, abnormalities involving 3q, 9q, 11q, 20q, 21q, 17, +8 or complex karyotype [> 3 abnormalities]; or other mutations designated as adverse-risk by the ELN criteria; (vi) Treatment-related AML (vii) Primary induction failure with partial response to therapy who achieve adequate cytoreduction (viii) Aplastic/hypoplastic marrow with or without detectable persistent disease after induction chemotherapy or after salvage chemotherapy.\n",
            " \n",
            " BIOMARKER = KMT2A rearranged \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Confirmed presence of a cancer-associated alteration considered pathogenic/likely pathogenic by FM and/or the Genetics Review Panel in one or more of the following genes: BRCA1, BRCA2, ATM, BAP1, MSH2, PALB2, and BRIP1 or in one or more of the DNA-repair genes tested in the FoundationOne FoundationOneCDx (F1CDx) panel including the following genes (Foundation One mutation analysis results performed prior to enrollment on this study may be accepted for eligibility review and in the event that a patient cannot undergo a biopsy and tumor is not available, Foundation Medicine liquid biopsy may be performed): ABL1, ATR, ATRX, BARD1, BRD4, CCND1, CHEK1, CHEK2, DOT1L, FANCC, FANCE, FANCG, FANCL, IKBKE, MEN1, MLH1, MSH2, MSH6, MUTYH, NPM1, PMS2, POLD1, POLE, RAD51, SMARCB1, STK11, TP53;\n",
            "EXCLUSION_CRITERIA: * Other malignancy within the last 5 years except: adequately treated non-melanoma skin cancer, curatively treated in situ cancer of the cervix, ductal carcinoma in situ (DCIS), stage 1, grade 1 endometrial carcinoma, or other solid tumors including lymphomas (without bone marrow involvement) curatively treated with no evidence of disease for >= 5 years. Patients with a history of localized triple negative breast cancer or localized resected prostate cancer may be eligible, provided they completed their adjuvant chemotherapy more than three years prior to registration, and that the patient remains free of recurrent or metastatic disease;\n",
            " \n",
            " BIOMARKER = triple negative triple negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. Has known deleterious/pathogenic mutation or suspected deleterious/pathogenic variant in BRCA1 or BRCA2 (HBOC) or MLH1, MSH2, MSH6, PMS2, or EPCAM (LS);\n",
            " \n",
            " BIOMARKER = BRCA2 mutation, BRCA2 variant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    Patients with tumors harboring actionable KEAP1/NFE2L2/STK11/NF1 mutations Patients with low ASNS expression levels (HGSOC or endometrial cancer) Patients who had immunotherapy (IO) melanoma (Minimum treatment duration of prior PD-1 or PD-L1-containing regimen of 12 weeks [or equivalent of 2 response evaluations]).    Patients with post-platinum HNSCC Patients with chondrosarcoma Patients with ARID1A mutant clear cell ovarian cancer;    Confirmed recurrent high-grade non-mucinous ovarian cancer with low ASNS expression levels that is platinum-resistant, defined as disease relapse within a PFI of < 6 months, and with less than 5 prior therapies.    Patients with tumors harboring actionable KEAP1/NFE2L2 mutations Patients with tumors harboring PIK3CA hotspot mutations, activating AKT mutations, and inactivating PTEN mutations (irrespective of KEAP1/NFE2L2 mutations) Patients with low ASNS expression levels (HGSOC);    Patients with NSCLC with actionable KEAP1/NFE2L2 mutations Patients with HGSOClow ASNS expression levels (irrespective of biomarker status for KEAP1/NFE2L2);\n",
            "EXCLUSION_CRITERIA: Human immunodeficiency virus (HIV) positive patients with a viral load > 400 copies/mL and a CD4+ T-cell count of <350 cells/uL or with a history of an acquired immunodeficiency syndrome (AIDS) opportunistic infection within the past 12 months are excluded. Patients with a higher viral load or lower CD4+ count (< 350 cells/uL) may be considered for eligibility if the patient has a potentially curable malignancy or for interventions in a later stage of development that have demonstrated prior activity with a given cancer.\n",
            " \n",
            " BIOMARKER = NFE2L2 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Patients in Cohort 1 must have (i) a germline or somatic mutation in BRCA1 or BRCA2; and (ii) must have received PARPi monotherapy or PARPi combination-therapy as their immediate prior therapy;   * Patients in Cohort 2 must have: (i) a germline or somatic mutation in any of the following deoxyribonucleic acid (DNA) damage response (DDR) genes: BARD1; FANCA; BRIP1; PALB2; RAD51; RAD51C; RAD51D, with no evidence of mutations in BRCA1 or BRCA2; and (ii) must have received PARPi monotherapy or PARPi combination therapy as the immediate prior therapy;   * Patients in Cohort 3 must be (i) patients who have had PR/CR on prior PARPi monotherapy or PARPi combination treatment; (ii) patients with no evidence of BRCA1 or BRCA2 mutations or any of the relevant DDR aberrations listed in cohort 2; and (iii) patients with no intervening therapy following prior PARP inhibitor-based treatment. Patients with ovarian cancer should not have progressed on platinum-therapy within six months of therapy;   * Patients in Cohort 4 must have KRAS mutated advanced solid tumors. Prior treatments with KRAS inhibitors are permitted. Patients with KRAS G12C mutations must have already had KRAS G12C targeted therapy (e.g., sotorasib) previously;\n",
            " \n",
            " BIOMARKER = FANCA somatic mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Pathogenic somatic mutation detected in genes encoding tyrosine kinase receptors (CSFR1, ERBB3 or ALK), RAS or RAF (may be from original or subsequent biopsy or peripheral blood/bone marrow aspirate). Clinical mutation reports may include quantitative polymerase chain reaction (PCR) (e.g. BRAFV600E) and/or Sanger or next generation sequencing. Immunohistochemistry (e.g. VE1 antibody for BRAFV600E) alone is not sufficient;\n",
            "EXCLUSION_CRITERIA: * Patients with activating mutations in MAP2K1 are not eligible for this study due to drug target specificity. Mutation status will be submitted to study team within 7 days of enrollment;\n",
            " \n",
            " BIOMARKER = RAF somatic mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Availability of a representative tumor specimen that is suitable for determination of PD-L1 status;\n",
            "EXCLUSION_CRITERIA: * NSCLC with an activating EGFR mutation or ALK fusion oncogene; * Known c-ros oncogene 1 (ROS1) rearrangement;\n",
            " \n",
            " BIOMARKER = ALK fusion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. Has known deleterious/pathogenic mutation or suspected deleterious/pathogenic variant in BRCA1 or BRCA2 (HBOC) or MLH1, MSH2, MSH6, PMS2, or EPCAM (LS);\n",
            " \n",
            " BIOMARKER = EPCAM mutation, EPCAM variant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * (b) Pathologically documented MCL [defined as either t(11;14) or overexpression of cyclin D1] for the MCL pilot study;\n",
            " \n",
            " BIOMARKER = cyclin D1 overexpression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: MATCH Treatment Subprotocol H: Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF V600E or V600K Mutations (Excluding Melanoma, Thyroid Cancer, Colorectal Adenocarcinoma, and Non-Small Cell Lung Cancer);\n",
            "INCLUSION_CRITERIA: * Patients must have a BRAF V600E or, V600K, V600R or V600D mutation, or another aberration, as identified via the MATCH Master Protocol;\n",
            "EXCLUSION_CRITERIA: * Patients with history of RAS mutation-positive tumors are not eligible regardless of interval from the current study;\n",
            " \n",
            " BIOMARKER = BRAF V600E \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial;\n",
            "TITLE: Phase Ib/II Trial of SX-682 in Combination With Nivolumab for Refractory RAS Mutated (RAS) Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC) (STOPTRAFFIC-1);\n",
            "INCLUSION_CRITERIA: * Tumor is determined to be RAS-mutated (KRAS or NRAS) and microsatellite stable/proficient in mismatch repair, as assessed by immunohistochemistry (IHC) and/or polymerase chain reaction (PCR)/next generation sequencing (NGS) in a Clinical Laboratory Improvement Act (CLIA) environment;\n",
            " \n",
            " BIOMARKER = KRAS mutated, KRAS mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Participants with known epidermal growth factor receptor (EGFR) mutations which are sensitive to available targeted inhibitor therapy (including, but not limited to, deletions in exon 19 and exon 21 [L858R] substitution mutations) are excluded; * Participants with known anaplastic lymphoma kinase (ALK) translocations which are sensitive to available targeted inhibitor therapy are excluded;\n",
            " \n",
            " BIOMARKER = epidermal growth factor receptor deletions in exon 19, EGFR deletions in exon 19 \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 4. Enough tumor samples from biopsy to testing PD-L1 expression level, and PD-L1 ≥ 1%;\n",
            "EXCLUSION_CRITERIA: 2. Non-squamous cell carcinoma with EGFR active mutation positive or ALK rearrangement; 2. Non-squamous cell carcinoma with EGFR active mutation positive or ALK rearrangement;\n",
            " \n",
            " BIOMARKER = EGFR mutation, EGFR mutation positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase 3, Randomized, Open-label Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced Epidermal Growth Factor Receptor-mutated (EGFRm) Non-small Cell Lung Cancer (NSCLC) After Failure of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy (HERTHENA-Lung02);\n",
            "INCLUSION_CRITERIA: 3. Has documentation of an EGFR-activating mutation detected from tumor tissue or blood sample: exon 19 deletion or L858R at diagnosis or thereafter.\n",
            " \n",
            " BIOMARKER = EGFR L858R \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Must have newly diagnosed, histologically confirmed CD20+ diffuse large b-cell lymphoma [DLBCL] (de novo or histologically transformed from a diagnosis of follicular lymphoma) at most recent representative tumor biopsy based on the pathology report, with a World Health Organization (WHO) 2016 classification and including:   * High grade B-cell lymphoma with MYC and BCL-2 and/or BCL-6 rearrangement with DLBCL morphology. Note: The local pathology report must be available at Screening to support CD20+ DLBCL histology. Composite/intermediate histology with any of the following components is not allowed: high grade B-cell lymphoma, NOS; Hodgkin's lymphoma; primary mediastinal (thymic) large B-cell lymphoma; Burkitt; plasmablastic lymphoma or any CD20- lymphoma, such as anaplastic lymphoma kinase-positive large B-cell lymphoma, human herpesvirus type 8-positive DLBCL, or primary effusion lymphoma.\n",
            " \n",
            " BIOMARKER = BCL-6 rearrangement \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations;\n",
            "INCLUSION_CRITERIA:     * NSCLC with uncommon EGFR mutation (eg, G719X) following standard-of-care therapy with an EGFR inhibitor.     * NSCLC with acquired resistance EGFR mutation (eg, C797S), following a 3rd generation EGFR inhibitor in the 1st line setting (in the absence of concurrent T790M).     * NSCLC with intrinsic resistance EGFR mutation (eg, L858R, G719X) with up to 2 lines of standard-of-care therapy with an EGFR inhibitor.     * NSCLC with acquired resistance EGFR mutation (eg, C797S) with up to 2 lines of therapy, the first line of which must be a 3rd generation EGFR inhibitor (in the absence of concurrent T790M). • Identification of one (or more) EGFR mutations identified in the absence of other known resistance mutations: * Intrinsic resistance EGFR mutations [eg, L858R [dose expansion only], G719X). * EGFR acquired resistance mutation (eg, C797S) to a 3rd generation EGFR inhibitor. * Tumor evidence of EGFR alterations including variants, or mutations with or without amplifications (eg, A289T/V, G598V, S645C).\n",
            " \n",
            " BIOMARKER = EGFR C797S \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer, A ComboMATCH Treatment Trial;\n",
            "TITLE: Phase 2 Trial of Fulvestrant and Binimetinib in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With a Frameshift or Nonsense Mutation or Genomic Deletion in NF1: A ComboMATCH Treatment Trial;\n",
            "INCLUSION_CRITERIA: * Patients must have NF1 nonsense or frameshift mutation, or NF1 whole gene deletion detected in tumor as determined by the ComboMATCH screening assessment; * The tumor must have been determined to be estrogen receptor (ER) and/or progesterone receptor (PgR) positive assessed by current American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for hormone receptor testing. Patients with >= 1% ER or PgR staining by immunohistochemistry (IHC) are considered positive; * The tumor must have been determined to be HER2-negative by current ASCO/CAP guidelines;\n",
            " \n",
            " BIOMARKER = NF1 gene deletion, NF1 Deletion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    a. Nodal types: i. PTCL, not otherwise specified ii. Angioimmunoblastic T-cell lymphoma iii. Anaplastic large cell lymphoma, anaplastic lymphoma kinase (ALK)-negative type;    b. Extra-nodal types: i. Enteropathy-associated T-cell lymphoma ii. Hepato-splenic T-cell lymphoma iii. Subcutaneous panniculitis-like T-cell lymphoma iv. Primary cutaneous gamma-delta T-cell lymphoma v. Primary cutaneous cluster of differentiation 8 positive (CD8+) aggressive epidermotropic lymphoma vi. Primary cutaneous cluster of differentiation 4 positive (CD4+) small/medium T-cell lymphoma;\n",
            "EXCLUSION_CRITERIA:    3. Anaplastic large cell lymphoma, ALK-positive type;    5. Primary cutaneous cluster of differentiation antigen 30 positive (CD30+) T-cell lymphoproliferative disorder;\n",
            " \n",
            " BIOMARKER = ALK -positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Patients in Cohort 1 must have (i) a germline or somatic mutation in BRCA1 or BRCA2; and (ii) must have received PARPi monotherapy or PARPi combination-therapy as their immediate prior therapy;   * Patients in Cohort 2 must have: (i) a germline or somatic mutation in any of the following deoxyribonucleic acid (DNA) damage response (DDR) genes: BARD1; FANCA; BRIP1; PALB2; RAD51; RAD51C; RAD51D, with no evidence of mutations in BRCA1 or BRCA2; and (ii) must have received PARPi monotherapy or PARPi combination therapy as the immediate prior therapy;   * Patients in Cohort 3 must be (i) patients who have had PR/CR on prior PARPi monotherapy or PARPi combination treatment; (ii) patients with no evidence of BRCA1 or BRCA2 mutations or any of the relevant DDR aberrations listed in cohort 2; and (iii) patients with no intervening therapy following prior PARP inhibitor-based treatment. Patients with ovarian cancer should not have progressed on platinum-therapy within six months of therapy;   * Patients in Cohort 4 must have KRAS mutated advanced solid tumors. Prior treatments with KRAS inhibitors are permitted. Patients with KRAS G12C mutations must have already had KRAS G12C targeted therapy (e.g., sotorasib) previously;\n",
            " \n",
            " BIOMARKER = RAD51 somatic mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 2. Histological or cytological confirmed diagnosis of HLA-A2+ NSCLC with no evidence of EGFR mutations or ALK or ROS1 rearrangement;\n",
            "EXCLUSION_CRITERIA: 1. Patient positive for actionable EGFR mutations or ALK or ROS1 rearrangement;\n",
            " \n",
            " BIOMARKER = EGFR mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Advanced solid tumour with identification of markers which may indicate potential for response to p300/CBP inhibition. Markers include loss of function mutations in CREBBP, EP300 or ARID1A, MYC gene amplifications or rearrangements and androgen receptor (AR) gene amplifications or over-expression.\n",
            " \n",
            " BIOMARKER = androgen receptor over-expression, AR over-expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 4. Known positive driver gene mutation, such as EGFR sensitive mutation, ALK gene translocation or ROS1 rearrangement.\n",
            " \n",
            " BIOMARKER = ALK translocation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   3. After completion of Dose level 3, subjects will need to demonstrate a defect in one or more DDR genes such as: ATM (including ATM protein loss by IHC), ATRX, ARID1A, BARD1, BRCA1, BRCA2, BRIP1, CDK12, CHEK2, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCM, MRE11A, MSH2, NBN, PALB2, RAD51, RAD51B, RAD51C, RAD51D, or other related genes at the discretion of the investigator in consultation with sponsor Medical Monitor; Or mutations in p53 pathway/MYC pathway.\n",
            " \n",
            " BIOMARKER = FANCF defect \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * For non-small cell lung cancer participants only: pathogenic somatic mutations or gene fusions in the following genes: EGFR, ALK, ROS1, NTRK, BRAF V600E and KRAS;\n",
            " \n",
            " BIOMARKER = BRAF fusions \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Three Arms Prospective, Randomized Phase II Study to Evaluate the Best Sequential Approach With Combo Immunotherapy (Ipilimumab/Nivolumab) and Combo Target Therapy (LGX818/MEK162) in Patients With Metastatic Melanoma and BRAF Mutation;\n",
            "INCLUSION_CRITERIA: 2. Histologically confirmed stage III (unresectable) or stage IV melanoma with the BRAF V600 mutation. Patients with mucosal melanoma (but not those with ocular melanoma) are eligible for study participation; 5. Presence of BRAF V600E or V600K mutation in tumor tissue prior to enrollment;\n",
            " \n",
            " BIOMARKER = BRAF V600E \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase 2, Open-Label Study in Subjects With Previously Untreated MET Amplified Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC);\n",
            "INCLUSION_CRITERIA: * Must have MET amplification in tumor tissue as determined by the Sponsor-designated central laboratory MET FISH Assay or in plasma and/or tissue by a Sponsor-approved assay.\n",
            "EXCLUSION_CRITERIA: * Alterations in EGFR, ALK, ROS1, or BRAF that predict sensitivity to available targeted therapy. Participants with other alterations that are candidates for available targeted therapy.\n",
            " \n",
            " BIOMARKER = ALK Alterations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial;\n",
            "TITLE: Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial;\n",
            "INCLUSION_CRITERIA: * Participants must have an activating AKT mutation (a known mutation in AKT1, AKT2, or AKT3, a single nucleotide variant, insertion, or deletion) as determined by the ComboMATCH screening assessment;\n",
            "EXCLUSION_CRITERIA: * Participants must not have an activating KRAS, NRAS, HRAS, or BRAF mutation (a single nucleotide variant, insertion, or deletion) as determined by the ComboMATCH screening assessment; * Participants with known diabetes mellitus must not require insulin therapy or have a baseline fasting glucose >150 mg/dL (8.3 mmol/L) or high glycosylated hemoglobin (Hb)A1c, (>= 8.0%), suggesting poorly controlled diabetes;\n",
            " \n",
            " BIOMARKER = AKT deletion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients must have PD-L1 expression Tumor Proportion Score (TPS) >= 1% in tumor cells. If PD-L1 expression TPS is unevaluable or the testing could not be completed, the patients are not eligible. The assay must have been performed by a Clinical Laboratory Improvement Act (CLIA) (or equivalent) certified laboratory; * Patients with known EGFR mutations (except exon 20 insertion), BRAF mutations (V600) or ALK or ROS1 translocations or other driver mutations that can be treated with oral tyrosine kinase inhibitors are excluded;\n",
            " \n",
            " BIOMARKER = BRAF mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations;\n",
            "TITLE: Phase I/II Study of Azacitidine in Combination With Quizartinib for Patients With Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms With FLT3 or CBL Mutations;\n",
            "INCLUSION_CRITERIA: 3. For hypomethylating agent naïve patients: int-2 or higher by IPSS or >5% bone marrow blasts if MDS or dysplastic CMML (WBC <13x109/L). Patients with proliferative (WBC >/= 13x109/L) CMML or MDS/MPN, or those with dysplastic CMML with high-risk molecular features (mutations in ASXL1, TP53 or more than 3 mutations) are also eligible independently of IPSS risk score or bone marrow blast percentage. 5. Detectable FLT3-ITD mutation in bone marrow and/or peripheral blood, or presence of CBL exon 8 or 9 deletions or point mutations.\n",
            "EXCLUSION_CRITERIA: 17. Female patients with reproductive potential who do not have a negative urine or blood beta-human chorionic gonadotropin (beta HCG) pregnancy test at screening.\n",
            " \n",
            " BIOMARKER = ASXL1 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients must have germline or somatic mutations in DDR genes: BARD1, BRCA1, BRCA2, BRIP1, FANCA, NBN, PALB2, RAD51, RAD51B, RAD51C, RAD51D; or actionable mutations in the PTEN gene, or hotspot mutations in the PIK3CA gene (E542, E545 or H1047 are accepted). Local testing in Clinical Laboratory Improvement Act (CLIA)-certified laboratory will be accepted. Only mutations that have been recognized as actionable by the MD Anderson Precision Oncology Decision Support (PODS) team will be accepted; * Patients with a mutation within both the DDR and PTEN/PIK3CA pathways will be assessed by the genomics Precision Oncology Decision Support group at MD Anderson, and the patient will be allocated to the PI3K or DDR expansion group deemed to be the main driver. If the actionability between the groups is deemed to be equivocal, then the patient will be allocated to the expansion cohort with fewer patients;\n",
            "EXCLUSION_CRITERIA: * Other malignancy unless curatively treated with no evidence of disease for >= 5 years except: adequately treated non-melanoma skin cancer, curatively treated in situ cancer of the cervix, ductal carcinoma in situ (DCIS), or stage 1, grade 1 endometrial carcinoma. A patient with a history of localized triple negative breast cancer may be eligible, provided the patient completed the adjuvant chemotherapy > 3 years prior to registration, and the patient remains free of recurrent or metastatic disease;\n",
            " \n",
            " BIOMARKER = RAD51C somatic mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * G6PD deficiency;\n",
            " \n",
            " BIOMARKER = G6PD deficiency \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients may not have a molecular alteration in ALK, ROS1, EGFR, BRAF, NTRK, RET, MET, or any other gene for which first-line FDA approved targeted therapy exists.\n",
            " \n",
            " BIOMARKER = ROS1 alteration \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 12. ER receptor status unknown, Human epidermal growth factor receptor 2 or FISH positive, or Human epidermal growth factor receptor 2 status unknown; 14. Hormone Receptor negative and not received (neo)adjuvant chemotherapy 15. Use of hormone replacement therapy within the last 6 weeks 16. Pregnant or lactating women or women of childbearing potential unwilling/unable to use non-hormonal contraception 17. No previous or concomitant malignancies except adequately treated squamous cell / basal cell carcinoma of the skin, in situ carcinoma of the cervix or ductal carcinoma in situ/lobular carcinoma in situ of the breast, unless there has been a disease-free interval of 10 years or more 18. Psychiatric or addictive disorders which could preclude obtaining informed consent 19. Clinical evidence of severe osteoporosis and/or history of osteoporotic fracture;\n",
            " \n",
            " BIOMARKER = Human epidermal growth factor receptor 2 positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations;\n",
            "TITLE: An Open Label, Multicenter, Single Arm Phase II Study to Evaluate the Activity and Tolerability of the Novel mTOR Inhibitor, MLN0128 (TAK-228), in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract Whose Tumors Harbor a TSC1 and/or a TSC2 Mutation;\n",
            "INCLUSION_CRITERIA: * Patient must have TCCs tumors harboring a TSC1 or TSC2 mutation identified by a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory;\n",
            " \n",
            " BIOMARKER = TSC1 Mutations, TSC1 mutation, TSC1 Mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Advanced solid tumour with identification of markers which may indicate potential for response to p300/CBP inhibition. Markers include loss of function mutations in CREBBP, EP300 or ARID1A, MYC gene amplifications or rearrangements and androgen receptor (AR) gene amplifications or over-expression.\n",
            " \n",
            " BIOMARKER = ARID1A loss of function mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Prior poly ADP ribose polymerase (PARP) inhibitor therapy is allowed; patients with ovarian cancer and a BRCA mutation should have had prior treatment with olaparib per guidelines for standard of care treatment;\n",
            " \n",
            " BIOMARKER = BRCA mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 7. histomolecular pathology confirming the absence of classic driver oncogene mutations in EGFR, ALK, or ROS1.\n",
            " \n",
            " BIOMARKER = ROS1 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 6. Have confirmation that EGFR-, ALK-, or ROS1-directed therapy is not indicated as primary therapy. Subjects who have failed directed therapy are not eligible for the study.\n",
            " \n",
            " BIOMARKER = ALK - \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   * Pathogenic somatic mutation detected in genes encoding tyrosine kinase receptors (CSFR1, ERBB3 or ALK), RAS or RAF (may be from original or subsequent biopsy or peripheral blood/bone marrow aspirate). Clinical mutation reports may include quantitative polymerase chain reaction (PCR) (e.g. BRAFV600E) and/or Sanger or next generation sequencing. Immunohistochemistry (e.g. VE1 antibody for BRAFV600E) alone is not sufficient;\n",
            "EXCLUSION_CRITERIA: * Patients with activating mutations in MAP2K1 are not eligible for this study due to drug target specificity. Mutation status will be submitted to study team within 7 days of enrollment;\n",
            " \n",
            " BIOMARKER = ALK somatic mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase 1 Study of the Polymerase Theta (POLQ) Inhibitor Novobiocin in BRCA-Mutant and Other DNA Damage Repair-Deficient Solid Tumors;\n",
            "INCLUSION_CRITERIA: * Patients must have histologically confirmed solid tumor with a known pathogenic mutation in BRCA1/2, PALB2, RAD51C, RAD51D, ATM, BARD1, BLM, BRIP1, CDK12, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCM, MRE11A, NBN (NBS1), RAD50 and RAD51B as confirmed by a Clinical Laboratory Improvement Amendments (CLIA)-certified method. Patients with alterations defined only by germline testing are eligible;\n",
            " \n",
            " BIOMARKER = FANCF mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. Locally advanced/metastatic non-small cell lung cancer diagnosed by histology or cytology. no epidermal growth factor receptor (EGFR) sensitive mutations, anaplastic lymphoma kinase (ALK) gene rearrangement, ROS Proto-oncogene 1 (ROS1) gene fusion.\n",
            " \n",
            " BIOMARKER = ROS Proto-oncogene 1 fusion, ROS1 fusion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: MATCH Treatment Subprotocol H: Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF V600E or V600K Mutations (Excluding Melanoma, Thyroid Cancer, Colorectal Adenocarcinoma, and Non-Small Cell Lung Cancer);\n",
            "INCLUSION_CRITERIA: * Patients must have a BRAF V600E or, V600K, V600R or V600D mutation, or another aberration, as identified via the MATCH Master Protocol;\n",
            "EXCLUSION_CRITERIA: * Patients with history of RAS mutation-positive tumors are not eligible regardless of interval from the current study;\n",
            " \n",
            " BIOMARKER = BRAF V600R \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.\n",
            "TITLE: Phase II Study of Ponatinib for Advanced Cancers With Genomic Alterations in Fibroblastic Growth Factor Receptor (FGFR) and Other Genomic Targets (KIT, PDGFRá, RET FLT3, ABL1);\n",
            "INCLUSION_CRITERIA: * Patients should have activating genomic alterations in FGFR (mutations, fusions or amplifications [> 6 copies]) or activating genomic alterations in KIT, platelet-derived growth factor receptor alpha [PDGFRα], ret proto-oncogene [RET], ABL proto-oncogene 1, non-receptor tyrosine kinase [ABL1] and fms-related tyrosine kinase 3 [FLT3] by any validated Clinical Laboratory Improvement Amendments [CLIA]-certified molecular testing (fluorescent in situ hybridization [FISH], polymerase chain reaction [PCR] or sequencing data are acceptable); CLIA validated results from other institutions; diagnostic labs (e.g. foundation medicine) are acceptable; additional types of activating alterations in these genes can be approved by the principal investigator (PI);\n",
            "EXCLUSION_CRITERIA:   * PDGFRA D842V mutation;   * cKIT D816V mutation;   * FLT3 D835V/Y/H/F or Y842C mutations;   * FGFR3 K652E mutation;\n",
            " \n",
            " BIOMARKER = FLT3 D835V/Y/H/F \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: The Expanded Access Use of Vorasidenib in Patients With IDH1 or IDH2 Mutated Glioma;\n",
            "INCLUSION_CRITERIA: * Have IDH-mutant oligodendroglioma or astrocytoma per WHO 2021 criteria, with the IDH1 or IDH2 gene mutation confirmed by tissue-based diagnosis.\n",
            "EXCLUSION_CRITERIA: * Patient has IDH1-mutant glioma that is predominantly contrast-enhancing and the patient is eligible for ivosidenib Patient Assistance Program or able to access ivosidenib through a third-party payer.\n",
            " \n",
            " BIOMARKER = IDH1 mutation, IDH1 Mutated, IDH1 mutated, IDH1-mutant mutant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   3. After completion of Dose level 3, subjects will need to demonstrate a defect in one or more DDR genes such as: ATM (including ATM protein loss by IHC), ATRX, ARID1A, BARD1, BRCA1, BRCA2, BRIP1, CDK12, CHEK2, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCM, MRE11A, MSH2, NBN, PALB2, RAD51, RAD51B, RAD51C, RAD51D, or other related genes at the discretion of the investigator in consultation with sponsor Medical Monitor; Or mutations in p53 pathway/MYC pathway.\n",
            " \n",
            " BIOMARKER = MSH2 defect \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer;\n",
            "TITLE: A Randomized Phase II Trial of Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer Eligible for Platinum-based Chemotherapy. Supported by: DIAGNOSTIC PROTOCOL for the VENTANA FOLR1 (FOLR1-2.1) CDx Assay Ventana No. RD004881; Protocol Document No. D152967;\n",
            "INCLUSION_CRITERIA: 4. Patients with wildtype BRCA1/2 mutation status or with a deleterious BRCA1/2 mutation in germline or somatic testing if they underwent PARP inhibitor therapy in previous treatment line.\n",
            "EXCLUSION_CRITERIA: 3. Unknown BRCA status.\n",
            " \n",
            " BIOMARKER = BRCA1/2 wildtype \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Diagnosis of mantle cell lymphoma (MCL) reviewed and approved by central laboratory: diagnosis must include morphology and expression of either cyclin D1 in association with other relevant markers (eg, CD19, CD20, PAX5 and CD5) or evidence of t(11;14) as assessed by cytogenetics, fluorescent in situ hybridization (FISH), or polymerase chain reaction (PCR);\n",
            " \n",
            " BIOMARKER = CD20 expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Known DPD deficiency;\n",
            " \n",
            " BIOMARKER = DPD deficiency \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor;\n",
            "TITLE: A Phase I Trial of Osimertinib (AZD9291) and Necitumumab in EGFR-Mutant Non-Small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor;\n",
            "INCLUSION_CRITERIA: * NSCLC must harbor at least one of the following EGFR activating mutations: Exon 21 L858R, Exon 19 deletion, Exon 18 G719X, Exon 21 L861Q or for EGFR Exon 20 insertion expansion cohort D, NSCLC must harbor an EGFR Exon 20 insertion performed by a Clinical Laboratory Improvement Act (CLIA) certified test; * For Dose Expansion Cohort A: patient must 1) have progression of disease on erlotinib, gefitinib or afatinib as last previous systemic treatment, 2) have biopsy of tumor taken after progression on erlotinib, gefitinib or afatinib which must be EGFR-T790M negative confirmed by central testing prior to treatment (if EGFR-T790M status is unknown, patients may consent for trial and for biopsy and testing for EGFR T790M will be performed as part of initial biopsy for trial), and 3) be treatment naive to 3rd generation EGFR-TKI (rociletinib, EGFR inhibitor HM61713 [HM61713] and osimertinib [AZD9291]) and EGFR monoclonal antibodies; * For Dose Expansion Cohort B (closed to accrual as of 8/30/18): patient must 1) have progression of disease on a 3rd generation EGFR-TKI such as AZD9291, rociletinib, HM61713, 2) be treatment naive to an EGFR monoclonal antibody, and 3) have a biopsy of tumor taken after progression on last EGFR-TKI that indicates loss of EGFR-T790M (EGFR-T790M negative) confirmed by central testing prior to treatment (if EGFR-T790M status is unknown, patients may consent for trial and for biopsy, and testing for EGFR T790M will be performed as part of initial biopsy for trial); * For Dose Expansion Cohort C: patient must 1) have progression of disease on a 3rd generation EGFR-TKI such as osimertinib (AZD9291), rociletinib, HM61713, 2) be treatment naive to an EGFR monoclonal antibody, 3) have a biopsy of tumor taken after progression on last EGFR-TKI that indicates preservation of EGFR-T790M post-progression on 3rd generation EGFR-TKI with biopsy confirmation by central testing prior to treatment (if EGFR-T790M status is unknown, patients may consent for trial and for biopsy, and testing for EGFR T790M will be performed as part of initial biopsy for trial); * For Dose Expansion Cohort D: patient must 1) tumor that harbors an EGFR Exon 20 insertion by a CLIA certified test, and 2) have progressive disease on or after platinum based chemotherapy, and 3) be treatment naïve to 3rd generation and beyond EGFR-TKI (i.e., osimertinib [AZD9291], poziotinib, TAK-778) and EGFR monoclonal antibody; patient who received 1st or 2nd generation EGFR-TKI (such as erlotinib, gefitinib, afatinib) are eligible provided that they did not achieve a response to treatment or they did not have a duration of treatment on EGFR-TKI of 6 months or more;\n",
            " \n",
            " BIOMARKER = EGFR Exon 19 deletion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.\n",
            "TITLE: A Phase II Study Evaluating Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated Non-small Cell Lung Cancer (NSCLC);\n",
            "INCLUSION_CRITERIA: 2. Patients with EGFR sensitizing mutations (Ex19del or L858R).\n",
            "EXCLUSION_CRITERIA: 3. Other positive driver mutations, including ALK, ROS1, MET14 exon skipping, BRAF, RET, etc.\n",
            " \n",
            " BIOMARKER = RET positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * For non-small cell lung cancer participants only: pathogenic somatic mutations or gene fusions in the following genes: EGFR, ALK, ROS1, NTRK, BRAF V600E and KRAS;\n",
            " \n",
            " BIOMARKER = EGFR fusions \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer, A ComboMATCH Treatment Trial;\n",
            "TITLE: Phase 2 Trial of Fulvestrant and Binimetinib in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With a Frameshift or Nonsense Mutation or Genomic Deletion in NF1: A ComboMATCH Treatment Trial;\n",
            "INCLUSION_CRITERIA: * Patients must have NF1 nonsense or frameshift mutation, or NF1 whole gene deletion detected in tumor as determined by the ComboMATCH screening assessment; * The tumor must have been determined to be estrogen receptor (ER) and/or progesterone receptor (PgR) positive assessed by current American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for hormone receptor testing. Patients with >= 1% ER or PgR staining by immunohistochemistry (IHC) are considered positive; * The tumor must have been determined to be HER2-negative by current ASCO/CAP guidelines;\n",
            " \n",
            " BIOMARKER = PgR positive, progesterone receptor positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements;\n",
            "TITLE: A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1);\n",
            "INCLUSION_CRITERIA: 1. Histologically or cytologically confirmed diagnosis of locally advanced, or metastatic solid tumor (including primary CNS tumors) (Stage IV, American Joint Committee on Cancer v.7) that harbors an ALK, ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement by protocol specified tests. 1. Histologically or cytologically confirmed diagnosis of locally advanced, or metastatic solid tumor (including primary CNS tumors) that harbors a ROS1, or NTRK1-3 gene fusion. 2. Subject must have a documented ROS1 or NTRK1-3 gene fusion determined by tissue-based local testing using either: 7. Subjects with advanced solid tumors harboring ROS1, NTRK1, NTRK2, or NTRK3 rearrangement will be assigned into 6 distinct expansion (EXP) cohorts provided all inclusion and exclusion criteria are met.    i. EXP-1: ROS1 TKI-naïve ROS1+ NSCLC ii. EXP-2: 1 Prior ROS1 TKI and 1 Platinum based chemo ROS1+ NSCLC iii. EXP-3: 2 Prior ROS1 TKIs ROS1+ NSCLC (No Chemo or IO) iv. EXP-4: 1 Prior ROS1 TKI ROS1+ NSCLC (No Chemo or IO) v. EXP-5: TRK TKI-naïve NTRK+ solid tumors vi. EXP-6: TRK TKI-pretreated NTRK+ solid tumors;\n",
            " \n",
            " BIOMARKER = NTRK1-3 fusion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer, A ComboMATCH Treatment Trial;\n",
            "TITLE: Phase 2 Trial of Fulvestrant and Binimetinib in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With a Frameshift or Nonsense Mutation or Genomic Deletion in NF1: A ComboMATCH Treatment Trial;\n",
            "INCLUSION_CRITERIA: * Patients must have NF1 nonsense or frameshift mutation, or NF1 whole gene deletion detected in tumor as determined by the ComboMATCH screening assessment; * The tumor must have been determined to be estrogen receptor (ER) and/or progesterone receptor (PgR) positive assessed by current American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for hormone receptor testing. Patients with >= 1% ER or PgR staining by immunohistochemistry (IHC) are considered positive; * The tumor must have been determined to be HER2-negative by current ASCO/CAP guidelines;\n",
            " \n",
            " BIOMARKER = ER positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 1. Diagnosis of Microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) and/or BRAF V600E mutation positive colorectal cancer. 19. Known dihydropyrimidine dehydrogenase deficiency.\n",
            " \n",
            " BIOMARKER = BRAF mutation positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   4. LungMate-004: Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma;   7. LungMate-007: Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma;   9. LungMate-012: Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma;\n",
            " \n",
            " BIOMARKER = EGFR Mutation-Positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements;\n",
            "TITLE: A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1);\n",
            "INCLUSION_CRITERIA: 1. Histologically or cytologically confirmed diagnosis of locally advanced, or metastatic solid tumor (including primary CNS tumors) (Stage IV, American Joint Committee on Cancer v.7) that harbors an ALK, ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement by protocol specified tests. 1. Histologically or cytologically confirmed diagnosis of locally advanced, or metastatic solid tumor (including primary CNS tumors) that harbors a ROS1, or NTRK1-3 gene fusion. 2. Subject must have a documented ROS1 or NTRK1-3 gene fusion determined by tissue-based local testing using either: 7. Subjects with advanced solid tumors harboring ROS1, NTRK1, NTRK2, or NTRK3 rearrangement will be assigned into 6 distinct expansion (EXP) cohorts provided all inclusion and exclusion criteria are met.    i. EXP-1: ROS1 TKI-naïve ROS1+ NSCLC ii. EXP-2: 1 Prior ROS1 TKI and 1 Platinum based chemo ROS1+ NSCLC iii. EXP-3: 2 Prior ROS1 TKIs ROS1+ NSCLC (No Chemo or IO) iv. EXP-4: 1 Prior ROS1 TKI ROS1+ NSCLC (No Chemo or IO) v. EXP-5: TRK TKI-naïve NTRK+ solid tumors vi. EXP-6: TRK TKI-pretreated NTRK+ solid tumors;\n",
            " \n",
            " BIOMARKER = ROS1 + \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase 1 Study of the Polymerase Theta (POLQ) Inhibitor Novobiocin in BRCA-Mutant and Other DNA Damage Repair-Deficient Solid Tumors;\n",
            "INCLUSION_CRITERIA: * Patients must have histologically confirmed solid tumor with a known pathogenic mutation in BRCA1/2, PALB2, RAD51C, RAD51D, ATM, BARD1, BLM, BRIP1, CDK12, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCM, MRE11A, NBN (NBS1), RAD50 and RAD51B as confirmed by a Clinical Laboratory Improvement Amendments (CLIA)-certified method. Patients with alterations defined only by germline testing are eligible;\n",
            " \n",
            " BIOMARKER = FANCA mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. Dose escalation part: patients with histologically or cytologically confirmed diagnosis of advanced (unresectable or metastatic) mesothelioma or other solid tumors. Patients with solid tumors other than mesothelioma must have local available data for loss-of-function NF2/LATS1/LATS2 genetic alterations (truncating mutation or gene deletion; LATS1/LATS2 mutations will only be included in the dose escalation part), or functional YAP/TAZ fusions. Patients with malignant EHE can be enrolled with only histological confirmation of the disease. Patients must have failed available standard therapies, be intolerant of or ineligible for standard therapy, or for whom no standard therapy exists.    Group 2: Advanced (unresectable or metastatic) solid tumor patients with available local data for NF2 truncating mutation or deletions. Patient must have failed available standard therapies, be intolerant or ineligible to receive such therapy, or for whom no standard therapy exists.\n",
            "EXCLUSION_CRITERIA:    3. Total calcium (corrected for low serum albumin);\n",
            " \n",
            " BIOMARKER = LATS2 loss-of-function \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Female participants who are at least 18 years of age on the day of signing informed consent with histologically confirmed diagnosis of small cell carcinoma of the ovary of hypercalcemic type (SCCOHT), ovarian clear cell carcinoma (OCCC), endometrioid ovarian carcinoma (EOC) or endometrioid endometrial carcinoma (EEC) with confirmed mutations in one of the SWI/SNF genes (SMARCA4, ARID1A) will be enrolled in this study.\n",
            " \n",
            " BIOMARKER = ARID1A mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations;\n",
            "TITLE: A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations;\n",
            "INCLUSION_CRITERIA: 1. Documented genetic ALK, ROS1, or NTRK1-3 alteration (point mutation, fusion, amplification) as identified by local testing in a Clinical Laboratory Improvement Amendments (CLIA) laboratory in the US or equivalently accredited diagnostic lab outside the United States (US) is required.    * Cohort 1: Subjects with NTRK fusion gene positive (NTRK+) advanced solid tumors (including primary CNS tumors), that are tropomyosin receptor kinase (TRK) TKI naïve;    * Cohort 2: subjects with NTRK+ advanced solid tumors (including primary CNS tumors), that are TRK TKI pre-treated;    * Cohort 3: subjects with tumors or ALCL characterized by other ALK/ROS1/NTRK alterations or NTRK fusions without centrally confirmed measurable disease or not otherwise eligible for Cohort 1 or 2.\n",
            " \n",
            " BIOMARKER = NTRK1-3 Alterations, NTRK1-3 alterations, NTRK1-3 alteration, NTRK1-3 point mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    Patients with tumors harboring actionable KEAP1/NFE2L2/STK11/NF1 mutations Patients with low ASNS expression levels (HGSOC or endometrial cancer) Patients who had immunotherapy (IO) melanoma (Minimum treatment duration of prior PD-1 or PD-L1-containing regimen of 12 weeks [or equivalent of 2 response evaluations]).    Patients with post-platinum HNSCC Patients with chondrosarcoma Patients with ARID1A mutant clear cell ovarian cancer;    Confirmed recurrent high-grade non-mucinous ovarian cancer with low ASNS expression levels that is platinum-resistant, defined as disease relapse within a PFI of < 6 months, and with less than 5 prior therapies.    Patients with tumors harboring actionable KEAP1/NFE2L2 mutations Patients with tumors harboring PIK3CA hotspot mutations, activating AKT mutations, and inactivating PTEN mutations (irrespective of KEAP1/NFE2L2 mutations) Patients with low ASNS expression levels (HGSOC);    Patients with NSCLC with actionable KEAP1/NFE2L2 mutations Patients with HGSOClow ASNS expression levels (irrespective of biomarker status for KEAP1/NFE2L2);\n",
            "EXCLUSION_CRITERIA: Human immunodeficiency virus (HIV) positive patients with a viral load > 400 copies/mL and a CD4+ T-cell count of <350 cells/uL or with a history of an acquired immunodeficiency syndrome (AIDS) opportunistic infection within the past 12 months are excluded. Patients with a higher viral load or lower CD4+ count (< 350 cells/uL) may be considered for eligibility if the patient has a potentially curable malignancy or for interventions in a later stage of development that have demonstrated prior activity with a given cancer.\n",
            " \n",
            " BIOMARKER = ASNS expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations;\n",
            "TITLE: Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients With Germline BRCA1 or BRCA2 Mutations;\n",
            "INCLUSION_CRITERIA: * Patients must have one of the following mutations: germline mutation in BRCA 1 or 2 that was tested in a Clinical Laboratory Improvement Act (CLIA) certified lab defined as positive and/or deleterious (that is, pathogenic or likely pathogenic variant). (NOTE: Patients with tumor somatic mutations are not eligible);\n",
            " \n",
            " BIOMARKER = BRCA1 mutations, BRCA 1 or 2 mutations, BRCA1 Mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer;\n",
            "TITLE: A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients With Advanced or Metastatic Solid Tumors Including EGFR-mutated Non-Small Cell Lung Cancer;\n",
            "INCLUSION_CRITERIA: * Participant must have histologically or cytologically confirmed, locally advanced or metastatic, non-small cell lung cancer (NSCLC) that is not amenable to curative therapy including surgical resection or chemoradiation. Additional Cohort specific disease requirements include: Cohorts 1, 3, 3b, 5, 6 and 7: epidermal growth factor receptor (EGFR) exon 19 deletion (Exon19del) or Exon 21 L858R mutation; Cohort 2: EGFR Exon 20ins mutation. Cohorts 1,5,and6: Participant should not have received any prior systemic therapy for locally advanced or metastatic NSCLC. Cohort 2: Participant should not have received any prior systemic therapy for locally advanced or metastatic NSCLC. Cohorts 3and3b: Participant must have progressed on or after osimertinib monotherapy as the most recent line of treatment. Osimertinib must have been administered as either the first-line treatment for locally advanced or metastatic disease or in the second-line setting after prior treatment with first- or second-generation EGFR tyrosine kinase inhibitor (TKI) as a monotherapy. Cohort 4: Participants need to currently be on an amivantamab IV Q2W regimen (1,050 mg or 1,400 mg depending on weight) for at least 8 weeks, as part of standard of care, an expanded access program, or as a rollover from a long-term extension, without any amivantamab dose reduction. Cohort 7: Participants must have progressed on or after the combination of amivantamab and lazertinib as the most recent line of treatment. The combination of amivantamab and lazertinib must have been administered as the first-line treatment for locally advanced or metastatic disease. Cohort 2, 3, 3b, and 7 only: Squamous NSCLC are excluded. EGFR mutation must have been identified as determined by Food and Drug Administration (FDA) approved or other validated test of either circulating tumor deoxyribonucleic acid (ctDNA) or tumor tissue in a clinical laboratory improvement amendments (CLIA) certified laboratory (sites in the United states [US]) or an accredited local laboratory (sites outside of the US). A copy of the initial test report documenting the EGFR mutation must be included in the participant records and a deidentified copy must also be submitted to the sponsor;\n",
            " \n",
            " BIOMARKER = EGFR leucine 858 to arginine, EGFR L858R, epidermal growth factor receptor L858R \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors;\n",
            "TITLE: A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors;\n",
            "INCLUSION_CRITERIA: 5. Group A: Histologically-confirmed primary cancer or brain metastasis with MET alteration identified through molecular testing. 6. Group B: Histiologically-confirmed WHO grade IV glioma (glioblastoma or gliosarcoma) with MET alteration identified through molecular testing. 7. Group C: NSCLC with documented activating mutation of the EGFR receptor including T790M status, and with acquired resistance on previous EGFR-TKI therapy, and MET alteration identified through molecular testing.\n",
            " \n",
            " BIOMARKER = EGFR T790M \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 1. BRCA1 or BRCA2 germline gene mutation test result with:    1. Pathogenic, ambiguous or inconclusive result available within 28 days prior to starting study treatment (subjects with BRCA1 or BRCA 2 variants of uncertain significance can enroll onto the study as long as there is no intent to administer PARP inhibitors for front-line maintenance therapy), or;    2. Known BRCA1 and BRCA2 somatic mutations, if testing is performed; 2. Known Somatic Homologous Recombination Deficiency (HRD) who will receive PARP inhibitor front-line maintenance therapy. Subjects with somatic HRD are eligible as long as there is no intent to administer PARP inhibitor front-line maintenance therapy.\n",
            " \n",
            " BIOMARKER = BRCA1 gene mutation, BRCA1 somatic mutations, BRCA1 variants \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC);\n",
            "INCLUSION_CRITERIA: * Previously registered to A151216, with the result of lung cancer harboring an EGFR exon 19 deletion or L858R mutation; the testing must have been performed by one of the following criteria:      * Patients with known resistant mutations in the EGFR tyrosine-kinase (TK) domain (T790M) are not eligible;      * Patients that are both EGFR mutant and anaplastic lymphoma kinase (ALK) rearrangements will be registered to A081105;\n",
            " \n",
            " BIOMARKER = EGFR exon 19 deletion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: -BRAFV600E mutation in tumor tissue or plasma as determined by a local laboratory PCR or NGS assay and documented in a local pathology report.\n",
            "EXCLUSION_CRITERIA: * EGFR mutation, ALK fusion oncogene, or ROS1 rearrangement. -Documentation of any tumor-driving molecular alteration (eg, BRAF, EGFR, ALK);\n",
            " \n",
            " BIOMARKER = ALK alteration \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status;\n",
            "TITLE: Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status;\n",
            "INCLUSION_CRITERIA: 3. RAS gene mutation or wild type, BRAF wild type, MSS type;\n",
            "EXCLUSION_CRITERIA: 14. BRAF gene mutation type, MSI-H;\n",
            " \n",
            " BIOMARKER = BRAF mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations;\n",
            "TITLE: A Phase I/II Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations;\n",
            "INCLUSION_CRITERIA: * IDH1 or IDH2 mutation status confirmed by TSO500 performed in LP, NCI;\n",
            " \n",
            " BIOMARKER = IDH1/2 mutation status, IDH1 mutation status \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease;\n",
            "TITLE: SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) Plus Palbociclib Versus Anastrozole Plus Palbociclib for the Treatment of Patients With Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease;\n",
            "INCLUSION_CRITERIA: * Histologically or cytologically documented diagnosis of ER+, HER2-negative breast cancer based on local laboratory results. * Previously untreated with any systemic anti-cancer therapy for their locoregionally recurrent or metastatic ER+ disease. * Have ER proteins but not overexpression of HER2 protein in their tumors;\n",
            " \n",
            " BIOMARKER = HER2 overexpression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer;\n",
            "TITLE: HERTHENA-Lung01: A Phase 2 Randomized Open-Label Study of Patritumab Deruxtecan (U3-1402) in Subjects With Previously Treated Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer (NSCLC);\n",
            "INCLUSION_CRITERIA:   * Prior treatment with osimertinib. Participants receiving an EGFR TKI at the time of signing informed consent should continue to take the EGFR TKI until 5 days prior to Cycle 1 Day 1. Participants in South Korea known to harbor a clinically actionable genomic alteration in addition to EGFR mutation (e.g., anaplastic lymphoma kinase [ALK] or ROS1 protocol oncogene 1 [ROS1] fusion) for which treatment is available must have also received prior treatment with at least 1 approved genotype-directed therapy, unless unable (i.e., if contraindicated). No new testing for these genomic alterations (e.g., ALK or ROS1 fusion) is required for Screening. * Documentation of an EGFR-activating mutation detected from tumor tissue or blood sample: exon 19 deletion or L858R.\n",
            " \n",
            " BIOMARKER = ROS1 alterations, ROS1 alteration, ROS1 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Diagnosis of mantle cell lymphoma (MCL) reviewed and approved by central laboratory: diagnosis must include morphology and expression of either cyclin D1 in association with other relevant markers (eg, CD19, CD20, PAX5 and CD5) or evidence of t(11;14) as assessed by cytogenetics, fluorescent in situ hybridization (FISH), or polymerase chain reaction (PCR);\n",
            " \n",
            " BIOMARKER = cyclin D1 expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Patients with documented glucose-6-phosphate dehydrogenase deficiency.\n",
            " \n",
            " BIOMARKER = glucose-6-phosphate dehydrogenase deficiency \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    * High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (HGBCL);    * Mantle cell lymphoma (MCL) (pathologically confirmed, with documentation of monoclonal B cells that have a chromosome translocation t(11;14)(q13;q32) and/or overexpress cyclin D1);    * Anti-CD20 monoclonal antibody (unless investigator determines that tumor is CD20-negative) and;    * Anti-CD20 monoclonal antibody (unless investigator determines that tumor is CD20-negative) and; 5. CD19 positive (detected by immunohistochemistry [IHC]).\n",
            " \n",
            " BIOMARKER = MYC rearrangements \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Advanced solid tumour with identification of markers which may indicate potential for response to p300/CBP inhibition. Markers include loss of function mutations in CREBBP, EP300 or ARID1A, MYC gene amplifications or rearrangements and androgen receptor (AR) gene amplifications or over-expression.\n",
            " \n",
            " BIOMARKER = EP300 loss of function mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Previously untreated patients with CD20-positive DLBCL, including one of the following diagnoses made according to the 2016 World Health Organization (WHO) classification of lymphoid neoplasms;   * High-grade B-cell lymphoma (HGBCL) with MYC and BCL2 and/or BCL6 translocations;\n",
            " \n",
            " BIOMARKER = BCL2 translocations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial);\n",
            "TITLE: A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY);\n",
            "INCLUSION_CRITERIA: * Participants must have documentation of NSCLC with a MET exon 14 skipping mutation determined by tissue-based or blood-based (circulating tumor DNA [ctDNA]) next generation sequencing (NGS) assay done within a laboratory with Clinical Laboratory Improvement Act (CLIA), International Organization for Standardization (ISO)/ International Electrotechnical Commission (IEC), College of American Pathologists (CAP), or similar certification. Documentation must either be:   * Submitted documentation in the LUNGMAP Rave Electronic Data Capture System of a MET exon 14 skipping mutation from a previously completed tissue or blood-based NGS test NOTE: Participants previously tested for and determined to have a MET exon 14 skipping mutation, outside of LUNGMAP, must also submit tissue for central Foundation Medicine (FMI) testing on the LUNGMAP screening protocol, if available; * Participants must not have other known actionable oncogenic alterations, such as (but not limited to) EGFR sensitizing mutations, EGFR T790M mutation, ALK gene fusion, ROS1 gene rearrangement, RET gene rearrangement, NTRK rearrangement, HER2 mutation, KRAS activating mutations, and BRAF V600E mutation;\n",
            " \n",
            " BIOMARKER = ALK fusion \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Patients with known TP53 mutant tumours (Note: testing is not mandatory for inclusion).\n",
            " \n",
            " BIOMARKER = TP53 mutant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:      * Subjects will be eligible for Part A irrespective of PD-L1 expression.      * Subjects will be eligible for Part A irrespective of EGFR or ALK mutation status. However, subjects with an EGFR sensitizing mutation or ALK translocation must have received and then progressed or been intolerant to at least 1 prior line of approved targeted therapy to be eligible for Part A.      * Subject has provided a formalin-fixed tumor sample from a biopsy of a tumor lesion either at the time of or after the diagnosis of metastatic disease AND from a site not previously irradiated, to assess for PD-L1 status. Biopsies obtained PRIOR to the administration of any systemic therapy to treat the subject's tumor (such as neoadjuvant/adjuvant therapy) will not be permitted for analysis. The tissue sample must be received by the central laboratory vendor prior to enrollment. Fine needle aspirates, Endobronchial Ultrasound (EBUS) or cell blocks are not acceptable. Needle or excisional biopsies, or resected tissue is required. If the tumor specimen is not evaluable for PD-L1 expression by the central laboratory, an additional tumor specimen may be submitted.      * Subject's tumor has PD-L1 expression of ≥50%, as determined by immunohistochemistry (IHC) at a central laboratory.      * Subject's tumor does not harbour an EGFR sensitizing (activating) mutation or ALK translocation. EGFR sensitizing mutations are mutations that are amenable to treatment with TKIs (e.g., erlotinib, gefitinib, afatanib, osimertinib). ALK translocations are amendable to treatment with TKIs such as crizotinib, alectinib and ceritinib. Investigators must produce the source documentation of the EGFR mutation and ALK translocation status in all subjects with non-squamous histology AND for subjects in whom testing is clinically indicated. If either an EGFR sensitizing mutation or ALK translocation is detected, additional information regarding the mutation status of the other molecule is not required. If the clinical site is unable to provide the source documentation, EGFR and ALK testing should be performed per institutional standard of care.\n",
            "EXCLUSION_CRITERIA: 30. In Part C, subject has an EGFR sensitizing mutation and/or an ALK translocation; 31. In Part C, baseline tumor specimen is not evaluable for PD-L1 expression by the central laboratory. If an additional tumor specimen is submitted AND evaluable for PD-L1 expression, the subject will be eligible to participate if PD-L1 expression is assessed as ≥50% by the central laboratory;\n",
            " \n",
            " BIOMARKER = PD-L1 expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation;\n",
            "TITLE: Randomized Phase II Trial of Encorafenib and Cetuximab With or Without Nivolumab (NSC #748726) for Patients With Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer;\n",
            "INCLUSION_CRITERIA: * Participants must have BRAF^V600E mutated colorectal cancer as tested in a Clinical Laboratory Improvement Act (CLIA)-certified laboratory; * Participants must have proficient mismatch repair (pMMR) or microsatellite stable (MSS) status as tested in a CLIA-certified laboratory and documented by the treating clinician. Proficient mismatch repair status can be determined by intact expression by immunohistochemistry of all 4 mismatch repair proteins (MLH1, MSH2, MSH6, and PMS2). Microsatellite instability can be determined by polymerase chain reaction (PCR);\n",
            " \n",
            " BIOMARKER = MSH6 expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of D3S-001 as Monotherapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation;\n",
            "TITLE: A Phase 1, Open-label, Dose-escalation and Dose-expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of D3S-001 Monotherapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation;\n",
            "INCLUSION_CRITERIA: * Subject must have documented KRAS p.G12C mutation identified within the last 5 years by a local test on tumor tissue or blood.\n",
            " \n",
            " BIOMARKER = KRAS mutation, Kirsten rat sarcoma viral oncogene homolog mutation, KRAS Mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: Documented HLA-A*02:01 positivity after the patient has provided written informed consent.    * lymphocytes ≥ 1 x 10⁹/L, among which ≥ 10 % of CD8+ T cells at screening or at baseline and;\n",
            "EXCLUSION_CRITERIA: 2. Patient has documented evidence of EGFR mutation, ALK fusion or ROS1 fusion (according to current ESMO clinical practice guidelines) or any mutation for which targeted treatment options would be indicated, as per SoC.\n",
            " \n",
            " BIOMARKER = EGFR mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors;\n",
            "TITLE: A Phase Ib, Multi-center, Open-Lable, Dose-Escalation and Dose-Expansion Study of Efficacy and Safety of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors;\n",
            "INCLUSION_CRITERIA:   3. Agreement to provide a required tumor tissue sample (preferably fresh biopsy tissue or archived tumor tissue within 2 years prior to first dosing) that has been tested by the central laboratory and determined to be positive for LTK gene fusion.\n",
            "EXCLUSION_CRITERIA:   1. Carrying known major driver gene mutations other than LTK gene, such as EGFR, MET, ALK, ROS1, NTRK, etc. (Patients with co-mutations may be discussed with the investigator for eligibility).\n",
            " \n",
            " BIOMARKER = ALK gene mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Tumor PD-L1 expression as determined by immunohistochemistry assay of archival tumor tissue or tissue obtained at screening; * Tumor PD-L1 expression as determined by immunohistochemistry assay of archival tumor tissue or tissue obtained at screening;\n",
            "EXCLUSION_CRITERIA: * Participants with the following muations, rearrangements, translocations are not eligible: EGFR, ALK, ROS1, BRAFV600E, and NTRK;\n",
            " \n",
            " BIOMARKER = ALK rearrangements \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients must have germline or somatic mutations in DDR genes: BARD1, BRCA1, BRCA2, BRIP1, FANCA, NBN, PALB2, RAD51, RAD51B, RAD51C, RAD51D; or actionable mutations in the PTEN gene, or hotspot mutations in the PIK3CA gene (E542, E545 or H1047 are accepted). Local testing in Clinical Laboratory Improvement Act (CLIA)-certified laboratory will be accepted. Only mutations that have been recognized as actionable by the MD Anderson Precision Oncology Decision Support (PODS) team will be accepted; * Patients with a mutation within both the DDR and PTEN/PIK3CA pathways will be assessed by the genomics Precision Oncology Decision Support group at MD Anderson, and the patient will be allocated to the PI3K or DDR expansion group deemed to be the main driver. If the actionability between the groups is deemed to be equivocal, then the patient will be allocated to the expansion cohort with fewer patients;\n",
            "EXCLUSION_CRITERIA: * Other malignancy unless curatively treated with no evidence of disease for >= 5 years except: adequately treated non-melanoma skin cancer, curatively treated in situ cancer of the cervix, ductal carcinoma in situ (DCIS), or stage 1, grade 1 endometrial carcinoma. A patient with a history of localized triple negative breast cancer may be eligible, provided the patient completed the adjuvant chemotherapy > 3 years prior to registration, and the patient remains free of recurrent or metastatic disease;\n",
            " \n",
            " BIOMARKER = BRCA2 somatic mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Prior documentation of a known Wnt activating mutation by a CLIA-accredited laboratory. Wnt activating mutations: CTNNB1, APC, AXIN1/2, RNF43, ZNRD3, RSPO2, RSPO3;\n",
            " \n",
            " BIOMARKER = AXIN1/2 activating mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Subjects with a targetable driver mutation in EGFR or ALK gene will be allowed on trial after failing all available targeted therapies and having experienced a disease progression following treatment with an anti-PD1 or PD-L1 immune checkpoint antibody and a platinum-containing doublet treatment, administered simultaneously or sequentially.\n",
            " \n",
            " BIOMARKER = EGFR mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase 1b/2 Study of Oral Decitabine/Cedazuridine (ASTX727) and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Ivosidenib or the Targeted Mutant IDH2 Inhibitor Enasidenib;\n",
            "INCLUSION_CRITERIA: * Subjects must have documented IDH1 or IDH2 gene mutation;\n",
            " \n",
            " BIOMARKER = IDH1 mutation, IDH1 Mutant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors;\n",
            "TITLE: A Single-Arm Phase-II Study of Niraparib in Locally Advanced or Metastatic Solid Tumor Patients With PALB2 Mutations;\n",
            "EXCLUSION_CRITERIA: * Participants who have variants of undetermined significance (VUS), but not pathogenic variants of PALB2, at the time of screening. * Participants with germline or somatic BRCA1 or BRCA2 mutations.\n",
            " \n",
            " BIOMARKER = BRCA1 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. BRCA1, BRCA2, PALB2, ATM, MLH1, MSH2, MSH6, PMS2, EPCAM pathogenic or likely pathogenic variant AND 1 first or second degree relative with PDAC; age 50+ or 10 years younger than earliest PDAC in family; 4. Familial Atypical Moles and Malignant Melanoma (FAMMM) with pathogenic or likely pathogenic CDKN2A variant; age 40+; 5. Peutz-Jegher syndrome with STK11 pathogenic or likely pathogenic variant; age 35+; 6. Hereditary pancreatitis with PRSS1 pathogenic or likely pathogenic variant and history of pancreatitis; age 40+; 1. ATM, BRCA1, BRCA2, or PALB2 pathogenic or likely pathogenic variant regardless of family history, age 50+; 2. Personal or family history of a pathogenic or likely pathogenic germline variant in ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2,PMS2, PRSS1, STK11;\n",
            " \n",
            " BIOMARKER = EPCAM variant \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer;\n",
            "TITLE: Single Arm, Open Label Phase 1b/2 Study of SGN-LIV1A in Combination With Pembrolizumab for First-Line Treatment of Patients With Unresectable Locally-Advanced or Metastatic Triple-Negative Breast Cancer;\n",
            "INCLUSION_CRITERIA: * Metastatic or locally-advanced, histologically documented TNBC (absence of HER2, ER, and PR expression);   * Part D only: Tumor tissue PD-L1 Combined Positive Score <10 expression.\n",
            " \n",
            " BIOMARKER = Triple Negative Triple Negative, TNBC TNBC, triple-negative triple-negative, Triple negative Triple negative, Triple-Negative Triple-Negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * PART B: Patients with recurrent or refractory Ewing sarcoma, desmoid tumors, osteosarcoma, liver tumors (HCC and hepatoblastoma), Wilms tumor, and tumors with Wnt pathway aberrations. For the Wnt pathway aberrations cohort we will include the most common CTNNB1 mutations (S37F, S45F, T41A, S45P, S33C, S37C, D32Y, S33F, T41I, G34R, G34V, D32N, S33P, G34E, D32G) as well as any loss of function mutations in the APC, Axin2FBXW7, TCF7L2, and RNF43 genes or any gain-of-function mutations in the GSK3B, LRP6, and LGR5 genes. For patients without prior sequencing, immunohistochemistry (IHC), is required. IHC showing strong nuclear beta-catenin staining will be accepted for the following tumor types: colorectal carcinoma, melanoma, endometrial cancer, ovarian cancer, neuroblastoma, non-Hodgkin lymphoma, pancreatic ductal adenocarcinoma, and solid pseudopapillary tumor of the pancreas;\n",
            " \n",
            " BIOMARKER = CTNNB1 S37C \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing;\n",
            "INCLUSION_CRITERIA: 3. Primary tumor tissue showing LOH of HLA-A*02 by NGS testing.\n",
            " \n",
            " BIOMARKER = HLA LOH, HLA Loss of Heterozygosity (LOH) \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:      * Patients without a mutation must be deemed eligible and appropriate for allo BMT by the PI. Some patients may meet the clinical history criteria listed below, but will not be eligible if it is thought that their clinical history is due to a condition apart from an immune defect. In addition, patients with a PID of mild severity, such as those with selective IgA deficiency, may meet at least two of the clinical history criteria, but may be deemed inappropriate for allo BMT by the PI if it is felt that the risks of the procedure outweigh the severity of the disease.\n",
            "EXCLUSION_CRITERIA: * MAGT1 mutation and active need to take anti-platelet agents and/or therapeutic anti-coagulation that cannot be interrupted during aplasia.\n",
            " \n",
            " BIOMARKER = MAGT1 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:    Presence of FLT3 mutations or internal tandem duplication or other mutations designated as adverse-risk by the ELN Leukemia Net AML Classification (see Appendix 2):    * t(6;9)(p23;q34.1); DEK-NUP214;    * t(v;11q23.3); KMT2A rearranged;    * t(9;22)(q34.1;q11.2); BCR-ABL1;    * inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2,MECOM(EVI1);    * Wild-type NPM1 and FLT3-ITDhigh;    * Mutated RUNX1;    * Mutated ASXL1;    * Mutated TP53 (iv) FAB M6 or M7 classification; (v) Adverse cytogenetics: -5, del 5q, -7, del7q, abnormalities involving 3q, 9q, 11q, 20q, 21q, 17, +8 or complex karyotype [> 3 abnormalities]; or other mutations designated as adverse-risk by the ELN criteria; (vi) Treatment-related AML (vii) Primary induction failure with partial response to therapy who achieve adequate cytoreduction (viii) Aplastic/hypoplastic marrow with or without detectable persistent disease after induction chemotherapy or after salvage chemotherapy.\n",
            " \n",
            " BIOMARKER = RUNX1 Mutated \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations;\n",
            "TITLE: Phase I/II Study of Azacitidine in Combination With Quizartinib for Patients With Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms With FLT3 or CBL Mutations;\n",
            "INCLUSION_CRITERIA: 3. For hypomethylating agent naïve patients: int-2 or higher by IPSS or >5% bone marrow blasts if MDS or dysplastic CMML (WBC <13x109/L). Patients with proliferative (WBC >/= 13x109/L) CMML or MDS/MPN, or those with dysplastic CMML with high-risk molecular features (mutations in ASXL1, TP53 or more than 3 mutations) are also eligible independently of IPSS risk score or bone marrow blast percentage. 5. Detectable FLT3-ITD mutation in bone marrow and/or peripheral blood, or presence of CBL exon 8 or 9 deletions or point mutations.\n",
            "EXCLUSION_CRITERIA: 17. Female patients with reproductive potential who do not have a negative urine or blood beta-human chorionic gonadotropin (beta HCG) pregnancy test at screening.\n",
            " \n",
            " BIOMARKER = FLT3 Mutations, FLT3 mutations, FLT3 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * PART B: Patients with recurrent or refractory Ewing sarcoma, desmoid tumors, osteosarcoma, liver tumors (HCC and hepatoblastoma), Wilms tumor, and tumors with Wnt pathway aberrations. For the Wnt pathway aberrations cohort we will include the most common CTNNB1 mutations (S37F, S45F, T41A, S45P, S33C, S37C, D32Y, S33F, T41I, G34R, G34V, D32N, S33P, G34E, D32G) as well as any loss of function mutations in the APC, Axin2FBXW7, TCF7L2, and RNF43 genes or any gain-of-function mutations in the GSK3B, LRP6, and LGR5 genes. For patients without prior sequencing, immunohistochemistry (IHC), is required. IHC showing strong nuclear beta-catenin staining will be accepted for the following tumor types: colorectal carcinoma, melanoma, endometrial cancer, ovarian cancer, neuroblastoma, non-Hodgkin lymphoma, pancreatic ductal adenocarcinoma, and solid pseudopapillary tumor of the pancreas;\n",
            " \n",
            " BIOMARKER = CTNNB1 S33P \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase 1/2 Study of an EZH2 Inhibitor (Tazemetostat) in Combination With Dual BRAF/MEK Inhibition in Patients With BRAF- Mutated Metastatic Melanoma Who Progressed on Prior BRAF/MEK Inhibitor Therapy;\n",
            "INCLUSION_CRITERIA: * Patient must have a diagnosis of BRAF^V600E/K-mutated metastatic melanoma; * PHASE 2 ONLY: Patient must have EZH2 alteration (somatic mutation or copy number alteration). Can be performed on either archival or fresh specimen. EZH2 alterations need to be documented by a Clinical Laboratory Improvement Act (CLIA)/Clinical Laboratory Improvement Program (CLIP)-certified next generation sequencing platform (Foundation One, Tempus, Guardant360, etc.); * PHASE 2 ONLY: Patient must agree to planned pre-treatment and planned on-treatment biopsy. A pre-treatment biopsy will be optional if patient has an archival tissue block or 5 formalin-fixed paraffin-embedded (FFPE) slides available from specimen used to document presence of eligible EZH2 alteration that is deemed adequate for evaluation;\n",
            "EXCLUSION_CRITERIA: * Has abnormalities known to be associated with MDS (e.g. del 5q, chr 7 abn) and multiple primary neoplasms (MPN) (e.g. JAK2 V617F) observed in cytogenetic testing and deoxyribonucleic acid (DNA) sequencing; * Patients with history of RAS mutation-positive tumors are not eligible regardless of interval from the current study. Note: Prospective RAS testing is not required. However, if the results of previous RAS testing are known, they must be used in assessing eligibility;\n",
            " \n",
            " BIOMARKER = RAS mutation-positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation;\n",
            "EXCLUSION_CRITERIA: * 17p-/TP53 amplification ≥20% (FISH);\n",
            " \n",
            " BIOMARKER = TP53 amplification \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Any known UGT1A polymorphism, heterozygous or homozygous;\n",
            " \n",
            " BIOMARKER = UGT1A polymorphism \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 15. No presence of complete dihydropyrimidine dehydrogenase (DPD) enzyme deficiency with DPYD gene testing mandatory at screening as per national guidelines;\n",
            "EXCLUSION_CRITERIA: 9. Known uncontrolled HIV infection. HIV-positive patients are eligible if their CD4+ cell count amounts to 300 cells per μL or more; HIV viral load must be undetectable per standard of care assay, and they must be compliant with antiretroviral treatment. 17. Presence of complete dihydropyrimidine dehydrogenase (DPD) enzyme deficiency with DPYD gene testing mandatory at screening as per national guidelines.\n",
            " \n",
            " BIOMARKER = dihydropyrimidine dehydrogenase deficiency, DPD deficiency \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 3. Known condition or suspicion of a very high risk predisposition to breast cancer: germline mutation of BRCA1/2, PALB2, TP53 or equivalent;\n",
            " \n",
            " BIOMARKER = BRCA1/2 germline mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * PART B: Patients with recurrent or refractory Ewing sarcoma, desmoid tumors, osteosarcoma, liver tumors (HCC and hepatoblastoma), Wilms tumor, and tumors with Wnt pathway aberrations. For the Wnt pathway aberrations cohort we will include the most common CTNNB1 mutations (S37F, S45F, T41A, S45P, S33C, S37C, D32Y, S33F, T41I, G34R, G34V, D32N, S33P, G34E, D32G) as well as any loss of function mutations in the APC, Axin2FBXW7, TCF7L2, and RNF43 genes or any gain-of-function mutations in the GSK3B, LRP6, and LGR5 genes. For patients without prior sequencing, immunohistochemistry (IHC), is required. IHC showing strong nuclear beta-catenin staining will be accepted for the following tumor types: colorectal carcinoma, melanoma, endometrial cancer, ovarian cancer, neuroblastoma, non-Hodgkin lymphoma, pancreatic ductal adenocarcinoma, and solid pseudopapillary tumor of the pancreas;\n",
            " \n",
            " BIOMARKER = CTNNB1 S45F \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase II Study of Amivantamab in EGFR or MET- Amplified Esophagogastric Cancer;\n",
            "INCLUSION_CRITERIA: * EGFR or MET amplification by tissue-NGS with copy number >8 and/or ctDNA amplification by any FDA and CLIA-approved assay; * No prior receipt of an EGFR or MET inhibitor for esophagogastric cancer. (Note: if a patient previously received a EGFR inhibitor, but subsequently demonstrated a MET amplification, or previously received a MET inhibitor, but subsequently demonstrated an EGFR-amplification, inclusion is permitted). * Patients with HER2+ (IHC 3+ or IHC 2+/FISH+) tumors must have progressed on trastuzumab.\n",
            " \n",
            " BIOMARKER = MET -amplified, MET amplified, MET amplification, MET Amplified \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 6. Progression during previous treatment with another BTK inhibitor, and/or presence of known mutations associated with resistance to therapy, e.g. Bruton´s Tyrosine Kinase (BTK) and Phospholipase C Gamma 2 (PLCg2);\n",
            " \n",
            " BIOMARKER = Phospholipase C Gamma 2 mutations, PLCg2 mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA:   1. Consistent with high-frequency microsatellite instability MSI-H;   2. Consistent with high tumor mutation load TMB-H (≥10 mutations/megabases);   3. High expression of PD-L1 (CPS score ≥5) 5. Expected survival time > 6 months； 6. ECOG (Eastern US Cooperative Oncology Group) score: 0-1 points; 7. Have not received anti-tumor immunotherapy; 8. Agree to provide archived tumor tissue samples for molecular testing; 9. Have good organ function:\n",
            " \n",
            " BIOMARKER = PD-L1 High expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: * Known drug-related, inherited, or acquired procoagulant disorder including prothrombin gene mutation 20210, antithrombin III deficiency, protein C deficiency, protein S deficiency and antiphospholipid syndrome but not including heterozygosity for the Factor V Leiden mutation or the presence of a lupus anticoagulant in the absence of other criteria for the antiphospholipid syndrome.\n",
            " \n",
            " BIOMARKER = prothrombin gene mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation;\n",
            "TITLE: The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome;\n",
            "INCLUSION_CRITERIA: * Patients must have a documented IDH1 or IDH2 mutation within 30 days of inclusion based on mutational testing. Only specific mutations that lead to a neomorphic phenotype will be eligible for enrollment, and include those listed below:   * IDH1: R132V, R132G, R132S, R132L, R132C and R132H;   * IDH2: R140W, R140L, R140Q, R172W, R172G, R172S, R172M, R172K.\n",
            "EXCLUSION_CRITERIA: * Management of treatment for patients with co-occurring mutations, like FLT3, will be prioritized by the treating physician after discussion of treatment options with the patient.\n",
            " \n",
            " BIOMARKER = IDH1 R132L \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = EXCLUSION_CRITERIA: 1. Diagnosis of Microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) and/or BRAF V600E mutation positive colorectal cancer. 19. Known dihydropyrimidine dehydrogenase deficiency.\n",
            " \n",
            " BIOMARKER = BRAF V600E \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase 1 Study of the Polymerase Theta (POLQ) Inhibitor Novobiocin in BRCA-Mutant and Other DNA Damage Repair-Deficient Solid Tumors;\n",
            "INCLUSION_CRITERIA: * Patients must have histologically confirmed solid tumor with a known pathogenic mutation in BRCA1/2, PALB2, RAD51C, RAD51D, ATM, BARD1, BLM, BRIP1, CDK12, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCM, MRE11A, NBN (NBS1), RAD50 and RAD51B as confirmed by a Clinical Laboratory Improvement Amendments (CLIA)-certified method. Patients with alterations defined only by germline testing are eligible;\n",
            " \n",
            " BIOMARKER = RAD50 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Positive for an EGFR exon 19 deletion or exon 21 L858R mutation; * Negative for acquired on-target EGFR alterations Inclusion Criteria for Colorectal Cancer Cohorts; * Negative for kirsten rat sarcoma viral oncogene homolog (KRAS) alterations; * Negative for neuroblastoma RAS viral oncogene homolog (NRAS) alterations; * Negative for proto-oncogene B-Raf (BRAF) V600E alterations;\n",
            " \n",
            " BIOMARKER = kirsten rat sarcoma viral oncogene homolog alterations, KRAS alterations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Non-squamous tumors must not be positive for EGFR exon 19 deletion or exon 21 L858R mutation (centrally as part of the ALCHEMIST-SCREEN protocol) and ALK rearrangement (centrally as part of ALCHEMIST-SCREEN and/or locally);   * NOTE: if the results of the central EGFR testing are negative, but the ALK testing was not able to be completed by the ALCHEMIST central lab, the ALK status will be considered negative (unless locally positive for ALK rearrangement) and the patient may be considered for enrollment onto EA5142, once PD-L1 results are received and all other eligibility requirements are met; * Tumors must have PD-L1 status tested centrally as part of the ALCHEMIST-SCREEN protocol;\n",
            " \n",
            " BIOMARKER = EGFR L858R \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: * Patients must have histologically confirmed, metastatic or unresectable malignancy of the following types: (a) non-small cell lung cancer (NSCLC), (b) triple-negative breast cancer (TNBC; defined by estrogen receptor [ER] < 1%, progesterone receptor [PR] < 1% and HER2 1+ or less by immunohistochemistry [IHC]; if HER-2 expression is 2+, a negative fluorescence in situ hybridization [FISH] testing is required) (c) pancreatic adenocarcinoma (PDAC), or (d) small cell lung cancer (SCLC); * Must have received at least one line of standard systemic treatment for locally advanced or metastatic disease setting of the respective tumor type; for NSCLC, it is either PD-1/PD-L1 inhibitor, or platinum-containing chemotherapy, or an EGFR tyrosine kinase inhibitor or an ALK inhibitor if sensitizing mutation present; TNBC: platinum-containing chemotherapy; PDAC: fluorouracil (5-FU-), gemcitabine-, or taxane-containing chemotherapy either with or without radiation therapy; SCLC: platinum-containing chemotherapy for limited or extensive stage disease;\n",
            "EXCLUSION_CRITERIA: * Patients with untreated brain metastases, spinal cord compression, or evidence of symptomatic brain metastases or leptomeningeal disease as noted on computed tomography (CT) or magnetic resonance imaging (MRI) scans should be excluded from this clinical trial, since neurologic dysfunction may confound the evaluation of neurologic and other adverse events (AEs); screening brain MRI (or CT if MRI contraindicated) will be required for patients with recurrent NSCLC, TNBC, or SCLC; brain MRI (or CT if MRI contraindicated) is required for PDAC if clinically suspected by patient's symptoms or neurological exam; should patient found to have brain metastasis, treatment of brain metastasis must precede the participation in this study; for patients with known and treated brain metastases is allowed in this study if they fulfill the following criteria:\n",
            " \n",
            " BIOMARKER = triple negative triple negative, TNBC TNBC, triple-negative triple-negative, Triple-Negative Triple-Negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Phase II Single-arm, Single-center Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Refractory Microsatellite Stable Colorectal Cancer;\n",
            "INCLUSION_CRITERIA:    * The eligible patient's tumors be classified as proficient in DNA mismatch repair (pMMR) by immunohistochemistry (IHC) for MMR protein expression (MLH1, MutS homolog 2 (MSH2), MutS homolog 6 (MSH6), PMS2. Tumors with intact expression of all MMR proteins will be considered pMMR.    * The eligible patient's tumor be classified by Pathologic Complete Response (pCR) as stable microsatellite stability status (MSS) for panel of microsatellite markers, OR;    * MSS by commercially available next generation sequencing testing. OR;    * If tumor-based test are not feasible, then commercially available circulating tumor DNA tests showing MSS status will also be acceptable. 3. The patients should have received at least two lines of systemic chemotherapies in metastatic setting. They should have received fluoropyrimidine, irinotecan, and oxaliplatin unless medically contraindicated. Prior anti-VEGF (vascular endothelial growth factor) therapy is accepted for enrollment since anti-VEGF therapy maintains its benefit across several lines of therapy. If clinically appropriate, the patients should have received anti-EGFR (epidermal growth factor receptor) therapy for all Rat sarcoma (RAS) wild type colorectal cancers and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E mutation-directed therapy for BRAF V600E mutant colorectal cancers.\n",
            "EXCLUSION_CRITERIA: 1. Microsatellite unstable colorectal (MSI-H) cancers identified by PCR testing OR by commercially available Next-generation sequencing (NGS) and Circulating tumor DNA (ctDNA) testing OR by loss of expression of one or more of the MMR enzymes (MLH1, MSH2, MSH6, PMS2) on immunohistochemistry. Only one such test is required to confirm eligibility.\n",
            " \n",
            " BIOMARKER = MMR loss of expression \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Phase 1 Study of the Polymerase Theta (POLQ) Inhibitor Novobiocin in BRCA-Mutant and Other DNA Damage Repair-Deficient Solid Tumors;\n",
            "INCLUSION_CRITERIA: * Patients must have histologically confirmed solid tumor with a known pathogenic mutation in BRCA1/2, PALB2, RAD51C, RAD51D, ATM, BARD1, BLM, BRIP1, CDK12, FANCA, FANCC, FANCD2, FANCE, FANCF, FANCM, MRE11A, NBN (NBS1), RAD50 and RAD51B as confirmed by a Clinical Laboratory Improvement Amendments (CLIA)-certified method. Patients with alterations defined only by germline testing are eligible;\n",
            " \n",
            " BIOMARKER = CDK12 mutation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_PARTIAL\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors;\n",
            "TITLE: A Phase Ib, Multi-center, Open-Lable, Dose-Escalation and Dose-Expansion Study of Efficacy and Safety of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors;\n",
            "INCLUSION_CRITERIA:   3. Agreement to provide a required tumor tissue sample (preferably fresh biopsy tissue or archived tumor tissue within 2 years prior to first dosing) that has been tested by the central laboratory and determined to be positive for LTK gene fusion.\n",
            "EXCLUSION_CRITERIA:   1. Carrying known major driver gene mutations other than LTK gene, such as EGFR, MET, ALK, ROS1, NTRK, etc. (Patients with co-mutations may be discussed with the investigator for eligibility).\n",
            " \n",
            " BIOMARKER = NTRK gene mutations \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 2. Healthy participants carriers of a germline pathogenic/likely pathogenetic variant (BRCA1 or BRCA2 or PALB2), or;    with a previous diagnosis of intraepithelial neoplasia of the breast (atypical ductal hyperplasia (ADH), lobular carcinoma in situ (LCIS), estrogen receptor (ER) positive ductal carcinoma in situ (DCIS)) within the last 3 years;\n",
            "EXCLUSION_CRITERIA: 1. Diagnosis of ER-negative (<10%) DCIS, or history of invasive breast cancer;\n",
            " \n",
            " BIOMARKER = ER -negative \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial;\n",
            "TITLE: Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial;\n",
            "INCLUSION_CRITERIA: * Participants must have an activating AKT mutation (a known mutation in AKT1, AKT2, or AKT3, a single nucleotide variant, insertion, or deletion) as determined by the ComboMATCH screening assessment;\n",
            "EXCLUSION_CRITERIA: * Participants must not have an activating KRAS, NRAS, HRAS, or BRAF mutation (a single nucleotide variant, insertion, or deletion) as determined by the ComboMATCH screening assessment; * Participants with known diabetes mellitus must not require insulin therapy or have a baseline fasting glucose >150 mg/dL (8.3 mmol/L) or high glycosylated hemoglobin (Hb)A1c, (>= 8.0%), suggesting poorly controlled diabetes;\n",
            " \n",
            " BIOMARKER = hemoglobin high \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = TITLE: PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation;\n",
            "TITLE: PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study;\n",
            "INCLUSION_CRITERIA: * GBM must have unmethylated MGMT as determined by central laboratory; * Diagnosis of GBM must be made by biopsy or surgical excision, either partial or complete; as long as there is sufficient tissue to determine MGMT status;\n",
            " \n",
            " BIOMARKER = MGMT methylation, MGMT Methylation \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n",
            "### User:\n",
            " With the clinical trial's context answer the below question.\n",
            " context = INCLUSION_CRITERIA: 3. Patients have positive ER expression in the primary tumor site by IHC (defined as >/=10%) (PR status is not required);\n",
            "EXCLUSION_CRITERIA: 6. Patients have HER2-positive breast carcinoma (IHC staining more than 3+ or HER2 gene amplification by FISH);\n",
            " \n",
            " BIOMARKER = HER2 -positive \n",
            " Is the BIOMARKER required to enroll in the trial? Please choose the best possible category:\n",
            "\n",
            " MUST: required to be eligible \n",
            " MUST_NOT: patients that have this biomarker are not eligible \n",
            " CAN: optional to have this biomarker and not mandatory to be eligible \n",
            " MUST_PARTIAL: Only some patients in the trial are required to have this biomarker \n",
            " MUST_NOT_PARTIAL:  Only some patients in the trial are excluded for having this biomarker \n",
            " NEUTRAL: unknown, the text does not mention this biomarker or data not clear. \n",
            "\n",
            "Take it step by step and fact check your answer. \n",
            "Answer in json format: answer (one of the categories).\n",
            "### Assistant: \n",
            "{\"answer\": \"MUST_NOT\"}\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(1141, 4)"
            ]
          },
          "metadata": {},
          "execution_count": 14
        }
      ],
      "source": [
        "!mkdir /content/data\n",
        "!cp /content/drive/MyDrive/bm_finetune/data_neural_train.jsonl /content/data\n",
        "train_dataset = load_dataset(\"json\", data_files=\"/content/data/data_neural_train.jsonl\", split= \"train\")\n",
        "train_dataset\n",
        "\n",
        "## Remove CAN labels from the dataset\n",
        "train_dataset = train_dataset.select(\n",
        "    (\n",
        "        i for i in range(len(train_dataset))\n",
        "        if not \"\\\"CAN\\\"\" in train_dataset[i]['output']\n",
        "    )\n",
        ")\n",
        "\n",
        "train_dataset = train_dataset.shuffle(seed=42)\n",
        "\n",
        "for d in train_dataset:\n",
        "  print(d['text'])\n",
        "\n",
        "train_dataset.shape"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "U-_4YGOYRpmu"
      },
      "source": [
        "## Setting Model Parameters\n",
        "\n",
        "We need to set various parameters for our fine-tuning process, including QLoRA (Quantization LoRA) parameters, bitsandbytes parameters, and training arguments:"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "H76_erzt1-on"
      },
      "outputs": [],
      "source": [
        "# The model that you want to train from the Hugging Face hub\n",
        "#model_name = \"mistralai/Mistral-7B-Instruct-v0.1\"\n",
        "model_name = \"Intel/neural-chat-7b-v3-1\"\n",
        "\n",
        "# Fine-tuned model name\n",
        "#new_model = \"mistralai-Code-Instruct\"\n",
        "new_model = \"neural-chat-finetune\""
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "nKzTy9MbR2DY"
      },
      "source": [
        "Setting the QLora Parameters"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "A_Yi1p_BR0bA"
      },
      "outputs": [],
      "source": [
        "################################################################################\n",
        "# QLoRA parameters\n",
        "################################################################################\n",
        "\n",
        "# LoRA attention dimension - number of parameters to train\n",
        "lora_r = 128\n",
        "#64 #8\n",
        "\n",
        "# Alpha parameter for LoRA scaling - impact of the data on the parameters\n",
        "lora_alpha =32\n",
        "#64 #16\n",
        "\n",
        "# Dropout probability for LoRA layers\n",
        "lora_dropout = 0.05\n",
        "\n",
        "################################################################################\n",
        "# bitsandbytes parameters\n",
        "################################################################################\n",
        "\n",
        "# Activate 4-bit precision base model loading\n",
        "use_4bit = True\n",
        "\n",
        "# Compute dtype for 4-bit base models\n",
        "bnb_4bit_compute_dtype = \"float16\" #\"float16\"\n",
        "\n",
        "# Quantization type (fp4 or nf4)\n",
        "bnb_4bit_quant_type = \"nf4\"\n",
        "\n",
        "# Activate nested quantization for 4-bit base models (double quantization)\n",
        "use_nested_quant = True\n",
        "\n",
        "################################################################################\n",
        "# TrainingArguments parameters\n",
        "################################################################################\n",
        "\n",
        "# Output directory where the model predictions and checkpoints will be stored\n",
        "output_dir = \"./results\"\n",
        "\n",
        "# Number of training epochs\n",
        "num_train_epochs = 2\n",
        "\n",
        "# Enable fp16/bf16 training (set bf16 to True with an A100)\n",
        "fp16 = False # True\n",
        "bf16 = False # False\n",
        "\n",
        "# Batch size per GPU for training\n",
        "per_device_train_batch_size = 1\n",
        "\n",
        "# Batch size per GPU for evaluation\n",
        "per_device_eval_batch_size = 1\n",
        "\n",
        "# Number of update steps to accumulate the gradients for\n",
        "gradient_accumulation_steps = 8\n",
        "\n",
        "# Enable gradient checkpointing\n",
        "gradient_checkpointing = True\n",
        "\n",
        "# Maximum gradient normal (gradient clipping)\n",
        "max_grad_norm = 0.3\n",
        "\n",
        "# Initial learning rate (AdamW optimizer)\n",
        "learning_rate = 2e-4\n",
        "\n",
        "# Weight decay to apply to all layers except bias/LayerNorm weights\n",
        "weight_decay = 0.001\n",
        "\n",
        "# Optimizer to use\n",
        "optim = \"paged_adamw_8bit\" # \"paged_adamw_32bit\"\n",
        "\n",
        "# Learning rate schedule (constant a bit better than cosine)\n",
        "lr_scheduler_type = \"constant\"\n",
        "\n",
        "# Number of training steps (overrides num_train_epochs)\n",
        "max_steps = -1\n",
        "\n",
        "# Ratio of steps for a linear warmup (from 0 to learning rate)\n",
        "warmup_ratio = 0.03\n",
        "\n",
        "# Group sequences into batches with same length\n",
        "# Saves memory and speeds up training considerably\n",
        "group_by_length = True\n",
        "\n",
        "# Save checkpoint every X updates steps\n",
        "save_steps = 25\n",
        "\n",
        "# Log every X updates steps\n",
        "logging_steps = 25\n",
        "\n",
        "################################################################################\n",
        "# SFT parameters\n",
        "################################################################################\n",
        "\n",
        "# Maximum sequence length to use\n",
        "max_seq_length = None\n",
        "\n",
        "# Pack multiple short examples in the same input sequence to increase efficiency\n",
        "packing = False\n",
        "\n",
        "# Load the entire model on the GPU 0\n",
        "device_map = {\"\": 0}"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "269-A6vtSNfg"
      },
      "source": [
        "### Loading the base model\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 49,
          "referenced_widgets": [
            "24dfd9117dbc4c62beece2fffe5543f4",
            "75c5f13022924696b021ba10da5f4432",
            "cb78453859e6483f98678904c56f3bd2",
            "bfe246667bd049f28bc21d29862cc412",
            "f15598d4aac843d4aaafacb00a906c21",
            "538d6ec978fb42cc9828d7d32ee6fdff",
            "2a604d165c9647fba2848f3146396cd3",
            "95ebeae483f74df6a9f7c748cc86b412",
            "faf24c405f3541be89bfc9e3c5f88471",
            "c24693169d7e4f81a0da3e6cc2731ac6",
            "1962e1a6b6ca4ccfa05d693d2f7e50b6"
          ]
        },
        "id": "QrBd2aB95aoj",
        "outputId": "f6889170-293d-4a48-96f4-fa5174100bf8"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Loading checkpoint shards:   0%|          | 0/2 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "24dfd9117dbc4c62beece2fffe5543f4"
            }
          },
          "metadata": {}
        }
      ],
      "source": [
        "# Load the base model with QLoRA configuration\n",
        "compute_dtype = getattr(torch, bnb_4bit_compute_dtype)\n",
        "\n",
        "bnb_config = BitsAndBytesConfig(\n",
        "    load_in_4bit=use_4bit,\n",
        "    bnb_4bit_quant_type=bnb_4bit_quant_type,\n",
        "    bnb_4bit_compute_dtype=compute_dtype,\n",
        "    bnb_4bit_use_double_quant=use_nested_quant,\n",
        ")\n",
        "\n",
        "base_model = AutoModelForCausalLM.from_pretrained(\n",
        "    model_name,\n",
        "    quantization_config=bnb_config,\n",
        "    device_map= device_map\n",
        ")\n",
        "\n",
        "base_model.config.use_cache = False\n",
        "base_model.config.pretraining_tp = 1\n",
        "\n",
        "# Load MistralAI tokenizer\n",
        "tokenizer = AutoTokenizer.from_pretrained(model_name, trust_remote_code=True,\n",
        "    add_eos_token=True,\n",
        "    add_bos_token=True,)\n",
        "tokenizer.pad_token = tokenizer.eos_token\n",
        "tokenizer.padding_side = \"right\""
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "GxYdQFqo5aol"
      },
      "source": [
        "## Fine-Tuning with qLora and Supervised Fine-Tuning\n",
        "\n",
        "We're ready to fine-tune our model using qLora. For this tutorial, we'll use the `SFTTrainer` from the `trl` library for supervised fine-tuning. Ensure that you've installed the `trl` library as mentioned in the prerequisites."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "JjsZSpT8ZM8c"
      },
      "outputs": [],
      "source": [
        "from peft import prepare_model_for_kbit_training\n",
        "\n",
        "base_model.gradient_checkpointing_enable()\n",
        "base_model = prepare_model_for_kbit_training(base_model)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 86,
          "referenced_widgets": [
            "0b82d9debba2405f92f9dfd7c393c878",
            "64923bb4877244e7916350d6a8837a48",
            "6faad55b665f46598b3c70d7ba782d91",
            "105eca41ac7341eb937e0d62cf2d43a6",
            "39d14f7c4ecf4b5189e43b31bde6be75",
            "7b93bb542a2841deacda061b5b31bf4a",
            "9ef16ace588c40e1b9cdbb4ce3dc8dfd",
            "b2b2cf5cf7f84a598af0f24ed7d6f7cd",
            "4dd061bb47ed464e9b0878400f5f78ee",
            "ecb2113d89dc4572a547dceb44edf64d",
            "d806811526024673a54eea15b579ef2c"
          ]
        },
        "id": "nFjA8D0d2oNz",
        "outputId": "003c7abb-ec4b-47b6-b3c9-5f4da37ce6e9"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/trl/trainer/sft_trainer.py:194: UserWarning: You didn't pass a `max_seq_length` argument to the SFTTrainer, this will default to 1024\n",
            "  warnings.warn(\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Map:   0%|          | 0/1141 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "0b82d9debba2405f92f9dfd7c393c878"
            }
          },
          "metadata": {}
        }
      ],
      "source": [
        "# Load LoRA configuration\n",
        "peft_config = LoraConfig(\n",
        "    lora_alpha=lora_alpha,\n",
        "    lora_dropout=lora_dropout,\n",
        "    r=lora_r,\n",
        "    target_modules=[\n",
        "        \"q_proj\",\n",
        "        \"k_proj\",\n",
        "        \"v_proj\",\n",
        "        \"o_proj\",\n",
        "        \"gate_proj\",\n",
        "        \"up_proj\",\n",
        "        \"down_proj\",\n",
        "        \"lm_head\",\n",
        "    ],\n",
        "    bias=\"none\",\n",
        "    task_type=\"CAUSAL_LM\",\n",
        ")\n",
        "\n",
        "# Set training parameters\n",
        "training_arguments = TrainingArguments(\n",
        "    output_dir=output_dir,\n",
        "    num_train_epochs=num_train_epochs,\n",
        "    per_device_train_batch_size=per_device_train_batch_size,\n",
        "    gradient_accumulation_steps=gradient_accumulation_steps,\n",
        "    optim=optim,\n",
        "    save_steps=save_steps,\n",
        "    logging_steps=logging_steps,\n",
        "    learning_rate=learning_rate,\n",
        "    weight_decay=weight_decay,\n",
        "    fp16=fp16,\n",
        "    bf16=bf16,\n",
        "    max_grad_norm=max_grad_norm,\n",
        "    max_steps=500, # the number of training steps the model will take\n",
        "    warmup_ratio=warmup_ratio,\n",
        "    group_by_length=group_by_length,\n",
        "    lr_scheduler_type=lr_scheduler_type,\n",
        "    report_to=\"tensorboard\",\n",
        "    #neftune_noise_alpha=5,# use neft to improve performance\n",
        ")\n",
        "\n",
        "# Set supervised fine-tuning parameters\n",
        "trainer = SFTTrainer(\n",
        "    model=base_model,\n",
        "    train_dataset=train_dataset,\n",
        "    peft_config=peft_config,\n",
        "    dataset_text_field=\"text\",\n",
        "    max_seq_length=max_seq_length,\n",
        "    tokenizer=tokenizer,\n",
        "    args=training_arguments,\n",
        "    packing=packing,\n",
        "\n",
        ")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "i187wmtT5aol"
      },
      "source": [
        "## Finetuning the model"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "xWxi9tqgEhyZ",
        "outputId": "4eb42b14-e156-41c6-a9f5-e31ee1b2de33"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "You're using a LlamaTokenizerFast tokenizer. Please note that with a fast tokenizer, using the `__call__` method is faster than using a method to encode the text followed by a call to the `pad` method to get a padded encoding.\n",
            "/usr/local/lib/python3.10/dist-packages/torch/utils/checkpoint.py:429: UserWarning: torch.utils.checkpoint: please pass in use_reentrant=True or use_reentrant=False explicitly. The default value of use_reentrant will be updated to be False in the future. To maintain current behavior, pass use_reentrant=True. It is recommended that you use use_reentrant=False. Refer to docs for more details on the differences between the two variants.\n",
            "  warnings.warn(\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <div>\n",
              "      \n",
              "      <progress value='203' max='500' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
              "      [203/500 57:40 < 1:25:13, 0.06 it/s, Epoch 1.42/4]\n",
              "    </div>\n",
              "    <table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              " <tr style=\"text-align: left;\">\n",
              "      <th>Step</th>\n",
              "      <th>Training Loss</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <td>25</td>\n",
              "      <td>0.777300</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>50</td>\n",
              "      <td>0.511900</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>75</td>\n",
              "      <td>0.408100</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>100</td>\n",
              "      <td>0.404700</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>125</td>\n",
              "      <td>0.390700</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>150</td>\n",
              "      <td>0.273000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>175</td>\n",
              "      <td>0.202000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>200</td>\n",
              "      <td>0.250000</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table><p>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/torch/utils/checkpoint.py:429: UserWarning: torch.utils.checkpoint: please pass in use_reentrant=True or use_reentrant=False explicitly. The default value of use_reentrant will be updated to be False in the future. To maintain current behavior, pass use_reentrant=True. It is recommended that you use use_reentrant=False. Refer to docs for more details on the differences between the two variants.\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.10/dist-packages/torch/utils/checkpoint.py:429: UserWarning: torch.utils.checkpoint: please pass in use_reentrant=True or use_reentrant=False explicitly. The default value of use_reentrant will be updated to be False in the future. To maintain current behavior, pass use_reentrant=True. It is recommended that you use use_reentrant=False. Refer to docs for more details on the differences between the two variants.\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.10/dist-packages/torch/utils/checkpoint.py:429: UserWarning: torch.utils.checkpoint: please pass in use_reentrant=True or use_reentrant=False explicitly. The default value of use_reentrant will be updated to be False in the future. To maintain current behavior, pass use_reentrant=True. It is recommended that you use use_reentrant=False. Refer to docs for more details on the differences between the two variants.\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.10/dist-packages/torch/utils/checkpoint.py:429: UserWarning: torch.utils.checkpoint: please pass in use_reentrant=True or use_reentrant=False explicitly. The default value of use_reentrant will be updated to be False in the future. To maintain current behavior, pass use_reentrant=True. It is recommended that you use use_reentrant=False. Refer to docs for more details on the differences between the two variants.\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.10/dist-packages/torch/utils/checkpoint.py:429: UserWarning: torch.utils.checkpoint: please pass in use_reentrant=True or use_reentrant=False explicitly. The default value of use_reentrant will be updated to be False in the future. To maintain current behavior, pass use_reentrant=True. It is recommended that you use use_reentrant=False. Refer to docs for more details on the differences between the two variants.\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.10/dist-packages/torch/utils/checkpoint.py:429: UserWarning: torch.utils.checkpoint: please pass in use_reentrant=True or use_reentrant=False explicitly. The default value of use_reentrant will be updated to be False in the future. To maintain current behavior, pass use_reentrant=True. It is recommended that you use use_reentrant=False. Refer to docs for more details on the differences between the two variants.\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.10/dist-packages/torch/utils/checkpoint.py:429: UserWarning: torch.utils.checkpoint: please pass in use_reentrant=True or use_reentrant=False explicitly. The default value of use_reentrant will be updated to be False in the future. To maintain current behavior, pass use_reentrant=True. It is recommended that you use use_reentrant=False. Refer to docs for more details on the differences between the two variants.\n",
            "  warnings.warn(\n",
            "/usr/local/lib/python3.10/dist-packages/torch/utils/checkpoint.py:429: UserWarning: torch.utils.checkpoint: please pass in use_reentrant=True or use_reentrant=False explicitly. The default value of use_reentrant will be updated to be False in the future. To maintain current behavior, pass use_reentrant=True. It is recommended that you use use_reentrant=False. Refer to docs for more details on the differences between the two variants.\n",
            "  warnings.warn(\n"
          ]
        },
        {
          "output_type": "error",
          "ename": "KeyboardInterrupt",
          "evalue": "ignored",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-9-59603b6f35ac>\u001b[0m in \u001b[0;36m<cell line: 2>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0;31m# Train model\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 2\u001b[0;31m \u001b[0mtrainer\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtrain\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      3\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[0;31m# Save trained model\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0mtrainer\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmodel\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0msave_pretrained\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mnew_model\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/trl/trainer/sft_trainer.py\u001b[0m in \u001b[0;36mtrain\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m    278\u001b[0m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmodel\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_trl_activate_neftune\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmodel\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    279\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 280\u001b[0;31m         \u001b[0moutput\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0msuper\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtrain\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    281\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    282\u001b[0m         \u001b[0;31m# After training we make sure to retrieve back the original forward pass method\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/transformers/trainer.py\u001b[0m in \u001b[0;36mtrain\u001b[0;34m(self, resume_from_checkpoint, trial, ignore_keys_for_eval, **kwargs)\u001b[0m\n\u001b[1;32m   1528\u001b[0m                 \u001b[0mhf_hub_utils\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0menable_progress_bars\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1529\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1530\u001b[0;31m             return inner_training_loop(\n\u001b[0m\u001b[1;32m   1531\u001b[0m                 \u001b[0margs\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1532\u001b[0m                 \u001b[0mresume_from_checkpoint\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mresume_from_checkpoint\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/transformers/trainer.py\u001b[0m in \u001b[0;36m_inner_training_loop\u001b[0;34m(self, batch_size, args, resume_from_checkpoint, trial, ignore_keys_for_eval)\u001b[0m\n\u001b[1;32m   1842\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1843\u001b[0m                 \u001b[0;32mwith\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0maccelerator\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0maccumulate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mmodel\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1844\u001b[0;31m                     \u001b[0mtr_loss_step\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtraining_step\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mmodel\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0minputs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1845\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1846\u001b[0m                 if (\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/transformers/trainer.py\u001b[0m in \u001b[0;36mtraining_step\u001b[0;34m(self, model, inputs)\u001b[0m\n\u001b[1;32m   2708\u001b[0m                 \u001b[0mscaled_loss\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbackward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2709\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 2710\u001b[0;31m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0maccelerator\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbackward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mloss\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   2711\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2712\u001b[0m         \u001b[0;32mreturn\u001b[0m \u001b[0mloss\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdetach\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;34m/\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mgradient_accumulation_steps\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/accelerate/accelerator.py\u001b[0m in \u001b[0;36mbackward\u001b[0;34m(self, loss, **kwargs)\u001b[0m\n\u001b[1;32m   1987\u001b[0m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mscaler\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mscale\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mloss\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbackward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1988\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1989\u001b[0;31m             \u001b[0mloss\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbackward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1990\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1991\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0mset_trigger\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/torch/_tensor.py\u001b[0m in \u001b[0;36mbackward\u001b[0;34m(self, gradient, retain_graph, create_graph, inputs)\u001b[0m\n\u001b[1;32m    490\u001b[0m                 \u001b[0minputs\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0minputs\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    491\u001b[0m             )\n\u001b[0;32m--> 492\u001b[0;31m         torch.autograd.backward(\n\u001b[0m\u001b[1;32m    493\u001b[0m             \u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mgradient\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mretain_graph\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcreate_graph\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0minputs\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0minputs\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    494\u001b[0m         )\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/torch/autograd/__init__.py\u001b[0m in \u001b[0;36mbackward\u001b[0;34m(tensors, grad_tensors, retain_graph, create_graph, grad_variables, inputs)\u001b[0m\n\u001b[1;32m    249\u001b[0m     \u001b[0;31m# some Python versions print out the first line of a multi-line function\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    250\u001b[0m     \u001b[0;31m# calls in the traceback and some print out the last line\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 251\u001b[0;31m     Variable._execution_engine.run_backward(  # Calls into the C++ engine to run the backward pass\n\u001b[0m\u001b[1;32m    252\u001b[0m         \u001b[0mtensors\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    253\u001b[0m         \u001b[0mgrad_tensors_\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
          ]
        }
      ],
      "source": [
        "# Train model\n",
        "trainer.train()\n",
        "\n",
        "# Save trained model\n",
        "trainer.model.save_pretrained(new_model)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "PixsfVRz38YA"
      },
      "source": [
        "## Merge and Share\n",
        "\n",
        "After fine-tuning, if you want to merge the model with LoRA weights or share it with the Hugging Face Model Hub, you can do so. This step is optional and depends on your specific use case."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Ujf17z-7--l5",
        "outputId": "b2d3cb48-0b73-4d52-c9d3-d560eab54309"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "0"
            ]
          },
          "metadata": {},
          "execution_count": 17
        }
      ],
      "source": [
        "# Empty VRAM\n",
        "import gc\n",
        "del base_model\n",
        "gc.collect()\n",
        "\n",
        "del trainer\n",
        "gc.collect()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ypNIoSou-_3j"
      },
      "outputs": [],
      "source": [
        "torch.cuda.empty_cache() # PyTorch clear cache"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 49,
          "referenced_widgets": [
            "f3612648d5fe4622b1eaa8880c5fd2df",
            "dfda9ecf2f1242f2afef73131c24cd61",
            "287763afcac240809c4f831e5dff37b6",
            "54296503748e4780b1eab56867f0b890",
            "d84f56e83301496691cead706497c569",
            "b58b6c4ae28949efbad81cf8da31714d",
            "e82a5984a5b247c9a0d9035793bb9bae",
            "0bdf60515a674b0ca82ab75748fde3da",
            "1786b4354c614fbbabb73259e72e49fb",
            "0a28d70916c94190967ce453531b45b0",
            "8598d3a1e09541ba8f4083d754ff4090"
          ]
        },
        "id": "UAqVf4s8WPhS",
        "outputId": "4fcca729-55c1-4f1a-8a2f-72f6bd8a7e35"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Loading checkpoint shards:   0%|          | 0/2 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "f3612648d5fe4622b1eaa8880c5fd2df"
            }
          },
          "metadata": {}
        }
      ],
      "source": [
        "compute_dtype = getattr(torch, bnb_4bit_compute_dtype)\n",
        "\n",
        "bnb_config = BitsAndBytesConfig(\n",
        "    load_in_4bit=use_4bit,\n",
        "    bnb_4bit_quant_type=bnb_4bit_quant_type,\n",
        "    bnb_4bit_compute_dtype=compute_dtype,\n",
        "    bnb_4bit_use_double_quant=use_nested_quant,\n",
        ")\n",
        "\n",
        "base_model = AutoModelForCausalLM.from_pretrained(\n",
        "    model_name,\n",
        "    quantization_config=bnb_config,\n",
        "    device_map= device_map\n",
        ")\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "mZIpeeD6bf0n"
      },
      "outputs": [],
      "source": [
        "tokenizer = AutoTokenizer.from_pretrained(model_name, trust_remote_code=True)\n",
        "tokenizer.pad_token = tokenizer.eos_token\n",
        "tokenizer.padding_side = \"left\""
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Generate before merging the model"
      ],
      "metadata": {
        "id": "NGsO88eETeSi"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "!mkdir /content/data\n",
        "!cp /content/drive/MyDrive/bm_finetune/data_neural_test.jsonl /content/data\n",
        "test_dataset = load_dataset(\"json\", data_files=\"/content/data/data_neural_test.jsonl\", split= \"train\")\n",
        "\n",
        "with open('prediction_before', 'a+') as wfile:\n",
        "    title = \"groundtruth\"+ \"\\t\"+ \"prediction\"+  \"\\n\" #+ \" \"\\t\" +prompt\"\n",
        "    wfile.write(title)\n",
        "\n",
        "for d in test_dataset:\n",
        "  prompt = \"\"\n",
        "  if 'neural' in model_name:\n",
        "    prompt = d['text'].partition('### Assistant:')[0].replace(\"<s>[INST]\", \"\") + '### Assistant:'\n",
        "  if 'mistral' in model_name:\n",
        "    prompt = d['text'].partition('[/INST]')[0] + \"[/INST]</s>\"\n",
        "\n",
        "  op = d['output'].partition('\"answer\"')[2].replace(\"\\\"\", \"\").replace(\":\", \"\").replace(\"}\", \"\").replace(\"{\", \"\").strip()\n",
        "  inp = d['input'].strip().replace(\"\\t\", \" \")\n",
        "  input_ids = tokenizer(prompt, return_tensors=\"pt\", truncation=True).input_ids.cuda()\n",
        "\n",
        "  outputs = base_model.generate(input_ids=input_ids, max_new_tokens=1024, do_sample=True, top_p=0.9,temperature=0.001)\n",
        "  response = tokenizer.batch_decode(outputs.detach().cpu().numpy(), skip_special_tokens=True)[0][len(prompt):]\n",
        "  #resp = response.replace(\"[/INST]\", \"\").strip().partition('\"answer\"')[2].replace(\"\\\"\", \"\").replace(\":\", \"\").replace(\"}\", \"\").replace(\"{\", \"\").strip()\n",
        "  resp = response.replace(\"[/INST]\", \"\").strip()\n",
        "\n",
        "  labels_all = [\"MUST_NOT_PARTIAL\", \"MUST_NOT\", \"MUST_PARTIAL\", \"MUST\", \"CAN\"]\n",
        "\n",
        "  # normalize output , remove explanations\n",
        "  for label in labels_all:\n",
        "    if label in resp:\n",
        "      resp = label\n",
        "      break\n",
        "\n",
        "  with open('prediction_before', 'a+') as wfile:\n",
        "    after = op+ \"\\t\"+ resp +  \"\\n\" # + \"\\t\"+ inp\n",
        "    print(\"AFTER: \" + after)\n",
        "    wfile.write(after.encode('ascii', 'ignore').decode())"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000,
          "referenced_widgets": [
            "7afa9fe916334ebea7a8f50849d53dc4",
            "e921e74952604e448deab364cac90c1a",
            "2acf03258fe24327995f081c67cb2a66",
            "32e0328b5e044a34a78f2136221ba21f",
            "1d77685f1d0d420ca502922c7726352c",
            "7ac69310fb9c4e12b69fd630d660ed80",
            "8b8617e1398243b7b8ae5bf5952a311b",
            "6cd8b94a9efc4e229d2dd4f0c71296d5",
            "35a393c94a8e4317a96534eec563a899",
            "2ad2d245d89b416facb2c0c03fdf7c86",
            "1a76871d03fa41c1a2a99f2dbaa3a705",
            "9dc2a5bd3d4c41f9a1e54412cb1df956",
            "eb1dcb40d8b04c70a37f7ccac701cfc3",
            "af0cca4eccae4d5a8f44bb2397d694bf",
            "5435f75a26374dea86d7f6a086cc5bc7",
            "ed6b28bcfac3430bac1519836c49b073",
            "eaee302858db467eb0065b78da7044ce",
            "a034d0d210a749d1bcea82a9e2809e33",
            "3c4437297c7a443bbbc7b67ef3e00e7f",
            "a73ca4b823d54aa7b7f878ff3270fe17",
            "5f35feacba75422eadaef0362fdd3bed",
            "3fbaf65ff1774251b8db426618a2896e",
            "0498207ee5144934a8a92b76571597d2",
            "26884d74035848c68d2f98c93174d289",
            "5d889e12c326407b9b64ebcdf7a0eee5",
            "c45081fc21894383a502a32622dc92a1",
            "d09ae039c89e48a283a5ef80e8cb3784",
            "08c52d0d1223470098ebb86a763a3521",
            "f362f1bb5b7c461e994776d52394625c",
            "e0585079adee46b89964ebc21bb0a102",
            "573e01d37c9d41bb861ebf0aec7df7bb",
            "8f8a8632835841789f84a112c1c68da0",
            "465ba00e1321448c9dc857f0a8d54e89"
          ]
        },
        "id": "ZRC0t4AJSTuZ",
        "outputId": "562af7d9-ac5a-4296-8302-0a04a19b86a4"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "mkdir: cannot create directory ‘/content/data’: File exists\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading data files:   0%|          | 0/1 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "7afa9fe916334ebea7a8f50849d53dc4"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Extracting data files:   0%|          | 0/1 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "9dc2a5bd3d4c41f9a1e54412cb1df956"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Generating train split: 0 examples [00:00, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "0498207ee5144934a8a92b76571597d2"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Asking to truncate to max_length but no maximum length is provided and the model has no predefined maximum length. Default to no truncation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST_NOT_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST_NOT_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST_NOT_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_NOT_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_NOT_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_NOT_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_NOT_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_NOT_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\t{\n",
            "  \"category\": \"NEUTRAL: unknown, the text does not mention this biomarker or data not clear.\"\n",
            "}\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n",
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000,
          "referenced_widgets": [
            "1b72366fc72d40429490ee9b352dd1e5",
            "8dfb4a6b8d2f4f3e8773f22cc5971c43",
            "e738664ac3c44ca3b580913fe2e28332",
            "0b7be129c8e04e948521937c3d08a8b6",
            "b0268002b9994d2eb492dbb247854ef5",
            "a4a93ac3fbde43ab8cdd7eff36ed48cf",
            "2a539222a3494dd5a89f94571a9d7f09",
            "0cb9e9d7a29d42acb2c1b11b4a224d68",
            "11f2a15a93b14160929a1eb2f043aff6",
            "876e04df01ce4d2f88879ac23f0e1d34",
            "74e9a4d8cfa7410cb2821d4be19f07a9",
            "6210dd38027b4eea82b8e2831f098a4f",
            "cb6842b8259f44b59222be43c2ca520e",
            "e13c8725505f4f84932df6f74ceea009",
            "55b815d8ab8b4e8e801864e3e5444774",
            "aa898d3f60514e5ba1b9026ee7c00a00",
            "7cdc4975d727456a878c103affe26f7e",
            "261e1ed6aab2452285c9775b3effba04",
            "6e4eabf2e1374055b576052e7189769c",
            "0e9ba97bec784f4db2027742c314c91b",
            "49097dc5e3704cdeb205e6d3f659bbf5",
            "88c486436d7b47a391790a6c7ec9b3e4",
            "8793806bdc7f4d2ca25b515a5a91bdb8",
            "9e12ea5c9b89488cb75022479cdae817",
            "5fef4b5a4ac04d01b3e557d51cbf2e47",
            "f402e69fc7be41fd9683623eaa5c9344",
            "9b2dc29d57a44c0ebe16953a5772668b",
            "924b7fa83f274c3da3c99e616a6435bb",
            "5420782552904609b674e632388a81f2",
            "dc3382437cf741798cecf0d9cfa8e7c7",
            "ade707fe59714484b8429791c6e71dfa",
            "e6ee950655714aa48045f5c2fec38aab",
            "e0c9dfa7322c40efbb68b0b5e521bd55"
          ]
        },
        "id": "qltXxR3cgWc9",
        "outputId": "29014426-2e3f-49ad-c6ed-10bbc0b75a38"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "mkdir: cannot create directory ‘/content/data’: File exists\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading data files:   0%|          | 0/1 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "1b72366fc72d40429490ee9b352dd1e5"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Extracting data files:   0%|          | 0/1 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "6210dd38027b4eea82b8e2831f098a4f"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Generating train split: 0 examples [00:00, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "8793806bdc7f4d2ca25b515a5a91bdb8"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Asking to truncate to max_length but no maximum length is provided and the model has no predefined maximum length. Default to no truncation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: CAN\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: CAN\t\n",
            "\n",
            "BEFORE: MUST\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST\t\n",
            "\n",
            "BEFORE: MUST\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST\t\n",
            "\n",
            "BEFORE: MUST\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST\t\n",
            "\n",
            "BEFORE: MUST\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST\t\n",
            "\n",
            "BEFORE: MUST\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_NOT\t\n",
            "\n",
            "BEFORE: MUST_NOT_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "BEFORE: MUST_PARTIAL\t\n",
            "\n",
            "BEFORE: MUST_PARTIAL\t\n",
            "\n"
          ]
        }
      ],
      "source": [
        "# ### Generate before merging the model\n",
        "\n",
        "# !mkdir /content/data\n",
        "# !cp /content/drive/MyDrive/bm_finetune/data_neural_test.jsonl /content/data\n",
        "# test_dataset = load_dataset(\"json\", data_files=\"/content/data/data_neural_test.jsonl\", split= \"train\")\n",
        "\n",
        "\n",
        "# for d in test_dataset:\n",
        "#   prompt = d['text'].partition('[/INST]')[0].replace(\"<s>[INST]\", \"\")\n",
        "#   op = d['output'].partition('\"answer\"')[2].replace(\"\\\"\", \"\").replace(\":\", \"\").replace(\"}\", \"\").replace(\"{\", \"\").strip()\n",
        "#   input_ids = tokenizer(prompt, return_tensors=\"pt\", truncation=True).input_ids.cuda()\n",
        "\n",
        "#   outputs_base = base_model.generate(input_ids=input_ids, max_new_tokens=1024, do_sample=True, top_p=0.9,temperature=0.001)\n",
        "#   response_base = tokenizer.batch_decode(outputs_base.detach().cpu().numpy(), skip_special_tokens=True)[0][len(prompt):]\n",
        "#   base_resp = response_base.replace(\"[/INST]\", \"\").strip().partition('\"answer\"')[2].replace(\"\\\"\", \"\").replace(\":\", \"\").replace(\"}\", \"\").replace(\"{\", \"\").strip()\n",
        "\n",
        "#   labels_all = [\"MUST_NOT_PARTIAL\", \"MUST_NOT\", \"MUST_PARTIAL\", \"MUST\", \"CAN\"]\n",
        "\n",
        "#   # normalize output , remove explanations\n",
        "#   for label in labels_all:\n",
        "#     if label in base_resp:\n",
        "#       base_resp = label\n",
        "#       break\n",
        "\n",
        "#   with open('prediction_before', 'a+') as writefile:\n",
        "#     before = op+ \"\\t\"+ base_resp + \"\\n\"\n",
        "#     print(\"BEFORE: \" + before)\n",
        "#     writefile.write(before.encode('ascii', 'ignore').decode())"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "IRWhV5WZ3-BO",
        "outputId": "718895ad-dc24-4a97-accb-9bb8422d07f5"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/peft/tuners/lora/bnb.py:213: UserWarning: Merge lora module to 4-bit linear may get different generations due to rounding errors.\n",
            "  warnings.warn(\n"
          ]
        }
      ],
      "source": [
        "import gc\n",
        "\n",
        "# clear cache\n",
        "torch.cuda.empty_cache()\n",
        "gc.collect()\n",
        "\n",
        "merged_model= PeftModel.from_pretrained(base_model, \"/content/results/checkpoint-175\")\n",
        "merged_model= merged_model.merge_and_unload()\n",
        "\n",
        "# Save the merged model\n",
        "#merged_model.save_pretrained(\"/content/merged_model\",safe_serialization=True)\n",
        "#tokenizer.save_pretrained(\"/content/merged_model\"),\n",
        "#tokenizer.pad_token = tokenizer.eos_token\n",
        "#tokenizer.padding_side = \"right\""
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Ighft1CWCEDu"
      },
      "outputs": [],
      "source": [
        "#merged_model= PeftModel.from_pretrained(base_model, new_model)\n",
        "#merged_model= merged_model.merge_and_unload()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "oz0lJd4SaE2G"
      },
      "outputs": [],
      "source": [
        "#!zip -r fine_tune_model.zip /content/merged_model"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# COPY trained model and UNZIP\n",
        "!cp /content/drive/MyDrive/bm_finetune/fine_tune_model_adapter.zip /content/\n",
        "!unzip /content/fine_tune_model_adapter.zip"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "lhkBRfzCj527",
        "outputId": "a89398f0-93c9-4eb1-f357-02c3528f5c2e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Archive:  /content/fine_tune_model_adapter.zip\n",
            "   creating: content/results/checkpoint-200/\n",
            "  inflating: content/results/checkpoint-200/adapter_model.safetensors  \n",
            "  inflating: content/results/checkpoint-200/tokenizer_config.json  \n",
            "  inflating: content/results/checkpoint-200/special_tokens_map.json  \n",
            "  inflating: content/results/checkpoint-200/rng_state.pth  \n",
            "  inflating: content/results/checkpoint-200/adapter_config.json  \n",
            "  inflating: content/results/checkpoint-200/trainer_state.json  \n",
            "  inflating: content/results/checkpoint-200/optimizer.pt  \n",
            "  inflating: content/results/checkpoint-200/tokenizer.json  \n",
            "  inflating: content/results/checkpoint-200/training_args.bin  \n",
            "  inflating: content/results/checkpoint-200/adapter_model.bin  \n",
            "  inflating: content/results/checkpoint-200/scheduler.pt  \n",
            "  inflating: content/results/checkpoint-200/README.md  \n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Run inference on merged model and store it as prediction_after"
      ],
      "metadata": {
        "id": "5nDD9bXbM8gd"
      }
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "RsEKx8jX7riR",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000,
          "referenced_widgets": [
            "933c9765181f497ab57efa26054c2350",
            "aa74a725dd9f406a9626040cb121ebd3",
            "46a12f491def4c2bab92bd1e9a0393fa",
            "63a6dc4dec1c413890004143848b126c",
            "067bf3f5e4f7483f8ece9b0e54533616",
            "13b37978acdd42abb8c9a782d709150a",
            "f32bbd3fbf6a4546bec91c32f288e5c8",
            "7467bbefb4744c5b97c162656d5ccd60",
            "ad439ff307fa4dde88eb4596b537f51b",
            "5331b157fbe44f63bca2e6f46c570845",
            "30420cc5939b4cf2a2b73a80335c0de7",
            "2ea54c46fe37462fa9776c77ba8a9623",
            "8096a3cd62cd4813bfbb80a12a84075a",
            "0728e52cc2074ae8ba269d065e180708",
            "bd8bdad9fa2444778b8c079297c50bcb",
            "a563b31fd0564d70a492ff4b689719c3",
            "200c45b8c044489f809a8d59998e3be2",
            "0f614a14d96b42d3bcefdf8c4e0982b5",
            "f4c5246480c94904a56796f908d53578",
            "f2ef0864efc645afaace884b651511c6",
            "ef7f6785077c4ea68a30a03125dd17b4",
            "8995a1783385465cb2d9ca10a650f94c",
            "60a1bd34744d47e7be591d5c31b683d4",
            "838c778deb034f87bd74d9051e547f32",
            "081fbb78f9024daa81bedce15526a25b",
            "fc8bb678b3e443e08cc95e2c69294742",
            "c27679b8b271476cbdfe8de8ac63c676",
            "606dfdcd00f44eb39f47c78aef954b5c",
            "388e12e16422455da54385910a18620c",
            "472c934a41e14e36b1fd3a79e48c4eac",
            "c30cdb9650984114b185b2a6188d25b3",
            "7472f2a6b5bc4000af7d3a7f49417591",
            "26d42787622c40559d75783400f4b93d"
          ]
        },
        "outputId": "f70ab308-1a2c-4224-ea49-c5e72d5c8147"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "mkdir: cannot create directory ‘/content/data’: File exists\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Downloading data files:   0%|          | 0/1 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "933c9765181f497ab57efa26054c2350"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Extracting data files:   0%|          | 0/1 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "2ea54c46fe37462fa9776c77ba8a9623"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Generating train split: 0 examples [00:00, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "60a1bd34744d47e7be591d5c31b683d4"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n",
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\t{\n",
            "  \"answer\": \"NEUTRAL\"\n",
            "}\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: CAN\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_NOT_PARTIAL\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_PARTIAL\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST_NOT\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\t{\n",
            "  \"answer\": \"NEUTRAL\"\n",
            "}\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The attention mask and the pad token id were not set. As a consequence, you may observe unexpected behavior. Please pass your input's `attention_mask` to obtain reliable results.\n",
            "Setting `pad_token_id` to `eos_token_id`:2 for open-end generation.\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "AFTER: MUST_PARTIAL\tCAN\n",
            "\n",
            "AFTER: MUST_PARTIAL\tMUST\n",
            "\n"
          ]
        }
      ],
      "source": [
        "!mkdir /content/data\n",
        "!cp /content/drive/MyDrive/bm_finetune/data_neural_test.jsonl /content/data\n",
        "test_dataset = load_dataset(\"json\", data_files=\"/content/data/data_neural_test.jsonl\", split= \"train\")\n",
        "\n",
        "with open('prediction_after', 'a+') as wfile:\n",
        "    title = \"groundtruth\"+ \"\\t\"+ \"prediction\"+  \"\\n\" #+ \" \"\\t\" +prompt\"\n",
        "    wfile.write(title)\n",
        "\n",
        "for d in test_dataset:\n",
        "  prompt = \"\"\n",
        "  if 'neural' in model_name:\n",
        "    prompt = d['text'].partition('### Assistant:')[0].replace(\"<s>[INST]\", \"\") + '### Assistant:'\n",
        "  if 'mistral' in model_name:\n",
        "    prompt = d['text'].partition('[/INST]')[0] + \"[/INST]</s>\"\n",
        "\n",
        "  op = d['output'].partition('\"answer\"')[2].replace(\"\\\"\", \"\").replace(\":\", \"\").replace(\"}\", \"\").replace(\"{\", \"\").strip()\n",
        "  inp = d['input'].strip().replace(\"\\t\", \" \")\n",
        "  input_ids = tokenizer(prompt, return_tensors=\"pt\", truncation=True).input_ids.cuda()\n",
        "\n",
        "  outputs = merged_model.generate(input_ids=input_ids, max_new_tokens=1024, do_sample=True, top_p=0.9,temperature=0.001)\n",
        "  response = tokenizer.batch_decode(outputs.detach().cpu().numpy(), skip_special_tokens=True)[0][len(prompt):]\n",
        "  #resp = response.replace(\"[/INST]\", \"\").strip().partition('\"answer\"')[2].replace(\"\\\"\", \"\").replace(\":\", \"\").replace(\"}\", \"\").replace(\"{\", \"\").strip()\n",
        "  resp = response.replace(\"[/INST]\", \"\").strip()\n",
        "\n",
        "  labels_all = [\"MUST_NOT_PARTIAL\", \"MUST_NOT\", \"MUST_PARTIAL\", \"MUST\", \"CAN\"]\n",
        "\n",
        "  # normalize output , remove explanations\n",
        "  for label in labels_all:\n",
        "    if label in resp:\n",
        "      resp = label\n",
        "      break\n",
        "\n",
        "  with open('prediction_after', 'a+') as wfile:\n",
        "    after = op+ \"\\t\"+ resp +  \"\\n\" # + \"\\t\"+ inp\n",
        "    print(\"AFTER: \" + after)\n",
        "    wfile.write(after.encode('ascii', 'ignore').decode())"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "woFAOkLfgkBk"
      },
      "outputs": [],
      "source": [
        "!cp /content/prediction_after drive/MyDrive/bm_finetune/\n",
        "!cp /content/prediction_before drive/MyDrive/bm_finetune/"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "jbAkHdKNfvFO",
        "outputId": "9334347f-926b-4d21-89b4-35e4473a9a39"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "  adding: content/results/checkpoint-175/ (stored 0%)\n",
            "  adding: content/results/checkpoint-175/adapter_model.safetensors (deflated 7%)\n",
            "  adding: content/results/checkpoint-175/tokenizer_config.json (deflated 69%)\n",
            "  adding: content/results/checkpoint-175/special_tokens_map.json (deflated 70%)\n",
            "  adding: content/results/checkpoint-175/rng_state.pth (deflated 25%)\n",
            "  adding: content/results/checkpoint-175/adapter_config.json (deflated 49%)\n",
            "  adding: content/results/checkpoint-175/trainer_state.json (deflated 69%)\n",
            "  adding: content/results/checkpoint-175/optimizer.pt (deflated 17%)\n",
            "  adding: content/results/checkpoint-175/tokenizer.json (deflated 74%)\n",
            "  adding: content/results/checkpoint-175/training_args.bin (deflated 50%)\n",
            "  adding: content/results/checkpoint-175/adapter_model.bin (deflated 7%)\n",
            "  adding: content/results/checkpoint-175/scheduler.pt (deflated 58%)\n",
            "  adding: content/results/checkpoint-175/README.md (deflated 67%)\n"
          ]
        }
      ],
      "source": [
        "!zip -r fine_tune_model_adapter.zip /content/results/checkpoint-175\n",
        "!cp /content/fine_tune_model_adapter.zip drive/MyDrive/bm_finetune/"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "from sklearn.metrics import confusion_matrix,ConfusionMatrixDisplay,classification_report\n",
        "from sklearn.preprocessing import LabelEncoder as le\n",
        "\n",
        "labels = [\"CAN\",\"MUST\",\"MUST_PARTIAL\",\"MUST_NOT\",\"MUST_NOT_PARTIAL\"]\n",
        "\n",
        "df = pd.read_csv(\"/content/prediction_before\", sep=\"\\t\")\n",
        "\n",
        "pred = df.loc[:,\"prediction\"].values.tolist()\n",
        "gt = df.loc[:,\"groundtruth\"].values.tolist()\n",
        "\n",
        "cm = confusion_matrix(gt, pred,labels = labels)\n",
        "\n",
        "\n",
        "ConfusionMatrixDisplay(cm).plot()\n",
        "\n",
        "print(classification_report(gt, pred, labels=labels))\n",
        "\n",
        "\n"
      ],
      "metadata": {
        "id": "LnWMXVWf_WCK",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 807
        },
        "outputId": "7a044c9e-4d7b-4448-edb6-f6a55838c71b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Precision and F-score are ill-defined and being set to 0.0 in labels with no predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Precision and F-score are ill-defined and being set to 0.0 in labels with no predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n",
            "/usr/local/lib/python3.10/dist-packages/sklearn/metrics/_classification.py:1344: UndefinedMetricWarning: Precision and F-score are ill-defined and being set to 0.0 in labels with no predicted samples. Use `zero_division` parameter to control this behavior.\n",
            "  _warn_prf(average, modifier, msg_start, len(result))\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "                  precision    recall  f1-score   support\n",
            "\n",
            "             CAN       0.17      0.67      0.27        21\n",
            "            MUST       0.11      0.30      0.16        10\n",
            "    MUST_PARTIAL       0.00      0.00      0.00        73\n",
            "        MUST_NOT       0.91      0.68      0.78        59\n",
            "MUST_NOT_PARTIAL       0.00      0.00      0.00         1\n",
            "\n",
            "       micro avg       0.35      0.35      0.35       164\n",
            "       macro avg       0.24      0.33      0.24       164\n",
            "    weighted avg       0.36      0.35      0.32       164\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 640x480 with 2 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "J_hU2be-5aom"
      },
      "source": [
        "## Test the merged model\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "29FRu3Md5aom"
      },
      "source": [
        "And that's it! You've successfully fine-tuned Mistral 7B Instruct for code generation. You can adapt this process for various natural language understanding and generation tasks. Keep exploring and experimenting with Mistral 7B to unlock its full potential for your projects.\n",
        "\n",
        "All the code will be available on my Github. Do drop by and give a follow and a star.\n",
        "\n",
        "[adithya-s-k - Overview](https://github.com/adithya-s-k)\n",
        "\n",
        "I also post content about LLMs and what I have been working on Twitter.\n",
        "\n",
        "[AdithyaSK (@adithya_s_k) / X](https://twitter.com/adithya_s_k)\n"
      ]
    }
  ],
  "metadata": {
    "accelerator": "TPU",
    "colab": {
      "provenance": [],
      "include_colab_link": true
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python",
      "version": "3.11.0"
    },
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "1b72366fc72d40429490ee9b352dd1e5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_8dfb4a6b8d2f4f3e8773f22cc5971c43",
              "IPY_MODEL_e738664ac3c44ca3b580913fe2e28332",
              "IPY_MODEL_0b7be129c8e04e948521937c3d08a8b6"
            ],
            "layout": "IPY_MODEL_b0268002b9994d2eb492dbb247854ef5"
          }
        },
        "8dfb4a6b8d2f4f3e8773f22cc5971c43": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_a4a93ac3fbde43ab8cdd7eff36ed48cf",
            "placeholder": "​",
            "style": "IPY_MODEL_2a539222a3494dd5a89f94571a9d7f09",
            "value": "Downloading data files: 100%"
          }
        },
        "e738664ac3c44ca3b580913fe2e28332": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0cb9e9d7a29d42acb2c1b11b4a224d68",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_11f2a15a93b14160929a1eb2f043aff6",
            "value": 1
          }
        },
        "0b7be129c8e04e948521937c3d08a8b6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_876e04df01ce4d2f88879ac23f0e1d34",
            "placeholder": "​",
            "style": "IPY_MODEL_74e9a4d8cfa7410cb2821d4be19f07a9",
            "value": " 1/1 [00:00&lt;00:00, 84.11it/s]"
          }
        },
        "b0268002b9994d2eb492dbb247854ef5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a4a93ac3fbde43ab8cdd7eff36ed48cf": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2a539222a3494dd5a89f94571a9d7f09": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0cb9e9d7a29d42acb2c1b11b4a224d68": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "11f2a15a93b14160929a1eb2f043aff6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "876e04df01ce4d2f88879ac23f0e1d34": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "74e9a4d8cfa7410cb2821d4be19f07a9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "6210dd38027b4eea82b8e2831f098a4f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_cb6842b8259f44b59222be43c2ca520e",
              "IPY_MODEL_e13c8725505f4f84932df6f74ceea009",
              "IPY_MODEL_55b815d8ab8b4e8e801864e3e5444774"
            ],
            "layout": "IPY_MODEL_aa898d3f60514e5ba1b9026ee7c00a00"
          }
        },
        "cb6842b8259f44b59222be43c2ca520e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7cdc4975d727456a878c103affe26f7e",
            "placeholder": "​",
            "style": "IPY_MODEL_261e1ed6aab2452285c9775b3effba04",
            "value": "Extracting data files: 100%"
          }
        },
        "e13c8725505f4f84932df6f74ceea009": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_6e4eabf2e1374055b576052e7189769c",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_0e9ba97bec784f4db2027742c314c91b",
            "value": 1
          }
        },
        "55b815d8ab8b4e8e801864e3e5444774": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_49097dc5e3704cdeb205e6d3f659bbf5",
            "placeholder": "​",
            "style": "IPY_MODEL_88c486436d7b47a391790a6c7ec9b3e4",
            "value": " 1/1 [00:00&lt;00:00, 52.50it/s]"
          }
        },
        "aa898d3f60514e5ba1b9026ee7c00a00": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7cdc4975d727456a878c103affe26f7e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "261e1ed6aab2452285c9775b3effba04": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "6e4eabf2e1374055b576052e7189769c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0e9ba97bec784f4db2027742c314c91b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "49097dc5e3704cdeb205e6d3f659bbf5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "88c486436d7b47a391790a6c7ec9b3e4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "8793806bdc7f4d2ca25b515a5a91bdb8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_9e12ea5c9b89488cb75022479cdae817",
              "IPY_MODEL_5fef4b5a4ac04d01b3e557d51cbf2e47",
              "IPY_MODEL_f402e69fc7be41fd9683623eaa5c9344"
            ],
            "layout": "IPY_MODEL_9b2dc29d57a44c0ebe16953a5772668b"
          }
        },
        "9e12ea5c9b89488cb75022479cdae817": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_924b7fa83f274c3da3c99e616a6435bb",
            "placeholder": "​",
            "style": "IPY_MODEL_5420782552904609b674e632388a81f2",
            "value": "Generating train split: "
          }
        },
        "5fef4b5a4ac04d01b3e557d51cbf2e47": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_dc3382437cf741798cecf0d9cfa8e7c7",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_ade707fe59714484b8429791c6e71dfa",
            "value": 1
          }
        },
        "f402e69fc7be41fd9683623eaa5c9344": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e6ee950655714aa48045f5c2fec38aab",
            "placeholder": "​",
            "style": "IPY_MODEL_e0c9dfa7322c40efbb68b0b5e521bd55",
            "value": " 164/0 [00:00&lt;00:00, 8025.22 examples/s]"
          }
        },
        "9b2dc29d57a44c0ebe16953a5772668b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "924b7fa83f274c3da3c99e616a6435bb": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5420782552904609b674e632388a81f2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "dc3382437cf741798cecf0d9cfa8e7c7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "ade707fe59714484b8429791c6e71dfa": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "e6ee950655714aa48045f5c2fec38aab": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e0c9dfa7322c40efbb68b0b5e521bd55": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "8fa943c95bc74a06af42e7734aa8f559": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_de23f9411f444ac38459a2aa6b11ee80",
              "IPY_MODEL_24e668b07f234ed384d36210d672755f",
              "IPY_MODEL_d89f3f8b9f664c97bfaf1da535578a63"
            ],
            "layout": "IPY_MODEL_f4090a57f4d24189b8869a7137a91c72"
          }
        },
        "de23f9411f444ac38459a2aa6b11ee80": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_4b1300419470471fb3c4b5d124f48952",
            "placeholder": "​",
            "style": "IPY_MODEL_c6266c0d21d748328d6fe2034808a027",
            "value": "Downloading data files: 100%"
          }
        },
        "24e668b07f234ed384d36210d672755f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_95c6d852e4f84021bee40890976e2661",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_84b798b9778d4f22af64c7d4f34afc62",
            "value": 1
          }
        },
        "d89f3f8b9f664c97bfaf1da535578a63": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_2df473cdaae8489f9fe3feb94d5e7d5b",
            "placeholder": "​",
            "style": "IPY_MODEL_b5a5b8a4c94d4f768d12bd30f50dabf4",
            "value": " 1/1 [00:00&lt;00:00, 74.05it/s]"
          }
        },
        "f4090a57f4d24189b8869a7137a91c72": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4b1300419470471fb3c4b5d124f48952": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c6266c0d21d748328d6fe2034808a027": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "95c6d852e4f84021bee40890976e2661": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "84b798b9778d4f22af64c7d4f34afc62": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "2df473cdaae8489f9fe3feb94d5e7d5b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b5a5b8a4c94d4f768d12bd30f50dabf4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "1a5c729aaf4444aa89c0364a2184070b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_19cc823392a341ff85f360f61f9e7949",
              "IPY_MODEL_5dadccaae49144248129d6e26fc3aabe",
              "IPY_MODEL_84670b0536354265a3db98329c997db3"
            ],
            "layout": "IPY_MODEL_6b3c4c4ef4b5423ebfd5f4dfe45b1329"
          }
        },
        "19cc823392a341ff85f360f61f9e7949": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d9717187cb2a4bcc97bdd75c8679d347",
            "placeholder": "​",
            "style": "IPY_MODEL_3b43f3ea893f47879dd33c2e18e27fa1",
            "value": "Extracting data files: 100%"
          }
        },
        "5dadccaae49144248129d6e26fc3aabe": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_16640ea12c1d49ab992dd899dd474ae7",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_8701c3ace8a74c0dbf918f296c768442",
            "value": 1
          }
        },
        "84670b0536354265a3db98329c997db3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f68dd2b4f6b14b22b5dbaeab6b0294ba",
            "placeholder": "​",
            "style": "IPY_MODEL_3ce6d5a376694cd29e129dff73446ef4",
            "value": " 1/1 [00:00&lt;00:00, 53.63it/s]"
          }
        },
        "6b3c4c4ef4b5423ebfd5f4dfe45b1329": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d9717187cb2a4bcc97bdd75c8679d347": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3b43f3ea893f47879dd33c2e18e27fa1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "16640ea12c1d49ab992dd899dd474ae7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8701c3ace8a74c0dbf918f296c768442": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "f68dd2b4f6b14b22b5dbaeab6b0294ba": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3ce6d5a376694cd29e129dff73446ef4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e89bf173756c418792c39233edbd5e78": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_1bae0da705a7454887f9534b3526e086",
              "IPY_MODEL_1dedd1aa882e460cba71b9622d000d25",
              "IPY_MODEL_c63018c0409146cc818df5d691b7859e"
            ],
            "layout": "IPY_MODEL_d5c96f4e5ece4557b7d2c208cb2b3d08"
          }
        },
        "1bae0da705a7454887f9534b3526e086": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5e65177d60b648ccadc305a2da72beee",
            "placeholder": "​",
            "style": "IPY_MODEL_00112f25d5fe4ca684eba34e237e4899",
            "value": "Generating train split: "
          }
        },
        "1dedd1aa882e460cba71b9622d000d25": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_56c4e0fa6b7a434bbb78ac5f46fcaba1",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_b816f484672f4f52b2992a9ce32973a1",
            "value": 1
          }
        },
        "c63018c0409146cc818df5d691b7859e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_1cb935f5100c4fe59ca1b89123398e6b",
            "placeholder": "​",
            "style": "IPY_MODEL_a823ba6d27c9463e973d9556ccda9217",
            "value": " 1294/0 [00:00&lt;00:00, 39796.08 examples/s]"
          }
        },
        "d5c96f4e5ece4557b7d2c208cb2b3d08": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5e65177d60b648ccadc305a2da72beee": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "00112f25d5fe4ca684eba34e237e4899": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "56c4e0fa6b7a434bbb78ac5f46fcaba1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "b816f484672f4f52b2992a9ce32973a1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "1cb935f5100c4fe59ca1b89123398e6b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a823ba6d27c9463e973d9556ccda9217": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "24dfd9117dbc4c62beece2fffe5543f4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_75c5f13022924696b021ba10da5f4432",
              "IPY_MODEL_cb78453859e6483f98678904c56f3bd2",
              "IPY_MODEL_bfe246667bd049f28bc21d29862cc412"
            ],
            "layout": "IPY_MODEL_f15598d4aac843d4aaafacb00a906c21"
          }
        },
        "75c5f13022924696b021ba10da5f4432": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_538d6ec978fb42cc9828d7d32ee6fdff",
            "placeholder": "​",
            "style": "IPY_MODEL_2a604d165c9647fba2848f3146396cd3",
            "value": "Loading checkpoint shards: 100%"
          }
        },
        "cb78453859e6483f98678904c56f3bd2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_95ebeae483f74df6a9f7c748cc86b412",
            "max": 2,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_faf24c405f3541be89bfc9e3c5f88471",
            "value": 2
          }
        },
        "bfe246667bd049f28bc21d29862cc412": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_c24693169d7e4f81a0da3e6cc2731ac6",
            "placeholder": "​",
            "style": "IPY_MODEL_1962e1a6b6ca4ccfa05d693d2f7e50b6",
            "value": " 2/2 [01:05&lt;00:00, 31.05s/it]"
          }
        },
        "f15598d4aac843d4aaafacb00a906c21": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "538d6ec978fb42cc9828d7d32ee6fdff": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2a604d165c9647fba2848f3146396cd3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "95ebeae483f74df6a9f7c748cc86b412": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "faf24c405f3541be89bfc9e3c5f88471": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "c24693169d7e4f81a0da3e6cc2731ac6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1962e1a6b6ca4ccfa05d693d2f7e50b6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0b82d9debba2405f92f9dfd7c393c878": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_64923bb4877244e7916350d6a8837a48",
              "IPY_MODEL_6faad55b665f46598b3c70d7ba782d91",
              "IPY_MODEL_105eca41ac7341eb937e0d62cf2d43a6"
            ],
            "layout": "IPY_MODEL_39d14f7c4ecf4b5189e43b31bde6be75"
          }
        },
        "64923bb4877244e7916350d6a8837a48": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7b93bb542a2841deacda061b5b31bf4a",
            "placeholder": "​",
            "style": "IPY_MODEL_9ef16ace588c40e1b9cdbb4ce3dc8dfd",
            "value": "Map: 100%"
          }
        },
        "6faad55b665f46598b3c70d7ba782d91": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b2b2cf5cf7f84a598af0f24ed7d6f7cd",
            "max": 1141,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_4dd061bb47ed464e9b0878400f5f78ee",
            "value": 1141
          }
        },
        "105eca41ac7341eb937e0d62cf2d43a6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ecb2113d89dc4572a547dceb44edf64d",
            "placeholder": "​",
            "style": "IPY_MODEL_d806811526024673a54eea15b579ef2c",
            "value": " 1141/1141 [00:00&lt;00:00, 2812.95 examples/s]"
          }
        },
        "39d14f7c4ecf4b5189e43b31bde6be75": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7b93bb542a2841deacda061b5b31bf4a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "9ef16ace588c40e1b9cdbb4ce3dc8dfd": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b2b2cf5cf7f84a598af0f24ed7d6f7cd": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4dd061bb47ed464e9b0878400f5f78ee": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "ecb2113d89dc4572a547dceb44edf64d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d806811526024673a54eea15b579ef2c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "f3612648d5fe4622b1eaa8880c5fd2df": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_dfda9ecf2f1242f2afef73131c24cd61",
              "IPY_MODEL_287763afcac240809c4f831e5dff37b6",
              "IPY_MODEL_54296503748e4780b1eab56867f0b890"
            ],
            "layout": "IPY_MODEL_d84f56e83301496691cead706497c569"
          }
        },
        "dfda9ecf2f1242f2afef73131c24cd61": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b58b6c4ae28949efbad81cf8da31714d",
            "placeholder": "​",
            "style": "IPY_MODEL_e82a5984a5b247c9a0d9035793bb9bae",
            "value": "Loading checkpoint shards: 100%"
          }
        },
        "287763afcac240809c4f831e5dff37b6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0bdf60515a674b0ca82ab75748fde3da",
            "max": 2,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_1786b4354c614fbbabb73259e72e49fb",
            "value": 2
          }
        },
        "54296503748e4780b1eab56867f0b890": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0a28d70916c94190967ce453531b45b0",
            "placeholder": "​",
            "style": "IPY_MODEL_8598d3a1e09541ba8f4083d754ff4090",
            "value": " 2/2 [00:18&lt;00:00,  8.25s/it]"
          }
        },
        "d84f56e83301496691cead706497c569": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b58b6c4ae28949efbad81cf8da31714d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e82a5984a5b247c9a0d9035793bb9bae": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0bdf60515a674b0ca82ab75748fde3da": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1786b4354c614fbbabb73259e72e49fb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "0a28d70916c94190967ce453531b45b0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8598d3a1e09541ba8f4083d754ff4090": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "7afa9fe916334ebea7a8f50849d53dc4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_e921e74952604e448deab364cac90c1a",
              "IPY_MODEL_2acf03258fe24327995f081c67cb2a66",
              "IPY_MODEL_32e0328b5e044a34a78f2136221ba21f"
            ],
            "layout": "IPY_MODEL_1d77685f1d0d420ca502922c7726352c"
          }
        },
        "e921e74952604e448deab364cac90c1a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7ac69310fb9c4e12b69fd630d660ed80",
            "placeholder": "​",
            "style": "IPY_MODEL_8b8617e1398243b7b8ae5bf5952a311b",
            "value": "Downloading data files: 100%"
          }
        },
        "2acf03258fe24327995f081c67cb2a66": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_6cd8b94a9efc4e229d2dd4f0c71296d5",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_35a393c94a8e4317a96534eec563a899",
            "value": 1
          }
        },
        "32e0328b5e044a34a78f2136221ba21f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_2ad2d245d89b416facb2c0c03fdf7c86",
            "placeholder": "​",
            "style": "IPY_MODEL_1a76871d03fa41c1a2a99f2dbaa3a705",
            "value": " 1/1 [00:00&lt;00:00, 77.75it/s]"
          }
        },
        "1d77685f1d0d420ca502922c7726352c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7ac69310fb9c4e12b69fd630d660ed80": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8b8617e1398243b7b8ae5bf5952a311b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "6cd8b94a9efc4e229d2dd4f0c71296d5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "35a393c94a8e4317a96534eec563a899": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "2ad2d245d89b416facb2c0c03fdf7c86": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1a76871d03fa41c1a2a99f2dbaa3a705": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "9dc2a5bd3d4c41f9a1e54412cb1df956": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_eb1dcb40d8b04c70a37f7ccac701cfc3",
              "IPY_MODEL_af0cca4eccae4d5a8f44bb2397d694bf",
              "IPY_MODEL_5435f75a26374dea86d7f6a086cc5bc7"
            ],
            "layout": "IPY_MODEL_ed6b28bcfac3430bac1519836c49b073"
          }
        },
        "eb1dcb40d8b04c70a37f7ccac701cfc3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_eaee302858db467eb0065b78da7044ce",
            "placeholder": "​",
            "style": "IPY_MODEL_a034d0d210a749d1bcea82a9e2809e33",
            "value": "Extracting data files: 100%"
          }
        },
        "af0cca4eccae4d5a8f44bb2397d694bf": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3c4437297c7a443bbbc7b67ef3e00e7f",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_a73ca4b823d54aa7b7f878ff3270fe17",
            "value": 1
          }
        },
        "5435f75a26374dea86d7f6a086cc5bc7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5f35feacba75422eadaef0362fdd3bed",
            "placeholder": "​",
            "style": "IPY_MODEL_3fbaf65ff1774251b8db426618a2896e",
            "value": " 1/1 [00:00&lt;00:00, 53.93it/s]"
          }
        },
        "ed6b28bcfac3430bac1519836c49b073": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "eaee302858db467eb0065b78da7044ce": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a034d0d210a749d1bcea82a9e2809e33": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3c4437297c7a443bbbc7b67ef3e00e7f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a73ca4b823d54aa7b7f878ff3270fe17": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "5f35feacba75422eadaef0362fdd3bed": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3fbaf65ff1774251b8db426618a2896e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0498207ee5144934a8a92b76571597d2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_26884d74035848c68d2f98c93174d289",
              "IPY_MODEL_5d889e12c326407b9b64ebcdf7a0eee5",
              "IPY_MODEL_c45081fc21894383a502a32622dc92a1"
            ],
            "layout": "IPY_MODEL_d09ae039c89e48a283a5ef80e8cb3784"
          }
        },
        "26884d74035848c68d2f98c93174d289": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_08c52d0d1223470098ebb86a763a3521",
            "placeholder": "​",
            "style": "IPY_MODEL_f362f1bb5b7c461e994776d52394625c",
            "value": "Generating train split: "
          }
        },
        "5d889e12c326407b9b64ebcdf7a0eee5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e0585079adee46b89964ebc21bb0a102",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_573e01d37c9d41bb861ebf0aec7df7bb",
            "value": 1
          }
        },
        "c45081fc21894383a502a32622dc92a1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8f8a8632835841789f84a112c1c68da0",
            "placeholder": "​",
            "style": "IPY_MODEL_465ba00e1321448c9dc857f0a8d54e89",
            "value": " 164/0 [00:00&lt;00:00, 6424.75 examples/s]"
          }
        },
        "d09ae039c89e48a283a5ef80e8cb3784": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "08c52d0d1223470098ebb86a763a3521": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f362f1bb5b7c461e994776d52394625c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e0585079adee46b89964ebc21bb0a102": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "573e01d37c9d41bb861ebf0aec7df7bb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "8f8a8632835841789f84a112c1c68da0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "465ba00e1321448c9dc857f0a8d54e89": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "933c9765181f497ab57efa26054c2350": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_aa74a725dd9f406a9626040cb121ebd3",
              "IPY_MODEL_46a12f491def4c2bab92bd1e9a0393fa",
              "IPY_MODEL_63a6dc4dec1c413890004143848b126c"
            ],
            "layout": "IPY_MODEL_067bf3f5e4f7483f8ece9b0e54533616"
          }
        },
        "aa74a725dd9f406a9626040cb121ebd3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_13b37978acdd42abb8c9a782d709150a",
            "placeholder": "​",
            "style": "IPY_MODEL_f32bbd3fbf6a4546bec91c32f288e5c8",
            "value": "Downloading data files: 100%"
          }
        },
        "46a12f491def4c2bab92bd1e9a0393fa": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7467bbefb4744c5b97c162656d5ccd60",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_ad439ff307fa4dde88eb4596b537f51b",
            "value": 1
          }
        },
        "63a6dc4dec1c413890004143848b126c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5331b157fbe44f63bca2e6f46c570845",
            "placeholder": "​",
            "style": "IPY_MODEL_30420cc5939b4cf2a2b73a80335c0de7",
            "value": " 1/1 [00:00&lt;00:00, 76.10it/s]"
          }
        },
        "067bf3f5e4f7483f8ece9b0e54533616": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "13b37978acdd42abb8c9a782d709150a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f32bbd3fbf6a4546bec91c32f288e5c8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "7467bbefb4744c5b97c162656d5ccd60": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ad439ff307fa4dde88eb4596b537f51b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "5331b157fbe44f63bca2e6f46c570845": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "30420cc5939b4cf2a2b73a80335c0de7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2ea54c46fe37462fa9776c77ba8a9623": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_8096a3cd62cd4813bfbb80a12a84075a",
              "IPY_MODEL_0728e52cc2074ae8ba269d065e180708",
              "IPY_MODEL_bd8bdad9fa2444778b8c079297c50bcb"
            ],
            "layout": "IPY_MODEL_a563b31fd0564d70a492ff4b689719c3"
          }
        },
        "8096a3cd62cd4813bfbb80a12a84075a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_200c45b8c044489f809a8d59998e3be2",
            "placeholder": "​",
            "style": "IPY_MODEL_0f614a14d96b42d3bcefdf8c4e0982b5",
            "value": "Extracting data files: 100%"
          }
        },
        "0728e52cc2074ae8ba269d065e180708": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f4c5246480c94904a56796f908d53578",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_f2ef0864efc645afaace884b651511c6",
            "value": 1
          }
        },
        "bd8bdad9fa2444778b8c079297c50bcb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ef7f6785077c4ea68a30a03125dd17b4",
            "placeholder": "​",
            "style": "IPY_MODEL_8995a1783385465cb2d9ca10a650f94c",
            "value": " 1/1 [00:00&lt;00:00, 49.82it/s]"
          }
        },
        "a563b31fd0564d70a492ff4b689719c3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "200c45b8c044489f809a8d59998e3be2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0f614a14d96b42d3bcefdf8c4e0982b5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "f4c5246480c94904a56796f908d53578": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f2ef0864efc645afaace884b651511c6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "ef7f6785077c4ea68a30a03125dd17b4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8995a1783385465cb2d9ca10a650f94c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "60a1bd34744d47e7be591d5c31b683d4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_838c778deb034f87bd74d9051e547f32",
              "IPY_MODEL_081fbb78f9024daa81bedce15526a25b",
              "IPY_MODEL_fc8bb678b3e443e08cc95e2c69294742"
            ],
            "layout": "IPY_MODEL_c27679b8b271476cbdfe8de8ac63c676"
          }
        },
        "838c778deb034f87bd74d9051e547f32": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_606dfdcd00f44eb39f47c78aef954b5c",
            "placeholder": "​",
            "style": "IPY_MODEL_388e12e16422455da54385910a18620c",
            "value": "Generating train split: "
          }
        },
        "081fbb78f9024daa81bedce15526a25b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_472c934a41e14e36b1fd3a79e48c4eac",
            "max": 1,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_c30cdb9650984114b185b2a6188d25b3",
            "value": 1
          }
        },
        "fc8bb678b3e443e08cc95e2c69294742": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7472f2a6b5bc4000af7d3a7f49417591",
            "placeholder": "​",
            "style": "IPY_MODEL_26d42787622c40559d75783400f4b93d",
            "value": " 164/0 [00:00&lt;00:00, 6604.13 examples/s]"
          }
        },
        "c27679b8b271476cbdfe8de8ac63c676": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "606dfdcd00f44eb39f47c78aef954b5c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "388e12e16422455da54385910a18620c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "472c934a41e14e36b1fd3a79e48c4eac": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "20px"
          }
        },
        "c30cdb9650984114b185b2a6188d25b3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "7472f2a6b5bc4000af7d3a7f49417591": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "26d42787622c40559d75783400f4b93d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        }
      }
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}